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The purpose of the present study was to further examine the relationship between 
adolescent psychiatric pathology and SMI by assessing the relationship between prior 
mental health services before the age of 18 and time of assessment on people’s insight 
into their illnesses.  A secondary relationship between adolescent psychiatric pathology 
and functioning in a variety of domains before, during, and after treatment was assessed.  
Overall, there was an inconsistent pattern of results and partial support of hypotheses.   
The current study was a retrospective longitudinal study in which assessments were given 
to 308 participants in an inpatient psychiatric rehabilitation unit every 6 months.  Results 
indicated that those with service use during adolescence were younger at admission to 
CTP, have slightly lower levels of education, had an earlier age of onset, and 
significantly more previous hospitalizations.  A relationship between Axis I and II 
diagnoses and service use was also identified.  Improvements in neurocognitive, 
sociocognitive, insight, and behavioral functioning measures are evident over the course 
of treatment, however are not consistent for all groups and all measures used within this 
 study. Contrary to the hypothesis, those adults with service usage in adolescence did not 
endorse differing overall insight or ability to relabel symptoms scores over the course of 
treatment. However, as hypothesized, there were no differences between those with and 
without service usage in adolescence on any measure of insight after one year of 
psychiatric rehabilitation. In general, the CTP participants endorsed lower insight into 
need for treatment scores across treatment.  Also, analyses revealed no significant 
relationship between whether or not someone used services in adolescence or APP 
severity level and rate of rehospitalization or discharge location restrictiveness. 
In summary, this study was exploratory in nature and inconsistent results and mixed 
support of hypotheses was found. This field of research has numerous implications for 
increasing insight and bettering outcomes for persons with SMI. 
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DEDICATION 
 
For my family, then and now. 
All it took was a bushel and a peck. 
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CHAPTER 1 – INTRODUCTION AND LITERATURE REVIEW 
Exploratory Analyses of a Developmental Conceptualization of Insight and Treatment 
outcomes of Individuals with Serious Mental Illness in Psychiatric Rehabilitation 
 
 Individuals with Serious Mental Illnesses (SMI) are commonly observed to have 
an extreme lack of awareness of their condition, the consequences of their mental illness, 
and their need for treatment.  Freud (1940) perceived that those with a diagnosis in the 
schizophrenia spectrum were acutely unaware of their own affect and cognitions.  The 
WHO International Pilot Study of Schizophrenia validated earlier observations by finding 
that poor insight is one of 12 symptoms or signs selected to identify Schizophrenia and 
was found to be a statistically significant discriminator (Carpenter, Strauss, & Bartko, 
1973).  Since these early findings, there has been resurgence in recent years of research 
studying the concept of insight and its impact on recovery in the SMI population 
(Carpenter, Strauss, & Bartko, 1973; Ghaemi & Pope, 1994; Lysaker, Bell, Milstein, 
Bryson, & Beam-Goulet, 1994; Schwartz, 1998; Smith et al, 1999). 
  
Definitions of Insight 
  The concept and definition of insight has changed over time.  Jaspers (1963) was 
one of the first researchers to differentiate awareness of illness from insight, with 
awareness of illness being defined as the feeling of being “ill and changed.”  Insight was 
differentiated by Jaspers (1963) as an “objectively correct estimate of the severity of the 
illness (and) an objectively correct judgment of its particular type” (p. 419).  Jaspers 
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thought that only when all of these features are present could the patient be considered to 
have insight (Jaspers, 1963; cited in Rusch & Corrigan, 2002).   
Recent studies suggest that insight is not dichotomous, but multidimensional 
(Amador, Strauss, Yale, & Gorman, 1991; David, 1990; David & Kemp, 1997). David 
(1990) proposed that three dimensions comprise the construct of insight: recognition that 
one has a mental illness, the ability to re-label unusual mental events as pathological, and 
the belief that one needs treatment and actual adherence to treatment.  These dimensions 
are not concrete but instead are overlapping, dynamic trends that account for diverse 
variations along the course of the illness.  The model proposed by David (1990) has face 
validity and thus is commonly used in research studying insight (McGorry & 
McConville, 1999; Schwartz, 1998).   
Amador et al. (1991) proposed another multidimensional model that differentiates 
between unawareness of illness and incorrect attribution of deficit or consequence of 
illness, and treats insight as a complex phenomenon with separate but interrelated 
mechanisms.  Amador et al. (1993) concluded that the best way to define poor insight is 
as a construct consisting of multiple components much like the symptoms associated with 
SMI.   
Insight can also be thought of as the ability to relate to professionals’ views and 
the ability to meaningfully converse about the subject (Rusch & Corrigan, 2002).  
Markova and Berrios (1995)  conceptualized insight, as assessed in clinical interviews 
and observations, as a combination of the person’s perception of his or her own 
condition, the clinician’s perception of the individual’s condition, and the clinician’s  
own conceptual understanding of the construct of insight.  Consequently, evaluating a 
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person’s insight can be affected by the person and clinician’s attitudes and beliefs, 
therapeutic alliance, sociocultural differences and backgrounds, and the clinician’s 
working definition of insight.   
Many differing techniques have been used to operationally define and measure 
insight.  Objectively measuring and identifying symptoms and the degree of insight is 
important for reliably using valid results to inform diagnosis and treatment decisions 
throughout the course of illness.  Although most current researchers agree that insight 
needs to be defined and measured as a multidimensional construct, some researchers 
continue to treat it as a dichotomous construct  Amador et al. (1991) try to measure the 
multidimensional nature insight throughout the course of illness by designing tools like 
the Scale to Assess Unawareness of Mental Disorders (SUMD), a delineated 5-point 
scoring method that rates responses to controlled stimuli during a semi-structured 
interview.  The SUMD assesses current and past insight as well as the individual’s insight 
into the future course of their disorder and treatment.  The SUMD includes a systematic 
assessment of historical records and other sources to determine what symptoms have 
actually been present.  Although this may seem a prerequisite to assessing insight, such 
systematic accounting is not always included, and the SUMD has an advantage over other 
instruments in this regard. Also, Amador and colleagues (1993) proposed an additional 
dimension of insight, as assessed by the SUMD, that is capable of measuring the time and 
memory dimensions of insight, with full insight including the past, present, and possible 
future course (need for future treatment, risk of relapse, etc.) of the disorder.  Thus, for 
example, an individual may understand that current hallucinations are illusory while fully 
believing the validity of past hallucinations.     
 
4 
Recently, researchers such as Frith (1992) and Lysaker et al. (2005) have begun to 
examine metacognition, the ability to think about thinking, and its relationship with the 
common signs and symptoms of schizophrenia.  Some researchers regard metacognition 
as a component of insight, with the assumption that when a person’s ability for 
metacognition is poor their degree of insight is lower.  Examining metacognition often 
involves theory of mind tasks.  Theory of mind is defined as the ability to form a 
representation of the consciousness of others and be able to draw conclusions about their 
motives and make inferences as to others’ internal feelings (Lysaker et al., 2005).  
Research examining theory of mind tasks have shown that greater impairment is linked 
with deficits in visual and verbal memory and poorer flexibility for abstract thought 
(Greig et al., 2004).  In a study by Lysaker et al. (2005), 61 men with schizophrenia were 
interviewed to examine the relationship between their scores on the metacognition 
assessment scale and quality of life, neurocognition, and insight.  When age and gender 
were controlled, it was concluded that higher levels of metacognition, as defined as 
purposeful problem solving, were associated with less emotional withdrawal and 
paranoia and better social functioning, verbal memory, and insight (Lysaker et al., 2005).   
Therefore, when an individual with SMI is able to use purposeful problem solving and 
metacognition he or she is able to better conceptualize his or her illness.  However, it is 
still unclear whether deficits in one’s own awareness are a separate property from third 
person metacognition.  
 
Etiology of Impaired Insight 
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If insight is a multidimensional construct, a single etiology is unlikely.  Several 
causes are suspected to interact in complex ways and are expressed in different ways in 
the heterogeneous SMI population.  It has been proposed that lack of insight in those that 
have schizophrenia is analogous to the neurocognitive deficits in the traumatic brain 
injury (TBI) population.  Several researchers have observed and measured the 
unawareness of deficits in those with TBI, and have linked this lack of awareness to 
defects in the right hemisphere (Amador et al., 1991; McGlynn & Schacter, 1989; 
Prigatano & Schacter, 1991 as cited in Rusch and Corrigan, 2002); yet, some researchers 
studying schizophrenia did not find a relationship between defects in the right hemisphere 
and lack of insight (David et al., 1995; Kemp & David, 1996; McEvoy et al., 1996).  
Researchers studying the schizophrenia spectrum have found that the left hemisphere is 
affected more than the right in the SMI population. There is one finding of a correlation 
between poor insight and increased ventricle-to-brain ratios (Takai et al., 1992), and poor 
insight into one’s disorder has been associated with lesions in the parietal lobe (McEvoy 
et al., 1996) and smaller brain size (Flashman, et al. 2000).  Using MRI, Flashman et al. 
(2000) found that patients with poorer insight had smaller brain size and intracranial 
volumes than patients with higher levels of insight or the comparison subjects.   
Researchers are currently divided as to whether or not unawareness of illness in 
the SMI population is best understood as the consequence  of cognitive deficits that 
complicate the person’s ability to understand confusing aspects of their mental illness and 
everyday life.  Lysaker et al. (1994) and McEvoy et al. (1996) found that poor insight is 
related to frontal lobe deficits as measured by poorer performance on tests of 
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neurocognition and executive functioning, but others have failed to find a relationship 
(Cuestra et al., 1995; Freudenreich et al., 2004). 
A different view of the etiology of impaired insight, not necessarily incompatible 
with neuropsychological views, is that it is a coping mechanism.  McGlashan et al. 
(1975) showed that there are two distinct recovery styles for those that are experiencing 
psychosis.  The first group, the “integrators,” incorporates their mental illness into their 
everyday lives and has a high sense of awareness of the course that their illness has taken.  
The second group, or those that “seal over,” refuse to discuss or even think about their 
mental illness and thus are inclined to have lower levels of awareness of their deficits, 
course of illness, and consequences of illness. These differences could be understood to 
reflect different coping style preferences.  In a follow-up study of 30 “recovered” 
patients, McGlashan and Carpenter (1981) found that the absence of a negative attitude 
towards illness and symptoms was critical to achieving a positive outcome. 
Due to the heterogeneous SMI population and the multifaceted nature of insight, 
insight as a coping mechanism may be more useful for some individuals, as well as more 
helpful in coping with some symptoms than others. Using the SUMD to measure 
symptoms, Mohammed et al. (1999) concluded that poor insight into negative symptoms 
(e.g. alogia, affective flattening, avolition) is associated with poor executive functioning 
while poor insight into positive symptoms (e.g. delusions, hallucinations, disorganized 
speech or thinking, grossly disorganized behavior, catatonic behaviors) is not associated 
with poor executive functioning.  Therefore, it can be theorized that unawareness of 
negative symptoms may be due to neurocognitive deficits related to the frontal lobe and 
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executive functioning, while unawareness of positive symptoms may mainly act as a 
coping mechanism.   
Poor insight as a coping method may also serve a protective role for individuals 
grappling with trying to understand their disorder who are experiencing higher levels of 
depression (Lysaker et al., 2005).  Coping by having poor insight can allow the individual 
to avoid reality and as a result improve self-esteem and circumvent depression.  Greater 
use of a form of coping, labeled accommodation or adaptation, was also a significant 
predictor of adjustment, providing support for the role of coping as a protective factor for 
people with schizophrenia (Lecomte & Mercier, 2005). 
  
Insight and Suicide Risk 
The role of poor insight as a coping method also suggests that good insight may 
paradoxically be a risk factor for depression and suicide.  Individuals with a disorder in 
the schizophrenia spectrum have a 20 percent higher chance of attempting suicide than 
the general population and have a lifetime suicide attempt rate of 20 to 40% (Meltzer, 
Anad, & Alphs, 2000).  In the SMI population, suicidal ideation and behavior have been 
linked to depression (Amador et al., 1994; Caldwell & Gottesman, 1990).  Research has 
indicated that higher levels of insight lead to lower self-esteem and greater depression, 
thus increasing risk of suicide attempts (Amador et al., 1994; Caldwell & Gottesman, 
1990; Evren & Evren, 2004; Pompili et al., 2004).  Baechler (1979; restated in Pompili et 
al., 2004) stated that “schizophrenics do not kill themselves insofar as they are 
schizophrenic but insofar as they are persons who know they are schizophrenic or are 
threatened with becoming so and who wish to avoid this fated outcome.”  Amador et al. 
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(1996) reported that in their study of 218 patients with schizophrenia, 169 individuals did 
not have suicidal behavior whereas 49 had suicidal behaviors or ideologies.  Amador and 
colleagues (1996) found in their study that patients who have more awareness of their 
delusions, blunted affect, and anhedonia were more likely to commit suicide.  In a study 
by Evren and Evren (2004), sixty individuals with schizophrenia were interviewed and 
their clinical case summaries were reviewed.  About half of the sample, 45%, had 
experienced suicidal ideation, had made one or more suicide attempts, had lower negative 
symptom scores, and had been diagnosed as depressed at one point in time.  For these 
individuals, their mean scores on the three components of insight were statistically 
significantly higher than for those who did not have a history of suicidal ideation or 
attempts.  Evren and Evren (2004) replicated other studies (e.g. Caldwell & Gottesman, 
1990) that indicated that those that did attempt suicide and those that did not attempt 
suicide did not differ on demographic characteristics such as age, gender, marital status, 
educational status, and employment history.  
 
The Role of Insight in Treatment and Recovery 
While increased levels of insight have been shown to be a risk factor for suicide, 
moderate levels of insight can also act as an important factor in treatment and recovery.  
Poor insight can create a barrier between practitioner and patient that may affect the 
alliance during therapy and the patient’s chance for long-term success.  Poor insight has 
been associated with poor work skills, more noncompliance, and more readmissions to 
hospitals (Lysaker et al., 1994).  Several studies have shown that high levels of insight 
are associated with improved outcome, fewer hospitalizations, better post-hospital 
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adjustment, and better medication compliance both in psychiatric in-patient settings and 
outpatient settings (Amador et al., 1993; Schwartz, 1998).  These findings support the 
view that increasing insight early during the course of treatment can increase the 
probability of treatment being successful.   
 
Insight and Human Development 
To fully understand insight into adult SMI, attention must be paid to the 
emotional, physical, and mental health difficulties that people experience as they 
transition from adolescence to adulthood.  Research indicates that one in five children 
have some form of a diagnosable mental, emotional, or behavioral disorder, yet 70 
percent of those children do not receive mental health services (Kenny et al., 2002).  In 
addition to a lack of a common approach to detecting and following these children across 
systems, the neglect of services seems to be due to factors such as the varying definitions 
and classifications of childhood psychiatric disorders, research with heterogeneous child 
samples, using differing age groups for studies examining “adolescence,” and multi-
disciplines disagreeing on what constitutes child and adolescence psychosis and 
emotional disorders. 
 The term Serious Emotional Disturbance, applied to people under age 18, is 
comparable to Serious Mental Illness applied to adults.  Both terms are used colloquially 
and legislatively to describe people who are diagnosed with a psychiatric disorder 
according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
(American Psychiatric Association, 1994), when the diagnosed condition results in 
severely impaired functioning and disability.   
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Children and adolescents can be diagnosed with different diagnoses as they progress 
through the lifespan even though their symptomatology may be similar; they can be 
deemed as having SED prior to age 18 and after they are 18 they can be deemed again as 
having SMI.  Therefore, it is difficult to estimate the rates of SED and SMI in the 
population age 16 – 21 (Jonikas, Laris, & Cook, 2003) and hence it is difficult to estimate 
the amount of the population that is not receiving mental health services. 
 Research into SMI has demonstrated that disorders in the schizophrenia spectrum 
are chronic and that poor outcome is often linked to earlier onset (Helgeland & 
Torgensen, 2005).  Helgeland and Torgensen (2005) also found diagnostic stability from 
adolescence psychiatric pathology to adulthood for schizophrenia spectrum disorders.  
Other researchers disagree with this finding, concluding that it is impossible to have valid 
diagnostic consistency between schizophrenia and psychosis in childhood (Chen, Swann, 
& Burt, 1996).  Due to these inconsistent results it is clear that further research into the 
transition from SED to SMI is needed. 
The transition from adolescence to adulthood can be understood in terms of 
developmental and institutional transitions (Vander Stoep, Davis, & Collins, 2000).  
Developmental transitions are biological and social in nature while institutional 
transitions refer to changes in service settings, legal, or bureaucratic status.  Research by 
Vander Stoep et al. (2000) suggests that establishing and maintaining peer and family 
relationships, employment, high levels of functioning, treatment adherence, and transition 
back into a community setting can be impeded or delayed throughout the lifespan by SED 
or psychiatric pathology in childhood or adolescence. 
 
11 
According to Helgeland and Torgersen (2005), SMI in adulthood is associated 
with developmental hardships such as complications during pregnancy, 
neurodevelopmental abnormalities, and delayed motor and language development, thus 
suggesting schizophrenia is a developmental mental illness with relative stability in 
childhood and adolescence and onset in early adulthood.  As a result it can be deduced 
that individuals with adolescent psychiatric pathology (APP) that have poor levels of 
insight may continue to have poor levels of insight once in the SMI population.   Clinical 
characteristics such as degree of psychopathology, length of previous hospitalizations, 
and age of first hospitalization are also associated with patterns of psychosocial treatment 
response and insight into one’s illness (Kupper and Hoffmann, 2000; Peer and Spaulding, 
2007).  Although research has not conceived a developmental theory of insight, it can be 
assumed that valuable information that can inform recovery decisions can be gleaned 
from future research viewing insight in a developmental context. 
Simply having APP can hinder an individual’s level of functioning and course of 
illness factors such as treatment adherence, but failure to engage in services can also be 
attributed to lack of insight (Carpenter, Strauss, & Bartko, 1973;  Ghaemi & Pope, 1994; 
Lysaker et al., 1994; Shwartz, 1998; Smith et al., 1999).  Developmental impairments are 
more ubiquitous in those with symptoms in adolescence or APP than in those with late 
onset schizophrenia (Helgeland & Torgersen, 2005), thus indicating a possible more 
biologically severe subtype of the SMI population.  Individuals that have the lowest 
degrees of insight and a history of APP may have more severe symptoms and may, 
despite receiving mental health services during adolescence, continue to have poor 
insight as adults receiving in-patient services.    
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Families are often a source of emotional support for those with a mental illness.  
Research has shown that individuals with APP have more dysfunctional family 
relationships as well as increased perceptions that their families are distant and do not 
offer support (Jonikas et al., 2003).  While adolescence individuals may seek support 
from other sources such as friends or significant others; for adolescents with mental 
illnesses this may not be possible due to poor social skills, paranoia, stigma associated 
from having a mental illness, blunted affect, and aggressive behaviors towards peers.  
Failure to establish or maintain relationships may force the person to manage their illness 
differently; poor insight may develop as a coping mechanism in adolescence to substitute 
for the lack of support from family and peers.  This method of coping may continue 
throughout the course of the illness and contribute to the individual’s insight remaining 
low after being admitted to inpatient treatment settings. 
In a study Van Meijel et al. (2002) healthcare professionals and families of 
patients with schizophrenia were interviewed.  All interviewees agreed that in order to 
improve outcomes for those with SMI earlier intervention and symptom recognition is 
needed.  Furthermore, all participants in the study agreed that a certain level of insight is 
needed to accomplish early recognition and intervention for the SMI population (Van 
Meijel et al., 2002).  Those that have lower levels of insight in adolescence while meeting 
criteria for SED may, with the help of mental health services and psychopharmacology, 
increase their levels of insight while making the transition into the SMI population.  This 
increased understanding of the need for services, ability to understand their mental 
illness, and the ability to re-label unusual mental events as pathological can have 
important implications for treatment and the chronicity of states of psychosis that the 
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patient experiences and copes with, as well as the number of times that they must be 
hospitalized.  However, individuals with extremely poor insight during adolescence and 
into adulthood may, despite intensive intervention, not be able to understand and re-label 
their illness and may be more likely to have poorer treatment outcomes.  Further research 
needs to accurately longitudinally measure, conceptualize, and define insight in order to 
inform our decisions for early identification and intervention strategies, as well as help 
explain the developmental transition from SED to SMI and the impact insight may have 
on this population with greater symptom severity.  The conclusion can be drawn that 
further analysis into the relationship of insight and the transition from SED or APP to 
SMI can create new contexts in which SED and SMI and the mental health services for 
each can be viewed. 
To date, there has been only one exploratory study conducted in a clinical setting 
that compares the characteristics of people with APP to those without.  In a study by 
Wynne (2009) the relationship between APP and SMI was examined by assessing the 
relationship between prior mental health services before the age of 18 and time of 
assessment on people’s insight into their illnesses as adults participating in a psychiatric 
rehabilitation.  The sample consisted of 112 patients recruited from an inpatient 
psychiatric rehabilitation unit at a state psychiatric hospital.  Results indicated that those 
with service use during adolescence were found to be younger at admission, have slightly 
lower levels of education, have an earlier age of onset, and significantly more previous 
hospitalizations.  A relationship between Axis II diagnosis and service use was also 
identified, indicating that having an Axis II diagnosis in adulthood and APP may signify 
that individuals had particularly noticeable symptoms that increased their chances of 
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being served in adolescence.   
Wynne (2009) also found that improvements in neurocognitive functioning were 
not evident over the course of treatment.   Although improvements in insight were 
evident over the course of treatment for the general CTP population, adults with SMI 
who used mental health services before the age of 18 did not significantly differ from 
those who did not use services before the age of 18 with respect to level of insight; except 
for awareness of illness at 6 months as measured by the IS.  Results of analyses on insight 
measures over the course of treatment by APP severity level suggest that increases in 
measures of insight are not evident for the medium and high APP severity groups and 
changes in total insight and insight into need for treatment are different for the no 
services in adolescence and low APP severity groups over time.  This field of research 
has numerous implications for measuring and increasing insight among persons with SMI 
and may have implications for treatment success within institutions and treatment 
outcomes once discharged into the community.   
A major factor contributing to the paucity of research in this area is the substantial 
methodological problems associated with this kind of research. The impact of prior 
mental health services in adolescence on SMI takes years to demonstrate full, measurable 
effects.  Obtaining historical information from treatment providers who served 
individuals during adolescence also proves problematic, as by the time this information 
has been requested by the adult’s treatment provider, long periods of time may have 
passed and the clinical information destroyed.  Furthermore, it takes years to accumulate 
the needed data in order to be able to understand this process.  Although the study by 
Wynne (2009) used data from a nine year period, there was low power for several key 
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analyses due to missing data and/or changes in the clinical assessment battery.  The use 
of multivariate analyses in this study was undermined by a low number of valid cases on 
many of the variables over time.  Therefore, conclusions about differences between 
groups, or the lack thereof, over the course of treatment are tentative due to insufficient 
power.  Even though there was low power the presence of several interactions between 
service use and APP severity levels and insight measures across treatment approaching 
statistical significance indicates that effects were “missed.”   At any rate, this study 
explored the relationship between service use and insight such that future studies in this 
area can make more informed research hypotheses using stricter constraints in research 
design to circumvent problems related to lack of power and missing data.  Thus further 
study using a greater amount of participants completing repeated measures over time 
could overcome low power problems and find statistically significant relationships 
between APP severity groupings and insight over time in treatment. 
In summary, previous research has indicated that psychosocial functioning (e.g., 
social competence, social interest) in SMI is a product of complex relationships between 
factors such as neurocognitive functioning (Brekke, Kohrt, & Green, 2001) and 
sociocognitive variables, such as locus of control, and that both of these domains have 
been implicated in the research on the concept of insight. A greater understanding of the 
interrelationships between these factors, utilizing the developmental conceptualization of 
insight proposed by Wynne (2009) may aid not only in improving conceptualization of 
insight and psychosocial functioning during treatment in adolescence and adulthood, but 
also treatment outcomes once individuals are in the community functioning as adults 
(Hoffmann & Kupper, 2002; Kupper & Hoffman, 2000; Smith et al., 1999).  Also, better 
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understanding of these complex relationships may be able to aid in improving treatment 
outcomes for those with SMI without solely depending on improving a person’s insight 
into their illness. 
 
Present Study 
The purpose of the present study was to further examine the relationship between 
adolescent psychiatric pathology, often captured by the term of art SED, and SMI by 
assessing the relationship between prior mental health services before the age of 18 and 
time of assessment on people’s insight into their illnesses.  Earlier understanding of 
degrees of insight in the SED population has important ramifications for the lifelong 
diagnosis and treatment of those with SMI.  Whereas poor levels of insight in 
adolescence in some individuals with more severe symptomatology may continue to be 
stable into adulthood despite receiving psychological services, some individuals with the 
help of mental health services may be able to increase their levels of insight over time 
and improve their likelihood of successful treatment outcome and transition into the 
community.  However, there are also reasons to believe these APP severity groups do not 
differ.  The reasons for which an individual interacts with mental health service systems 
are complicated and there is no one path to treatment.  For example, family involvement 
for people with SMI varies greatly.  If one person has an active family and another does 
not, the former may be more likely to have a receive services or be screened for APP than 
the latter, independent of their functional abilities, simply because a family member 
advocated for the appointment.  Alternatively, an individual may repeatedly encounter 
mental health professionals in adolescence, typifying a more chronic course that may be 
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better served through guardianship, but no interested party seeks guardianship on behalf 
of the individual.  These confounds suggest that we need to know more about the concept 
of insight and APP and its correlates to the clinical picture for these same people as they 
transition and receive adult psychiatric services.   
 
 The present study had two primary objectives:  
1.  To determine if there was a pattern of differential functioning for adults with SMI with 
or without mental health service use during adolescence across various levels of 
functioning.  In general, it was anticipated that individuals with adolescent psychiatric 
pathology would demonstrate lower overall functioning than those without adolescent 
psychiatric pathology. As described above, these are individuals that for various 
unknown reasons, received mental health services during adolescence. Research indicates 
that this population may represent individuals experiencing more severe 
symptomatology, and that adolescent psychiatric pathology can impede treatment success 
in adulthood.  Because of this, hypothesis 1 predicted that those individuals who had 
various levels of APP will show demonstrably lower functioning in the clinical setting.  
Thus, it was hypothesized that the APP severity would correlate with clinical functioning.  
Specifically, the groups would differ in statistically significant ways across all domains 
of functioning measured (neurocognitive, social cognitive, symptomatology, and 
behavioral functioning). 
A. Upon Admission. Hypothesis 2 predicts that at the time of admission, individuals with 
adolescent psychiatric pathology would demonstrate lower overall functioning than those 
without adolescent psychiatric pathology on neurocognitive, social cognitive, and 
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behavioral functioning measures. However, hypothesis 3 predicted that because of prior 
contact with services, those individuals with adolescent psychiatric pathology would have 
higher levels of insight into their disorder at admission than those without adolescent 
psychiatric pathology.  In addition, hypothesis 4 anticipated that those with adolescent 
psychiatric pathology would have higher levels of symptomatology.  When analyses 
using different levels of adolescent psychiatric pathology were conducted, hypothesis 5 
predicted that those with adolescent psychiatric pathology that required hospitalization in 
adolescence or high mental health service utilization in adolescence would have higher 
levels of insight into their disorder at admission than those with none or less adolescent 
psychiatric pathology.  However, hypothesis 6 predicted this group would also have the 
highest levels of symptomatology and would have the lowest scores on neurocognitive 
and sociocognitive measures.    
B. Over the course of treatment. Hypothesis 7 predicted that overall differences in 
functioning, symptomatology, and treatment adherence would not remain over the course 
of treatment.  It was hypothesized that as a result of psychiatric rehabilitation there would 
be an increase in neurocognitive functioning, insight into disorder, internal locus of 
control, and behavioral functioning and a decrease in external locus of control and 
symptomatology for those with and without adolescent psychopathology.  That is, it is 
hypothesis 8 anticipated that both groups would show improvement in functioning over 
the course of psychiatric rehabilitation.  It was predicted that significant differences at 
admission or six months would not remain between those with adolescent psychiatric 
pathology and those without adolescent psychiatric pathology in all areas after 12 months 
of treatment.  However, it was predicted that those individuals with adolescent 
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psychiatric pathology would demonstrate higher symptomatology after 12 months of 
rehabilitation.  Furthermore, when different levels of adolescent psychiatric pathology 
were used in analyses, hypothesis 9 predicted that as adolescent psychiatric pathology 
becomes more severe functioning will decrease, there would be more severe 
symptomatology.  Overall, while it was hypothesized there would be differences in a 
variety of domains it was also hypothesized that differences in insight upon admission 
would not remain one-year after beginning psychiatric rehabilitation.   
2.  To determine if there is a pattern of differential outcome following discharge for 
individuals with adolescent psychiatric pathology from those without.  While previous 
research had not been conducted to inform hypotheses in this area, it was generally 
hypothesized that there would be differences between groups in terms of treatment 
outcome.  Specifically: 
C. Discharge disposition. Hypothesis 10 predicts that discharge disposition would differ 
between the two groups in that individuals with severe adolescent psychiatric pathology 
would be discharged to a more restrictive setting. This hypothesis was based on the idea 
that those individuals who used high amounts of mental health services or were 
hospitalized during adolescence may have represented a group with more severe 
symptomatology and may have been hospitalized more and for longer periods of time 
during the course of their illness.  These individuals may, though frequent 
hospitalizations, been reinforced to fulfill the “patient role” and have been 
institutionalized, thus representing a group or participants who take a longer time to 
transition into the community and may influence treatment providers’ notions such that 
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there is an assumption that individuals who were hospitalized during adolescence require 
higher levels of care and supervision. 
D. Rehospitalization rate. Hypothesis 11 predicted that there would be a greater rate of 
rehospitalization for those with APP than those without APP.  Furthermore, when 
analyses were conducted between the different APP severity groups, hypothesis 12 
predicted that those individuals in the medium and highest APP severity groups would 
have a greater rate of rehospitalization than those in the low to no APP severity groups.  
In addition, hypothesis 12 predicted that those in the highest APP severity group would 
have the greatest rate of rehospitalization, as these individuals may represent a subgroup 
experiencing more severe and refractory symptoms that can be potential barriers to living 
in the community for extended periods.  
 
Based on the results of these analyses, exploratory analyses were undertaken to 
glean additional information about the role of service use and APP severity level in the 
psychiatric rehabilitation and insight of individuals with SMI.  This data was 
accumulated over the course of thirteen years, allowing for a preliminary look at the 
therapeutic consequences of prior mental health service usage and the longitudinal effects 
of psychiatric rehabilitation treatment for these individuals.  The archival database 
utilized in this proposed study was ideal for this type of research.  It afforded the 
opportunity to study populations with different service histories under a similar set of 
clinical circumstances over an extended period of time. Although one previous study 
(Wynne, 2009) sought to better understand the relationship between mental health service 
utilization during adolescence on insight scores across treatment in adulthood, it should 
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be reiterated that the proposed study built on the previous study by Wynne (2009), was 
highly exploratory in nature, and sought to expand the scope of previous research by 
including a larger sample size and more assessment measures that have been implicated 
as important to the study of the concept of insight and in the treatment outcome for those 
with SMI.  This was a critical first step in the analysis of the role of mental health service 
usage during adolescence and adolescent psychiatric pathology in the treatment of adults 
with SMI and these adult’s insight into their mental illness. 
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CHAPTER 2 - METHOD 
Design Overview 
 The primary purpose of this study was to assess the relationship of mental health 
service usage and adolescent psychiatric pathology severity with insight before, during, 
and after treatment.  In addition, a secondary relationship between adolescent psychiatric 
pathology and functioning in a variety of domains before, during, and after treatment was 
assessed.  The participants with adolescent psychiatric pathology were compared to those 
without to determine if any differences existed.  Also, when adolescent psychiatric 
pathology was separated into three separate groups by the amount and type of services 
utilized during adolescence, these three different levels of adolescent psychiatric 
pathology were compared to those without.  Univariate and multivariate analyses were 
conducted within and between the two groups service groups (service use vs. no service 
use in adolescence) and the four APP severity level groups with respect to overall 
functioning using multiple measures described below.  
Setting 
The Psychiatric Rehabilitation Program, formerly known as and will continue to 
be referred to in this paper as the Community Transition Program (CTP), was an inpatient 
unit at the Lincoln Regional Center (LRC) a public state psychiatric hospital in Lincoln, 
Nebraska.  This 40-bed inpatient unit hosted a comprehensive psychiatric rehabilitation 
program for those most disabled by mental illness in the State of Nebraska.  Individuals 
were typically discharged to a less restrictive setting after a 9 to 18 month period of 
intensive treatment, with the average length of stay being 12 months.  Treatment 
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engagement was encouraged through the use of contingency management based on social 
learning theory.  The regimen included pharmacotherapy, psychoeducational groups and 
classes to target improved management of symptoms and disorder, and training aimed at 
improving occupational, leisure, and social skills. The treatment was designed to target 
multiple levels and domains of functioning for individuals with SMI, rather than only 
targeting an isolated area of deficit (e.g., symptoms). Thus, treatment did not focus on 
clinical diagnosis.  Rather, treatment plans using functional analysis were individualized 
and based on making step-wise improvements in deficient areas of functioning and 
capitalizing on observed and participant perceived areas of relative strength of the 
individual.  Treatment plans were designed by a multidisciplinary treatment team 
including nurses, social workers, psychiatrists, occupational therapists, psychologists, and 
psychiatric technicians.  In addition, program participants were encouraged to be active 
members of their own treatment team for the purpose of increased engagement in 
treatment and to promote the concept of recovery in the therapeutic milieu. Consequently, 
the CTP referred to individuals as “participants” instead of patients, reinforcing the idea 
of active engagement of participants in their treatment. For a detailed outline on the 
theoretical foundation and practical applications of this innovative, state-of-the-art 
treatment technology read Treatment and Rehabilitation of Severe Mental Illness 
(Spaulding et al., 2003).  
The Lancaster County Community Mental Health Center (LCCMHC) also 
contributed data to the archival database.  Since a majority of participants from CTP are 
served by LCCMHC upon discharge, ongoing program evaluation using records at 
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LCCMHC yielded data pertaining to outcome such as rehospitalization rate, discharge 
location, and use of services in the community.  
 
Participants 
Participants discharged from the CTP program from 1996 through March 2009 
contributed data to the archival database utilized in this study. The CTP program 
participants were not directly involved in any specific research procedure.  Rather, the 
database included the ongoing clinical data collected as part of the routine assessment 
process described further below at the CTP and additional data gathered through chart 
review. 
Participants of the CTP must have had as part of the criterion for admission an 
Axis I major mental disorder administrative designation as SPMI. This sample represents 
a severe and treatment refractory subpopulation.  They were referred to the CTP because 
of either extended institutionalization in custodial settings or repeated re-hospitalizations 
with no stable community functioning. The sample consisted of 354 participants.  All 
subjects met DSM-IV (American Psychiatric Association, 1994) criteria for 
schizophrenia, schizoaffective disorder, or bipolar disorder.  Participants were between 
the ages of 18 and 60.   
DSM-IV (American Psychiatric Association, 1994) diagnoses for patients with 
schizophrenia, schizoaffective disorder, and bipolar disorder were confirmed prior to the 
study by interviews with the participants, chart reviews, reviews of historical 
documentation, and consultation with the program director and treatment team.  Patient 
data was used only when ratings from these different sources produced the same 
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diagnosis.  All patients were on various combinations of antipsychotics, mood stabilizers, 
and anxiolytic medications during the study. 
Initially, the archival database had 354 participants.  Because available outcome 
data in the database pertained to the most recent admission to CTP and multiple 
individuals in the database received rehabilitation at various stages in their life and 
disorder, all previous admissions before the most recent admission were excluded from 
analyses to maximize the number of valid cases available for analyses.  Also, participants 
with lengths of stay in the CTP program of less than six months were excluded from 
analyses since treatment effects were captured as there was not adequate time to 
participate in the CTP rehabilitation program or have multiple assessment administrations 
within six months time.   
A vast majority of CTP participants were either civilly committed or admitted by 
a legal guardian.  Either way, treatment was typically viewed as involuntary in that most 
did not decide for themselves to enter the program.  This was particularly important in 
developmental analyses of insight due to individuals being hospitalized in adolescence 
being made wards of the state at an earlier age.  Involuntary treatment may play a role in 
the concept of “insight,” as some researchers have suggested that insight is often viewed 
in clinical contexts as an individual’s degree of agreement with treatment providers 
(Rusch & Corrigan, 2002).  Analyses took this variable into account and determined 
differences amongst those with and without mental health service use in adolescence and 
between the different APP severity levels.    
 
Measures 
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 Demographic and Clinical Characteristics 
 Through chart review at CTP, information regarding the demographic and clinical 
characteristics of participants was included in the archival database.  These variables 
included gender, age, years of education, race/ethnicity, marital status, legal status, 
number of previous hospitalizations in the participant’s lifetime, age of first 
hospitalization, Axis I and Axis II psychiatric diagnoses, comorbid Axis I diagnoses, 
length of stay at CTP, and other relevant variables.   
 
 Neurocognition Measures 
 1) Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; 
Randolph, 1997). The RBANS is a brief neurocognitive screening assessment 
(approximately 25 minutes) ideal for individuals who may lack levels of attention needed 
to complete longer assessments.  There are two forms of the RBANS (Form A and Form 
B), intended to minimize the practice effects of repeated administrations. The twelve 
subtests of the RBANS are grouped into five neurocognitive domains.  The five domain 
scores of the RBANS include immediate memory, delayed memory, attention, language, 
and visuospatial/constructional functioning. In addition, a total index score represents 
overall cognitive functioning.  Convergent validity has been established in people 
diagnosed with schizophrenia for the RBANS with other neuropsychological constructs, 
like memory and intelligence (Gold, Queern, Iannone, & Buchanan, 1999; Hobart, 
Goldberg, Bartko, & Gold, 1999).  In addition, sensitivity to patterns of cognitive 
impairment in SMI and general reliability and validity have been evaluated (Gold et al., 
1999; Hobart et al., 1999).   
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2) COGLAB (Spaulding, Garbin, & Dras, 1989). COGLAB was created as a 
computerized test battery comprised of tests common in the psychopathology literature.  
The WCST, a measure of executive functioning, was used in an effort to understand the 
subject’s ability for abstract thought, cognitive flexibility, and to replicate past studies 
that have found a significant relationship between the WCST and insight (Lysaker et al., 
1994; McEvoy et al., 1996).  CTP standard assessment included two of the tests from the 
battery; however, for the current study the Card Sorting Task (WCST; an adaptation of 
the Wisconsin Card Sorting Task, Heaton et al., 1993) was used. The WCST is a 
computerized neuropsychological test of “set shifting” in which participants are asked  to 
display their ability to be flexible when exposed to changing schedules of reinforcement 
by matching a target card to one of four stimulus cards without being told the matching 
principle of color, shape, or number that changes frequently without warning to the 
subject.  The WCST was used to measure executive functioning and its known sensitivity 
to impairment in concept formation, cognitive flexibility, and abstract thought (Lysaker 
et al., 1994; Lysaker et al., 1998).  The WCST allows clinicians and researchers to assess 
frontal lobe functions such as strategic planning, organized searching, utilizing 
environmental feedback to shift cognitive sets, goal oriented or problem solving 
behavior, and decreasing impulsive responses.  The computerized WCST takes 
approximately 12-20 minutes to complete and provides objective measures of overall 
success by computing the number of categories achieved, number of trials, number of 
errors, number of perseverative errors, percentage of perseverative errors, and the 
consolidation index as a measure of set-shifting.  
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Good discriminant validity was demonstrated between individuals diagnosed with 
schizophrenia and controls in an early study of the COGLAB (Spaulding et al., 1989).  
Results from large multivariate studies conducted with normal and “patient” populations 
indicate overall acceptable psychometric properties of the COGLAB (Spaulding, 
Hargrove, Crinean, & Martin, 1981; Spaulding et al., 1989). 
3) Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996).  The RAVLT, 
is a seven trial list-learning task with alternative forms consisting of 15 words presented 
in an auditory format.  Participants were instructed to recall as many words as they can 
from the list immediately following each of five trials. A distractor trial was then 
presented consisting of a different list of 15 words and participants are required to recall 
as many words from this distractor list. Finally, participants were required to recall as 
many words as possible from the original list without it being presented again.  In 
general, the RAVLT provides a measure of verbal memory. The number of words 
remembered after the fifth trial is the most commonly used RAVLT score.  Acceptable 
discriminant validity between memory impaired vs. memory intact patients and normal 
vs. neurological patients has been demonstrated, as well as adequate test-retest validity 
(Schmidt, 1996).  
 4) Rey-Osterrieth Complex Figure Test (RCFT; Rey, 1941).  This is a test of 
visuoconstructional ability and nonverbal memory.  It is comprised of four tasks: a copy 
trial, immediate recall trial, delayed recall trial, and a recognition task. Figures were 
scored using the 18-point scoring system, originally developed by Osterrieth (1944), and 
outlined in Meyers & Meyers (1995).   
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 5) The Trailmaking Test (A&B) (Army Individual Battery, 1944).  This two 
component test assesses attention, visual scanning, and information processing.  In Part 
A, individuals connected circles numbered 1 through 25 by drawing a line sequentially 
from 1 to 25 as quickly as possible.  In Part B, individuals completed a similar task 
alternating sequentially between numbers and letters (e.g. 1 to A, A to 2, 2 to B, B to 3).  
Performance was measured by subtracting the number of errors from the total possible 
score, resulting in two scores, one for each trial. 
 6) Neuropsychological Assessment Battery Screening Memory Domain (NAB) 
(Stern & White, 2001). The NAB Screening Memory Domain score is a composite 
measure of the participant’s verbal and visual memory functioning, based on the sum of 
the Screening Shape Learning Immediate Recognition, Screening Shape Learning 
Delayed Recognition, Screening Story Learning Immediate Recall, and the Screening 
Story Learning Delayed Recall scores. The Screening Memory Domain score is used as 
an indicator of an individual’s verbal explicit learning, visual explicit learning, verbal 
free recall after a brief delay, and visual delayed recognition memory after a brief delay 
(Stern & White, 2001). The reliability coefficient of the Screening Memory Domain 
score is .79 (Stern & White, 2001). 
 7) Controlled Oral Word Association Test (COWAT or FAS) (Benton & 
Hamsher, 1976). The COWAT measures verbal fluency and word generating ability, or 
the ability to rapidly generate and organize verbal information. In a series of 60-s trials, 
participants were asked to name as many words as possible that began with specified 
letters of the alphabet F, A, and S. Total number of words generated was scored. 
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Theory of Mind Measures 
1) Hinting Task (Corcoran, Mercer & Frith, 1995). The Hinting Task measures 
theory of mind abilities and requires working memory, verbal comprehension, and verbal 
production abilities.  A summary score was generated based on ability and facility of 
comprehension and interpretation of social implications.  Limited psychometric data is 
available, however, the Hinting Task is sensitive to deficits in schizophrenia, correlates 
with other ToM measures and has good face validity in studies with seriously mentally ill 
participants (Corcoran & Frith, 2003). 
 
Socialcognition Measures 
 
1) Inventory for the Measurement of Self-Efficacy and Externality (I-SEE or 
FKK; Krampen, 1991). The I-SEE provides a measure of global attributional style, or 
locus of control. It is comprised of 32 items which were each rated on a six point Likert 
scale ranging from strongly disagree to strongly agree. The measure consists of four 
main scales: “internality” (i.e., “whether I have an accident is based on my own 
behavior”); “self-concept of one’s own competence” or “self-efficacy” (i.e. “I can do 
many things to protect my self-interest”); “powerful others’ in controlling beliefs” (i.e., 
“other people often prevent my plans from becoming reality”); and “chance in controlling 
beliefs” (i.e., “whether I fall ill is a matter of chance”).  These scales were combined to 
yield two composite scales a general external scale (“externality”) and a general internal 
scale (“self-concept of one’s own efficacy”) which represents participant’s beliefs about 
their self-efficacy.  Krampen (1991) established reliability for the two composite scales.  
2) The Internal, Personal, Situational Attribution Questionnaire (IPSAQ) 
(Kinderman & Bentall, 1997) assesses a more interpersonal attributional style based on 
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participants explanations of positive and negative social scenarios.  It yields two 
measures: an externalizing bias (Eb) score (the degree to which persons attribute negative 
events to external factors and attribute positive events to themselves) and personalizing 
bias (Pb) (the degree to which persons attribute negative events to other people as 
opposed to situational factors).  
 3) The Coping Strategies Task (CST) (Mindt & Spaulding, 2002).  The CST is 
used for assessing coping-related cognition in individuals with schizophrenia-spectrum 
disorders.  The CST is comprised of four coping subscale scores including: Social 
Support Seeking, Self-Controlling, Escape Avoidance, and Planful Problem Solving. 
Reliability analyses reveal that the CST and its subscales demonstrated adequate 
reliability, although one subscale (Behavior Reaction) demonstrated less robust split-half 
and test-retest reliabilities. Concurrent validity was evaluated by analyzing the 
relationship between the CST and measure of stress, observed behavior, and 
neurocognition.  Correlational analyses have revealed that coping attributions, as 
measured by the CST, were found to be association with perceived stress, observed 
behavior, and executive functioning.  
 
Insight Measures 
  1)  Insight Scale (IS; Birchwood, Smith, Drury, Healy, Macmillan, & Slade, 
1994). This brief self-report measure (8 items) allows participants to choose one of three 
responses: agree, disagree or unsure, for each item. It yields a total score and three 
subscale scores representing David’s (1990) three domains of insight. The correct answer 
for each was counted as one point and each dimension is scored on a scale of 0-4, with an 
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overall insight score ranging from 0 to 12 with higher scores indicating higher levels of 
insight.  The three subscales, therefore, are: “need for treatment” (i.e., “I do not need 
medication”), “ability to relabel psychotic experiences” (“some of my symptoms were 
made by my mind”), and “awareness of illness” (“I am mentally well”). This measure of 
insight focused on insight into functional impairment rather than specific illness 
categorizations.  This self-report questionnaire is well validated and used extensively 
with the SMI population, with test-retest reliability equaling .90 (Birchwood et al., 1994). 
2) The Self-Appraisal of Illness Questionnaire (SAIQ) (Marks, Fastenau, Lysaker, 
& Bond, 2000).  The SAIQ is a self-report instrument designed to assess attitudes toward 
mental illness among persons receiving psychiatric treatment. The SAIQ is a pencil and 
paper self-report instrument composed of 17 items. The format for each item is a 
statement or a question. The items addressed acknowledgment of illness, beliefs about the 
outcome of illness, acknowledgment of a need for psychiatric treatment, and extent of 
worry about illness and about illness related issues. Participants were asked to respond to 
the statements and questions using a four-point Likert scale, which varies according to 
the statement or question content.  The validity of the SAIQ was examined through a 
factor analysis. Three factors emerged: Need for Treatment, Worry, and 
Presence/Outcome of Illness. The three SAIQ subscales are correlated with researcher 
rated insight scales and neuropsychological tests. Results indicate that the Need for 
Treatment and Presence/Outcome subscales were significantly correlated with both 
researcher-rated insight scales and with neuropsychological tests of executive 
functioning. The Worry subscale has been found to not be related to either researcher-
rated insight scales or neuropsychological tests (Marks, et al., 2000).  
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 Behavioral Functioning Measures 
1) Nurse Observation Scale for Inpatient Evaluation (NOSIE-30; Honigfeld, 
Roderic, & Klett, 1966). The NOSIE is a 30-item behavioral checklist format completed 
by nursing staff at CTP, with responses ranging from zero (never) to four (always). Two 
psychiatric technicians completed the checklist weekly for each participant.  Items cover 
six areas of unit (“ward”) functioning: social competence (“refuses to do ordinary things 
expected of him or her”), social interest (“tries to be friendly with others”), neatness 
(“keeps clothes neat”), irritability (“gets angry or easily annoyed”), psychoticism (“talks, 
mutters, or mumbles to self”), and motor retardation (“is slow-moving or sluggish”).  
When combined, these six areas represent a total assets score. Adaptive functioning 
scales (i.e., social interest) were positively weighted and maladaptive scales (i.e., 
irritability) were negatively weighted when determining the total assets score. This 
measure has been widely used as part of the psychiatric rehabilitation treatment and was a 
routine assessment in the treatment program.  Analyses within the CTP population have 
yielded Pearson correlations between 0.68 and 0.72 for all scales (Penn, Mueser, 
Spaulding, Hope, & Reed, 1995; Spaulding et al., 1999b). Also, a more recent reliability 
update of this measure confirmed it remains reliable in modern treatment settings, with 
inter-rater reliability on the total assets score at 0.76, on maladaptive scales at 0.68, and 
adaptive scales at 0.75 (Lyall, Hawley, & Scott, 2004).  
 
 Symptomatology Measures Over Course of Treatment 
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1) The Brief Psychiatric Rating Scale – Extended Versions (BPRS-E; Lukoff, 
Nuechterlein, & Ventura, 1986; Van der Does, Linszen, Dingemans, Nugter, & Scholte, 
1993). Used to evaluate symptoms, the BPRS-E was used routinely every six months at 
CTP.  In general, the BPRS-E is widely used to assess changes in psychiatric symptoms.  
Using a Likert scale from 1 (symptom is not present) to 7 (symptom is very severe), 
clinicians rated individuals based on interview content and general, observed behavior on 
24 items.  The BPRS-E is a widely used instrument and reliability and validity have been 
demonstrated (Bailley, Lachar, Rhoades, Diefenbach, Espadas, & Varner, 2004). Factor 
analyses on the former 18-item version and the newer 24-item version have yielded four, 
five, and six factor solutions of symptom items (e.g., Spaulding, Reed, Sullivan, 
Richardson, & Weiler, 1999a; Perlick, et al., 1999; Burger et al., 1997).  The six-factor 
solution validated by Spaulding, Fleming, Reed, Sullivan, Storzbach, & Lam (1999a) was 
used in this study because the original validation took place with the same population at 
CTP. A standard principal component analysis of the BPRS (Spaulding et al., 1999a) 
yielded six factors: Psychotic Disorganization, Hallucinations/Delusions, Paranoia, 
Emotional Blunting, Agitation/Elation and Anxiety/Depression. 
 
Symptomatology Measures at Admission 
The following assessments were administered at time of admission to CTP and as 
deemed necessary by the treatment team.  In order to obtain the largest sample, only 
admission scores on the following assessments was used. 
1) The Beck Hopelessness Scale (BHS) (Beck & Steer, 1988).  The BHS is a self-
report instrument that consists of 20 true-false statements designed to assess the extent of 
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positive and negative beliefs about the future during the previous week and takes less 
than five minutes to complete. Each of the 20 statements was scored 0 or 1.  A total score 
was calculated by summing the pessimistic responses for each of the 20 items. The BHS 
has been standardized using psychiatric inpatients and outpatients (Beck et al., 1974; 
Beck & Steer, 1988).  Beck and Steer (1988) report high internal reliability across diverse 
clinical and nonclinical populations with reliabilities ranging from .87 to .93.  The BHS 
has adequate one-week test-retest reliability in a psychiatric outpatient sample (r = .69; 
Beck & Steer, 1988).  Correlation coefficients between the BHS and the Beck Depression 
Inventory pessimism item range from .42 to .64 in clinical samples (Beck & Steer, 1988).  
 2) Beck Depression Inventory-II (BDI-II) (Beck, Steer, & Brown, 1996).  The 
BDI-II is a 21-item self-report assessment of depressive symptoms. The respondent was 
asked to rate how much he or she has been bothered by each symptom on a 4-point scale 
ranging from 0 to 3.  Each item consists of four statements that reflect gradations in the 
intensity of a particular depressive symptom. The respondent chooses the statement that 
best corresponds to the way that he or she has felt for the past two weeks. The 
psychometric properties of the inventory have been reviewed by Beck, Steer, and Brown 
(1996).  
3) Suicide Probability Scale (SPS) (Cull & Gill, 1988).  The SPS is a 36-item self-
report measure of current suicidal ideation, hopelessness, negative self-evaluation, and 
hostility that takes approximately 10 minutes to administer.  Subjects answered each item 
on a 4-point scale ranging from 1 (“None or a little of the time”) to 4 (“Most or all of the 
time”). There are three summary scores: A Suicide Probability Score, a total weighted 
score and a normalized T-score. The Suicide Probability Score can be adjusted to reflect 
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different a priori base rates for particular clinical populations.  The internal reliability for 
the SPS is high (Cronbach alpha = .93) and has high test-retest reliability over a three-
week period (r = .92; Cull & Gill, 1988).  Although the SPS was designed to be a 
measure of suicide risk, there is a paucity of research studies that have tested the 
predictive validity of this measure. 
 
 Outcome Measures 
 1) Rehospitalization rate. One of the primary goals, often inappropriately cited as 
the only goal, of treatment programs is the prevention of future hospitalizations and the 
decrease of inpatient hospital days and use of emergency services (Cook, Pickett, 
Razzano, Fitzgibbon, Jonikas, & Cohler, 1996; Anthony, Cohen, & Vitalo, 1978). The 
inclusion of data from LCCMHC was a critical part of analyzing outcome from the CTP 
program since a majority of participants were served through LCCMHC upon discharge 
from CTP.  Program evaluation activity at the LCCMHC has in the past, and hopefully in 
the future, established a rehospitalization data-tracking program.  The data available for 
participants prior to 2005 was cross-checked with chart reviews at CTP and chart reviews 
and interviews with staff at LCCMHC.  The data for participants from 2005-2009 was 
obtained and/or cross-checked from LCCMHC.  Since the archival database in this study 
included people discharged from CTP in 1996 to people discharged from CTP in 2009, 
people may range in the possible amount of time since discharge.  This study explored 
ways of addressing this such as the percentage of hospital days out of all hospitals and 
non-hospital days since discharge and the survival rate (or how long before the first 
rehospitalization). 
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 2) Discharge disposition.  The restrictiveness and nature of the setting to which 
individuals were discharged from the CTP can also serve as a measure of outcome.  
There were at least 35 different discharge locations to which people went following CTP. 
Less restrictiveness (e.g., independent living) was characteristic of better outcome and 
less symptomatology.  For the purposes of this study, there were essentially four 
categories of discharge location from most restrictive to least restrictive: 1) Regional 
Center transfer, 2) Psychiatric Residential Rehabilitation, 3) Assisted Living, and 4) 
Independent living.  These categories were based on interviews with the CTP program 
director and CTP social workers who were primarily responsible for discharge planning 
and most familiar with community services as part of previous research in the 
construction of the archival database.  These four categories did not encompass all 
discharges from CTP such as those to nursing homes or developmentally disabled (DD) 
group homes. Few individuals were discharged to nursing homes, which were considered 
more restrictive than even psychiatric residential rehabilitation.  Discharges to nursing 
homes from CTP were rare and typically due to the persons’ medical rather than 
psychiatric condition, and therefore were not included in analysis.  Similarly, very few 
people were discharged to DD settings because one of the exclusion criteria from 
admission to CTP was developmental disability.   
 
Procedure 
 Data Collection 
An archival longitudinal database was used in this study.  Approval for 
construction of this deidentified archival clinical data for research purposes was obtained 
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from the university IRB and the state hospital research committee.  Most of the archival 
data came from the CTP clinical archives, but additional data pertaining to outcome and 
community functioning was collected from Lancaster County Community Mental Health 
Center.  Clinical data was routinely collected as part of the CTP program and contributed 
significantly to the database.   
In addition, extensive chart review at both CTP and LCCMHC added additional 
data regarding hospitalization history and general clinical and demographic 
characteristics. In addition to the initial interview in which participants were asked about 
what mental health services they received before the age of 18, a large amount of 
historical information was gathered from a review of participants’ past records and social 
history reports.  Prior mental health services usage before the age of 18, coded as no 
service use vs. service use, was derived from whether or not a participant received any 
type of mental health services before age 18 (therapy, medications used for mental 
illnesses, special behavioral school classes or programs, institutionalization during 
adolescence, etc.).  These prior history variables addressed whether or not the participant 
had any DSM diagnosis, displayed prolonged characteristics pertinent to the 
schizophrenia spectrum prior to age 18, or if they could have been termed has having 
“serious emotional disturbance” during pre-adolescence or adolescence.   
Information regarding symptoms at onset, whether or not the patient had 
premorbid behavioral problems, and number of previous hospitalizations was also 
obtained.  Although instances of violence and delinquency in adolescents were noted, 
individuals were not assessed as having SED or APP in adolescence simply due to 
delinquency or aggression.  These variables, taken into account with the other historical 
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variables, were used to assess categorize individuals who used services prior to the age of 
18 into different APP severity level groupings.  Those participants that did not receive 
services or have any historical variables indicating APP were coded as not having APP in 
adolescence. Individuals with one or two instances of mental health service use (i.e. met 
with a mental health provider once for evaluation,) were coded as the low severity APP 
group while individuals with more frequent or longer duration of mental health services 
prior to the age of 18 were coded as the moderate APP group. Those participants that 
were institutionalized during childhood and or adolescents and had received extensive 
mental health services at that time were coded as the high severity APP group. , Data 
from 354 participants discharged from the CTP program between 1996 and March 2009 
were used in analyses.   
 Assessments at CTP.  All participants completed a comprehensive clinical 
assessment upon admission to the CTP program and most of these assessments were 
repeated at six month intervals throughout a person’s hospitalization in order to monitor 
treatment response and inform future treatment planning decisions.  These assessments 
primarily included measures of neurocognitive and social cognitive functioning.  Clinical 
psychology graduate students or trained clinical assistants administered and scored all 
measures according to standardized instructions.  Scoring was assisted by several 
computerized scoring programs.  One significant change occurred in the routine 
assessment battery during the thirteen-year period from which the archival data was 
extracted.  The RBANS, the IS, and social cognitive measures were added to the 
assessment battery between 2000 and 2001 when new admissions arrived during that 
time.  The RAVLT, and SAIQ were phased out at that time in order to maintain that the 
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assessment battery could be completed in a manageable amount of time or in favor of 
newer assessment measures with stronger psychometric properties.  Therefore, 
individuals discharged before 2000 did not have RBANS and social cognitive data.  
Likewise, people who entered the program at the time of the change did not have 
RAVLT, and SAIQ data.  The RBANS was phased out in 2005-2006 and the NAB was 
used instead.   Therefore, individuals discharged after 2000 and before 2006 had RBANS 
data while those participants entering the program between 2006 and 2009 had NAB 
data. Results using the RBANS and NAB were analyzed separately.  Assessments 
continued to be collected at six-month intervals and therefore biannual neurocognitive 
and/or social cognitive data, as well as insight data was available for most participants. 
Analyses were conducted for the different APP severity groups on the various 
psychological assessments available at CTP during those participant’s involvement with 
the program.  Comparisons between and within groups were conducted across the 
different domains of assessments for different time points. 
 In addition, assessments of various areas of functioning and overall functioning 
were regularly completed in the context of the general milieu.  Psychiatric technicians 
completed NOSIE assessments on a weekly basis.  The monthly average of weekly 
ratings was included in the present database, making monthly NOSIE data pertaining to 
each person’s unit functioning available.  Data entry and management was completed by 
a trained clinical psychology graduate student on a monthly basis to be used in treatment 
progress meetings.  At the time of extraction, the data was subjected to fidelity checks to 
monitor if the behaviors are being correctly recorded and contingencies implemented as 
intended by the treatment team. 
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The current study was a retrospective longitudinal study in which three 
assessments were taken from all participants in the study during the intake within two 
weeks of admission, at 6 months, and a year after admission.  The 12 month time period 
was selected because the average length of stay at CTP is around 12 to 14 months which 
maximizes the amount of data available at any given time point.  The greater part of 
treatment in skills training is also delivered within this time frame.  All participants were 
interviewed and given the BHS, BDI-II, socialcognition battery, neurocognition battery, 
BPRS, and insight measures within the first two-weeks of their stay in the in-patient unit.  
Patients were interviewed again at 6-months for their semi-annual review, and at one-
year for their annual review and given the BPRS, socialcognition and neurocognition 
batteries, and insight measures at each time point.  The NOSIE was completed by 
psychiatric technicians weekly for each participant.  Average monthly scores were 
computed for the six areas and total assets score on the NOSIE.  NOSIE scores within 
two weeks of admission, after six months of treatment, and after one year of treatment 
were used in the present study.  
 LCCMHC.  Comprehensive chart review and interviews with LCCMHC staff 
were completed by a clinical psychology graduate student involved in program 
evaluation activity as part of a practicum placement at LCCMHC.  After collecting 
hospitalization data, the data was cross-checked with LRC records through chart review 
to ensure its accuracy.  Not all CTP participants were served by LCCMHC upon 
discharge, nor has discharge data been obtained for those individuals served from 2006-
2009.  Whenever possible data for these individuals was obtained through LRC records.   
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 After the archival database was completed with data from both settings, two 
graduate students completed additional quality assurance checks.  Data was subjected to 
cross-checking with original and computerized archival data to ensure its reliability and 
accuracy.  Once outcome data was obtained or completed for those individuals served 
from 2006 to 2009 the same methods described above were used to ensure reliability and 
accuracy. 
 Data Cleaning 
 Before analyses, data was examined for skewness and potential outliers.  It was 
necessary to ensure normal distribution of the dependent variables because most of the 
analyses that were used in this study assume normality.  Distributional skewing and 
asymmetrical outliers can both produce skew and therefore transformation and/or outlier 
windsorizing was applied only after examining the nature of the skew.  Any dependent 
variables that demonstrated a skewed distribution (skewness > +/- 1.00) without outliers 
was normalized using conservative transformation procedures.  Using Tukey’s Hinges, 
the data was systematically screened for outliers.  All outliers were included after a 
windsorizing procedure which replaces extreme values with the highest acceptable value 
was applied (Hoaglin, Mosteller & Tukey, 1983).  All variables were cleaned to within 
acceptable skewness range with the exception of the rehospitalization and previous 
hospitalizations data.  A few variables required both square root transformation and 
windsorizing of extreme outliers in order to normalize the distribution.  Using the above 
procedures, all variables were cleaned to within acceptable skewness range with the 
exception of the rehospitalization data.  The nature of this data prevented transformation 
or windsorizing.  Therefore, the rehospitalization data were analyzed disregarding skew.  
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However, follow-up analyses were conducted by creating categorical variables to further 
corroborate the results.   
 Data Analysis 
This study was exploratory in nature. In general, the study aimed to determine if 
there are differences between those who have different levels of adolescent psychiatric 
pathology and those who do not, and in particular to follow-up preliminary research 
(Wynne, 2009).  The thirteen hypotheses of this study are evaluated with combinations of 
group contrast and correlational analyses.  A hierarchical strategy for data analysis was 
used, starting with omnibus multivariate analyses of variance (MANOVA) performed 
within the domains of measurement selected for analysis (clinical, cognitive, behavioral, 
etc), then continuing to ANOVA’s on specific measures and scales, followed by planned 
comparison cell contrasts, and finally correlational analysis.  Analysis of variance 
(ANOVA) and its variants were the primary statistic used in order to replicate earlier 
results (Wynne, 2009).  One-way ANOVAs with time 1 or time 2 covariates were used 
whenever possible.  Whether or not individuals used services in adolescence, and further 
analyses utilizing Adolescent psychiatric pathology groupings were the between-subjects 
factor and each set of measures were the within-subjects factors.  One tailed t-tests were 
used in analyses because of specific directional hypotheses. In addition, evaluating the 
relationships between categorical variables was accomplished through Chi square 
analysis.  Also, results were compared across the different assessment measures used at 
different time periods at CTP, possibly providing results for future results on different 
factors or clusters of neurocognitive, socialcognitive, symptom, and insight measures that 
can be grouped together to better capture the multidimensional, and perhaps 
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developmental nature of insight in individuals who had varying levels of APP and are 
now participating in psychiatric rehabilitation as adults.   
 Because this is an exploratory study of a very complex database and there was an 
unusual amount of missing data, appropriate use of MANOVA was prevented.  
Significant omnibus MANOVA results were not strictly interpreted as necessary for 
further group comparisons.  Since the specific analyses relate to the respective study 
hypotheses in complex ways, the results will be organized according to the hypotheses, 
with the relevant analyses identified and described for the respective hypotheses in turn. 
 Unequal n correction. Due to the significant differences in the number of 
participants in each condition, a correction of unequal n’s was performed. The most 
accepted procedure that best fits the collected data was used during analysis.    
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CHAPTER 3 – RESULTS 
The overall purpose of this study is to determine if there is a pattern of differential 
functioning for adults with SMI with or without a history of using mental health services 
in adolescence, and further delineated into APP severity groupings, across various levels 
of functioning. Before proceeding to evaluate the hypotheses, descriptive analyses of the 
demographic and clinical characteristics of people with different amounts of service use 
during adolescence are described.   
Demographic and Clinical Characteristics of People at CTP 
Of the 320 participants in this study, 171 (53.4%) used or had contact with mental 
health services during adolescence, see Tables 1-3.  Of the people who did not use 
services during adolescence, 63.1% (n = 94) are male and 35.6% (n = 53) are female.  Of 
the people who did use services 64.1% (n = 109) are male and 35.9% (n = 61) are female; 
the difference in gender proportions between service users and non-users  is not 
statistically significant, X2(1) = 0.001, p = .98. 
Analyses using the No Service Use in adolescence vs. Service Use in adolescence 
distinction reveals a pattern of relationships among several demographic variables.   
There is a significant relationship between diagnostic subtype and mental health service 
use, X2 (8) = 19.14, p = .01 (see Table 4).  Those diagnosed with Schizophrenia, 
Chronic/Undifferentiated Type, Schizoaffective Disorder, and “other” are more likely to 
have used mental health services during adolescence than those diagnosed with 
Schizophrenia, Paranoid Type.  Also, there is a significant relationship between Axis II 
diagnostic subtype and service use, X2 (9) = 18.14, p = .03 (see Table 5).  Those 
diagnosed with Paranoid Personality Disorder are less likely to have received services 
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during adolescence than those diagnosed with Borderline Personality Disorder.  Those 
diagnosed with Borderline Personality Disorder are more likely to have received services 
during adolescence than those without an Axis II diagnosis, which are more likely to 
have not used services during adolescence.   
There is not a significant relationship between race and service use, X2 (5) = 2.37, 
p = .797 (see Table 6).  When those participants identified as African American, 
Hispanic, Asian American, or Other are combined into one category and compared to 
those identified as Caucasian, or “White,” there is not a significant relationship with 
service use, X2 (1) = .007, p = 0.93. This suggests that people who are“Non-White” are 
just as likely as those who are “White” to receive or have access to mental health services 
during adolescence.  There is not a significant relationship between marital status and 
service use, X2 (4) = 6.29, p = .18 (see Table 7).   
Finally, analyses between service use and age, length of stay at CTP, age at first 
hospitalization, number of previous hospitalizations in lifetime, and years of education 
reveal significant relationships. The means and standard deviations for each group for 
these variables are shown in Table 8. Analyses using one-way ANOVAs reveal a 
significant difference between groups in age F (1, 306) = 42.20, p < .001; number of 
years of education, F (1, 281) = 24.31, p < .001; the number of previous hospitalizations, 
F (1, 296) = 4.46, p = .04; and in the age of onset, F (1, 246) = 71.82, p < .001.  There is 
no significant difference between groups on length of stay, F (1, 135) = 2.33, p = .13.  
To summarize the results of the descriptive analyses, those with service use 
during adolescence tend to be younger at admission to CTP, have slightly lower levels of 
education, and have an earlier age of onset and more previous hospitalizations, as 
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expected.  A relationship between Axis I and Axis II diagnoses and service use was 
identified.  Those diagnosed with Schizophrenia, Chronic/Undifferentiated Type, 
Schizoaffective Disorder, and “other” are more likely to have used mental health services 
during adolescence than those diagnosed with Schizophrenia, Paranoid Type.  Those 
diagnosed with Paranoid Personality Disorder are less likely to have received services 
during adolescence than those diagnosed with Borderline Personality Disorder; whereas 
those diagnosed with Borderline Personality Disorder are more likely to have received 
services during adolescence with “other” or no diagnosis. These results are consistent 
with expectations previously outlined and support the reliability of the distinctions made 
between who did or did not use mental health services prior to the age of 18 used in this 
study  
 
Hypothesis 1 
The first hypothesis of this study is to determine if there is a pattern of differential 
functioning between adults with SMI with or without mental health service use during 
adolescence across various levels of functioning both at admission and across treatment.  
In general, it is anticipated that individuals with adolescent psychiatric pathology will 
demonstrate lower overall functioning than those without adolescent psychiatric 
pathology. Because of this, hypothesis 1 predicts that those individuals who used mental 
health services in adolescence will show demonstrably lower overall functioning in the 
clinical setting than individuals who did not use mental health services during 
adolescence.  Thus, it is hypothesized that the service usage will correlate with clinical 
functioning.  Specifically, the groups (No Service Use vs. Service Use) will differ across 
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all domains of functioning measured (neurocognitive, social cognitive, symptomatology, 
and behavioral functioning) at admission and over the course of treatment. 
 
Functioning at Admission 
 Neurocognitive Functioning 
 The RBANS, RCFT, RAVLT, COGLAB Card Sort, Trails A & B, COWAT/FAS, 
and NAB were included in analyses as measures of neurocognitive functioning.  
Bivariate correlations between whether or not individuals used mental health services 
prior to age 18 and the neurocognitive variables included in analyses are shown in Table 
9.  
 Between groups ANOVAs were conducted to maximize the power available to 
detect any differences between individuals who used mental health services in 
adolescence vs. those who did not use services on the neurocognitive variables (Tables 10 
and 11).  Contrary to all hypotheses, on all measures of neurocognition individuals with 
SMI who used services prior to the age of 18 do not demonstrate poorer neurocognitive 
functioning than those who did not use services, all Fs < 3.33, all ps > .07.  Of the 14 
tests, one significant test is expected.  Two reached trend level, p = .07-.08.  However, 
when planned comparisons were made as expected better performance on RCFT 
Recognition was attained by individuals who did not use services prior to the age of 18 
(M = 20.54) than by individuals who had used services prior to age 18 (M = 18.17), t (71) 
= 1.82, p = .04.  Furthermore, as hypothesized better performance on Trails B was 
achieved by individuals without service use prior to age 18 (M = 105.14) than by 
individuals who had used services prior to age 18 (M = 125.24), t (114) = -1.63, p = .05. 
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Also as hypothesized, scores on RBANS Total were greater for individuals without 
service usage in adolescence (M = 75.50) than by individuals who had used services prior 
to age 18 (M = 69.74), t (92) = 1.77, p = .04.  These significant planned comparisons 
indicate analyses utilizing ANOVAs did not have enough power in some instances to 
detect significant differences.  
Furthermore, when individuals who used services prior to age 18 are grouped 
based on adolescent psychiatric pathology, APP severity groups do not differ in 
statistically significant ways on neurocognitive measures at admission, all Fs < 2.18, all 
ps >.10 (Table 11).  Of the 14 tests, one significant test is expected.  However, no tests 
reached trend level. Overall, contrary to hypotheses, these results suggest that participants 
with low, medium, and high APP severities do not significantly differ from those without 
APP at the time of admission, with respect to neurocognitive functioning.   
 
 Social cognitive functioning  
 The I-SEE (FKK), a measure of attributional style, the Hinting Task, a measure of 
theory of mind, the IPSAQ, a measure of interpersonal attributional style, and the CST, a 
measure of coping-related cognition, were used to examine social cognitive differences 
between individuals with SMI who used services in adolescence and those who did not 
use services prior to the age of 18.  It is hypothesized that people who used services prior 
to the age of 18 would demonstrate lower overall sociocognitive functioning than those 
who did not use services.  Furthermore, when analyses utilize APP severity groupings it 
is hypothesized that individuals in the high APP severity group will have the lowest 
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scores on social cognition measures at admission.  Bivariate correlations can be found in 
Table 12.   
Despite not having any significant MANOVA results, univariate ANOVAs were 
conducted to maximize the power available to detect any differences in the 
neurocognitive variables because an extremely low number of valid cases in the 
MANOVA analyses may have prevented any significant differences from being detected.  
Exploratory analyses using one-way between groups ANOVAs reveal no significant 
differences between those who did and did not use services prior to the age of 18 on 
measures of social cognition at admission, all Fs < 2.58, all ps > .12 (Table 13). Of the 17 
tests, one significant test is expected.  However, no tests reached trend level. When 
planned comparisons were completed, no significant differences exist between the 
groups. 
 Furthermore, when APP severity grouping were considered in analyses groups do 
not differ in statistically significant ways on socialcognition measures at admission, all Fs 
< 2.49, all ps >.07 (Table 14).  Of the 14 tests, one significant test is expected.  Two 
reached trend level, p = .07-.08. Overall, contrary to hypotheses, these results suggest that 
participants who used mental health services in adolescence do not significantly differ 
from those without service use in adolescence at the time of admission, with respect to 
social cognitive functioning.  In addition, there do not appear to be substantial differences 
in social cognitive functioning at admission for the various APP severity levels.   
 
Insight  
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 The Birchwood Insight Scale (IS), a measure of insight representing David’s 
(1990) three domains of insight, and the Self-Appraisal of Illness Questionnaire, a 
measure designed to assess attitudes towards mental illness among people receiving 
psychiatric treatment, were used to examine insight differences between individuals with 
SMI who used services in adolescence and those who did not use services prior to the age 
of 18.  It is hypothesized that because of prior contact with services, those individuals 
with contact with mental health services in adolescence have higher levels of insight into 
their disorder at admission than those who did not use mental health services in 
adolescence.  Furthermore, when analyses utilize APP severity groupings, it is 
hypothesized that individuals in the high APP severity group would have greater insight 
scores at admission than individuals with no, low, or medium APP. The bivariate 
correlation matrix for the insight measures and their subscales can be found in Table 15.  
Exploratory analyses using one-way ANOVAs reveal no significant differences 
between those who did and did not use services prior to the age of 18 on measures of 
insight at admission, all Fs < 2.56, all ps > .13 (Table 16).  Of the seven tests, one 
significant test is expected yet none reached trend level. When planned comparisons were 
completed, as expected scores on SAIQ Presence/Outcome of Illness subscale scores 
were greater for individuals with service usage in adolescence (M = 14.29) than for 
individuals who did not use services prior to age 18 (M = 12.20), t (15) = -1.60, p = .05.   
Furthermore, analyses utilizing APP severity groupings indicate APP severity 
groups do not differ in statistically significant ways on insight measures at admission, all 
Fs < 1.59, all ps >.20 (Table 17).  Overall, contrary to hypotheses, these results suggest 
that participants who used mental health services prior to the age of 18 do not 
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significantly differ from those who did not use services in adolescence at the time of 
admission, with respect to insight.  In addition, there are not significant differences in 
insight at admission for the various APP severity levels. Note in Table 17 one significant 
F test is expected and only one reached trend level at p = .06 - .08. 
 
Behavioral functioning 
 The NOSIE total assets score was used as a measure of general behavioral 
functioning. Bivariate correlation of NOSIE subscales can be found in Table 18.  It is 
expected that those who used mental health services prior to the age of 18 would 
demonstrate poorer behavioral functioning at admission than those who did not use 
services in adolescence.  Contrary to the hypothesis, a one-way ANOVA does not reveal 
a significant difference, F (1, 119) = 2.46, p = .12, on total assets between individuals 
without mental health service usage in adolescence (M = 157.68, SD = 24.13) and those 
who used mental health services in adolescence (M = 150.50, SD = 26.26) (Table 18).  Of 
the seven tests, one significant test is expected yet none reached trend level. When 
planned comparisons were completed, no significant differences between those with 
mental health service usage in adolescence and those without mental health service usage 
in adolescence. 
In addition, it is hypothesized that individuals in the high APP severity group 
demonstrate poorer functioning on behavioral functioning measures. When NOSIE total 
assets are examined across APP severity groups using a one-way ANOVA, contrary to 
hypotheses individuals with more severe adolescent psychiatric pathology do not 
 
53 
demonstrate poorer behavioral functioning at admission than those individuals with none, 
low, and medium APP, F (3, 117) = 1.60, p = .19 (Table 19). 
 Because the NOSIE is comprised of three adaptive functioning scales and three 
maladaptive functioning scales, further exploratory analyses were conducted to determine 
if differences were apparent across all areas of functioning assessed by the NOSIE or 
whether the differences were specific to particular subscales.  Pearson correlations reveal 
significant intercorrelations among all subscales and the total assets score. The bivariate 
correlation matrix can be found in Table 17.   
 Follow-up analyses did not reveal significant differences between those with 
mental health service use prior to age 18 and those without mental health service use 
prior to age 18 on the NOSIE subscales at admission, all Fs < 2.46, all ps >.12 (see Table 
18).  When NOSIE subscales were examined across APP severity groups using a one-
way ANOVA, contrary to hypotheses individuals with more severe adolescent 
psychiatric pathology do not demonstrate poorer behavioral functioning on five of six 
subscales at admission than those individuals with none, low, and medium APP, all Fs < 
2.15, all ps > .09.  Differences between APP severity groups are found for the NOSIE 
Motor Retardation subscale, F (3, 117) = 2.70, p = .05 (see Table 19 for means and 
standard deviations).  However, contrary to hypotheses, individuals in the high APP 
group have lower NOSIE Motor Retardation scores, thus indicating better functioning, 
than those in the medium and low APP groups and had NOSIE Motor Retardation scores 
equivalent to those without APP (LSD minimum mean difference = 2.1). 
 Overall, results of NOSIE analyses do not support hypotheses that those with 
mental health service use in adolescence demonstrate poorer behavioral functioning upon 
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admission than those without mental health service use in adolescence.  Furthermore, 
hypotheses are not supported that differences in behavioral functioning at admission exist 
between the different APP severity groupings.  Although significant difference was found 
on the NOSIE Motor Retardation subscale, results were opposite to hypothesized and the 
high APP severity group received lower scores than individuals in the low and medium 
APP severity groups.    
  
 Symptomatology 
 It was hypothesized that individuals who used mental health services in 
adolescence would have a higher level of symptomatology at admission than those who 
did not use services prior to the age of 18 .  Contrary to hypothesis, a one-way ANOVA 
reveals no significant mean difference, F (1, 154) = 0.10, p = .75, in overall 
symptomatology at admission as measured by the BPRS total score between those who 
used mental health services prior to age 18 (M = 48.29, SD = 14.62) and those who did 
not use services prior to age 18 (M = 47.60, SD = 12.15).  Also it was hypothesized that 
when APP severity groupings are considered those individuals with the most severe APP 
demonstrate a higher level of symptomatology than those with less severe APP. Contrary 
to hypothesis, there is no significant mean difference, F (1, 154) = 0.10, p = .75, in 
overall symptomatology between those without APP and the various levels of APP 
severity (Tables 22 and 23). 
Six factor scores for the BPRS were computed in order to evaluate symptom 
groupings as opposed to the gross overall measure of symptomatology provided by the 
total score. The six factors used were Psychotic Disorganization, 
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Hallucinations/Delusions, Paranoia, Emotional Blunting, Agitation/Elation and 
Anxiety/Depression.  One-way ANOVAs for each of the BPRS factor scores were 
conducted to determine whether differences existed between groups in symptom areas.  
There are no significant differences between individuals who used mental health services 
prior to the age of 18 and those who did not use services prior to age 18 for any of the 
symptom factor scores, all Fs < 2.65, all ps >.11, see Table 22.  Of the six tests, one 
significant test is expected yet none reached trend level. When planned comparisons were 
completed, contrary to hypothesis scores on BPRS Paranoia Factor scores were greater 
for individuals without service usage in adolescence (M = 9.00) than for individuals who 
did use services in adolescence (M=8.14), t (155) = 1.63, p = .05.  Furthermore, when 
analyses consider differences between APP severity groupings, there are no significant 
mean differences for any symptom factor scores, all Fs < 1.48, all ps >.22, see Table 23.  
Of the six tests, one significant test is expected yet none reached trend level. 
 Finally, one-way ANOVAs for each of the 24 BPRS items were conducted to 
determine if there were differences in any specific symptoms between individuals who 
used mental health services prior to age 18 and those individuals who did not use 
services.  Two significant differences emerged.  People who used mental health services 
in adolescence (M = 1.79, SD = 1.37) have a higher rating of Suicidality, F (1, 156) = 
10.36, p = .002, than those who did not use mental health services in adolescence (M = 
1.23, SD = .62). Although a significant difference occurs between the groups on 
Uncooperativeness, F (1, 155) = 3.91, p = .05, contrary to hypothesis those who did not 
use services in adolescence (M = 1.83, SD = 1.23) have a  higher rating of 
Uncooperativeness than those individuals who used services in adolescence (M = 1.49, 
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SD = .91).  Results of all the one-way ANOVAs can be found in Table 24.  Of the 24 
analyses, one is expected to be significant.  Two analyses were significant and three 
analyses reached trend level, p = .06.  When planned comparisons were completed, as 
hypothesized scores on BPRS Suicidality item scores were greater for individuals with 
service usage in adolescence (M = 1.79) than for individuals who did not use services in 
adolescence (M = 1.23), t (156) = -3.22, p < .001.  Also, as hypothesized BPRS Guilt 
item scores were greater for individuals with service usage in adolescence (M = 2.19) 
than for individuals who did not use services in adolescence (M = 1.84), t (156) = -1.69, p 
= .05.  As hypothesized, BPRS Hallucination item scores were greater for individuals 
with service usage in adolescence (M = 2.41) than for individuals who did not use 
services in adolescence (M = 1.87), t (156) = -1.91, p = .03.  Also, as hypothesized BPRS 
Self-Neglect item scores were greater for individuals with service usage in adolescence 
(M = 2.39) than for individuals who did not use services in adolescence (M = 2.05), t 
(156) = -1.89, p = .03.  Contrary to hypotheses, BPRS Grandiosity item scores were 
lower for individuals with service usage in adolescence (M = 1.63) than for individuals 
who did not use services in adolescence (M = 2.13), t (156) = 1.88, p = .03.   Also 
contrary to hypotheses, BPRS Suspiciousness item scores were lower for individuals with 
service usage in adolescence (M = 2.33) than for individuals who did not use services in 
adolescence (M = 2.77), t (156) = 1.62, p = .05.  Finally, contrary to hypotheses BPRS 
Uncooperativeness item scores were lower for individuals with service usage in 
adolescence (M = 1.49) than for individuals who did not use services in adolescence (M = 
1.83), t (155) = 1.95, p = .03.  Results of these planned comparisons indicated analyses 
using ANOVAs did not have enough power to detect significant differences.       
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 One-way ANOVAs for each of the 24 BPRS items were conducted to determine 
if there are differences in any specific symptoms between those with no APP, low APP, 
medium APP, and high APP and two significant differences emerged.  Partial support for 
hypotheses is found as people with medium or high APP have a higher rating on 
Suicidality, F (3, 154) = 5.34, p = .002, than those without APP or low APP. A 
significant difference is found between the groups on Disorientation, F (3, 153) = 3.73, p 
= .01.  Contrary to hypothesis, those with no, medium, or high APP receive lower ratings 
of Disorientation than those with low APP.  Results of all the one-way ANOVAs can be 
found in Table 24.  Of the 24 analyses, one is expected to be significant.  Two analyses 
were significant and no analyses reached trend level. 
Further analyses of symptomatology measures at admission included the SPS, 
BDI-II, and the BHS. Again, it was anticipated that individuals who used services in 
adolescence would have a higher level of symptomatology at admission than individuals 
who did not use services in adolescence.  One-way ANOVAs for the BDI-II, BHS, SPS 
Suicidality scale, SPS Negative Self-Evaluation scale, and the SPS Hostility scale at 
admission reveal no significant mean differences, all Fs < 3.30, all ps > .07 (Table 22).  
Two significant differences emerge for the SPS Total score and the SPS Hopelessness 
scale score.  As hypothesized, people who used mental health services in adolescence (M 
= 61.02, SD = 10.22) receive higher symptomatology scores as measured by the SPS 
Total score, F (1, 122) = 7.41, p = .01, than those who did not use mental health services 
in adolescence (M = 56.02, SD = 10.19), and further directional planned compairisons 
also found this result, t (122) = -2.72, p < .01. Also, as hypothesized, people who used 
mental health services in adolescence (M = 57.48, SD = 13.09) received higher 
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symptomatology scores as measured by the SPS Hopelessness score, F (1, 122) = 3.76, p 
= .05, than those who did not use mental health services in adolescence (M = 53.33, SD = 
10.42), planned comparisons for this variable were also significant, t (122) = -1.94, p = 
.03.  Further planned comparisons found as hypothesized SPS Hostility scores were 
higher for individuals with service usage in adolescence (M = 56.88) than for individuals 
who did not use services in adolescence (M=52.81), t (121) = -1.82, p = .04. 
One-way ANOVAs were also conducted to determine if there were differences in 
any specific symptoms between those with no APP, low APP, medium APP, and high 
APP and two significant differences emerged.  Partial support for hypotheses is found as 
people with medium or high APP (which were equivalent to each other) are rated with a 
higher level of symptomatology as measured by the SPS Total score, F (3,120) = 3.34, p 
= .02, than those without APP or low APP. Results of all the one-way ANOVAs and 
means and standard deviations can be found in Table 23.   
Overall, results of analyses using the BPRS total, BPRS factor scores, and BPRS 
items suggest that only a significant relationship exists on two BPRS items for service 
use and level of symptomatology. The amount of significant differences between those 
who used services in adolescence and those who did not use services in adolescence is 
close to what is expected to occur by chance, thus lowering confidence that these 
differences occur due to specific differences between the groups on measures of 
symptomatology. Although those who used services prior to adolescence receive higher 
suicidality scores than those who did not use services, those who did not use services in 
adolescence are deemed more uncooperative than individuals who did use mental health 
services in adolescence.  Planned comparisons found that individuals with service usage 
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in adolescence are rated higher on suicidality, guilt, hallucinations, and self-neglect.  
However, contrary to hypotheses results from planned comparisons indicate individuals 
with mental health service usage are rated lower on grandiosity, suspiciousness, and 
uncooperativeness.  When analyses are conducted between APP severity level and BPRS 
total, BPRS factor scores, and BPRS items only two significant differences emerge.  
Again as hypothesized, those individuals with medium or high APP receive higher 
suicidality scores than those without APP or in the low APP severity group.   
Results of analyses of symptomatology at admission using the BDI-II, BHS, and 
SPS Total and SPS scales suggest several differences exist.  As hypothesized, individuals 
who had mental health services in adolescence demonstrate more symptomatology at 
admission than those who did not have services in adolescence as measured by the SPS 
Total and SPS Hopelessness scale scores.  Planned comparisons also found that 
individuals with mental health service usage in adolescence have more hostility as 
measured by the SPS Hostility scale.  When analyses are conducted between 
symptomatology measures and APP severity levels, partial support for hypotheses is 
found, as individuals with medium or high APP receive higher SPS Total scores than 
those with no or low APP. 
   
Functioning Over the Course of Treatment  
When analyzing difference over the course of treatment, it is predicted that 
overall differences in functioning and symptomatology, and will not remain over the 
course of treatment.  It is hypothesized that as a result of psychiatric rehabilitation there 
will be an increase in neurocognitive functioning, insight into disorder, internal locus of 
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control, and behavioral functioning and a decrease in external locus of control and 
symptomatology for those who did and did not use services in adolescence.  That is, it is 
hypothesized that both groups will show improvement in functioning over the course of 
psychiatric rehabilitation.  However, it is predicted that those individuals who used 
services prior to age 18 will demonstrate higher symptomatology after 12 months of 
rehabilitation.  Furthermore, when different levels of adolescent psychiatric pathology are 
used in analyses, it is predicted that as adolescent psychiatric pathology becomes more 
severe functioning will decrease and there will be higher symptomatology.  Overall, 
while it is hypothesized there will be differences in a variety of domains it is also 
hypothesized that differences in insight upon admission will not remain one-year after 
beginning psychiatric rehabilitation.   
 
 Neurocognitive Functioning Across Treatment. 
 As described above, it was anticipated that while there will be difference in 
neurocognitive functioning between those who used mental health services in 
adolescence and those who did not use services in adolescence, neurocognitive 
functioning will improve over the course of treatment for both groups, and there will be 
no differences between groups on neurocognitive measures after one year of treatment.  
A 2 (service use) x 3 (assessment time) repeated measure ANOVA was completed for 
each measure.   
There is not an interaction of assessment time and service use as they relate to 
WCST Correct score (F(2, 72) = .64, p = .53).  Contrary to hypotheses, there is no main 
effect for WCST correct over time (F(2, 72) = .66, p = .52) or for service use (F(1, 36) = 
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1.35, p = .25). However, when planned comparisons were analyzed contrary to 
hypothesis WCST correct scores were higher for individuals with service usage in 
adolescence (M = 24.66) than for individuals who did not use services in adolescence (M 
= 21.74), t (58) = -2.01, p = .02.  There is not an interaction between assessment time and 
service use as they relate to WCST Perseverative Errors (F(2, 112) = 1.36, p = .26).  
Contrary to hypotheses, there is no main effect of time for WCST Perseverative Errors 
(F(2, 112) = 2.53, p = .08).  However, there is a main effect for service use (F(1, 56) = 
5.13, p = .03), with more overall WCST Perseverative errors made by those who did not 
use services prior to age 18  (M = 26.72, SD = 16.00) than from those individuals who did 
use services prior to the age of 18 (M = 20.52, SD = 11.58) (LSD minimum mean 
difference = 3.90). However, this pattern of the main effect is only descriptive for 
performance after six months and one year of participating in a psychiatric rehabilitation 
program   
WCST Perseverative Errors Score Across Treatment
0
5
10
15
20
25
30
35
Time 1 Time 2 Time 3
Assessment Time
WC
ST
 Pe
rse
ve
rat
ive
 
Er
ror
s S
co
re No Service Use
Service Use
 
Figure 3.1 Service Main Effect for Service Usage Groups on WCST Perseverative Error Score Across 
Treatment 
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There is no interaction between assessment time and service use as they relate to 
WCST Random Errors over time (F(2, 112) = 0.17, p = .84).  As hypothesized, there is a 
main effect for WCST Random Errors over time (F(2, 112) = 3.66, p = .03), with more 
random errors made at admission than after six to twelve months of rehabilitation, 
representing an increase in neurocognitive functioning (LSD minimum mean difference = 
2.98).  This pattern is descriptive for both those that did and did not use mental health 
services in adolescence.  As hypothesized, a main effect for service use is not found (F(1, 
56) = 0.71, p = .41) and differences do not exist between those who did and did not use 
mental health services in adolescence after one year of treatment.  
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Figure 3.2 Time Main Effect for Service Usage Groups on WCST Random Error Score Across Treatment 
 
 
There is not an interaction between assessment time and service use as they relate 
to WCST Consolidation Index scores (F(2, 72) = .10, p = .91).  Contrary to hypothesis 
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there is no main effect for WCST Consolidation Index scores over time (F(2, 72) = 1.92, 
p = .15) or for service use (F(1, 36) = .71, p = .40).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 26, 29 - 32. 
There is an interaction of assessment time and service use as they relate to 
RAVLT scores (F(2, 18) = 5.25, p = .02, Mse = 2.34).  The pattern of this interaction is 
that RAVLT performance increased over time as hypothesized for those that did not use 
mental health services in adolescence, whereas contrary to hypothesis individuals who 
did use services in adolescence demonstrate no significant difference on RAVLT scores 
from admission to 6 and scores decrease at one year of treatment (LSD minimum mean 
difference = 1.37).  However, individuals who used mental health services in adolescence 
receive higher RAVLT scores at admission and six months than those who did not 
services in adolescence and as hypothesized this difference between groups does not exist 
after one year of treatment (Table 27, 33). Planned comparisons found no difference 
between groups at time one, however contrary to hypothesis RAVLT scores were higher 
for individuals with service usage in adolescence (M = 9.50) than for individuals who did 
not use services in adolescence (M=6.43), t (30) = -2.61, p = .01. Again, as hypothesized 
planned comparisons found no differences in RAVLT scores between groups after one 
year of treatment There is no main effect for RAVLT over time (F(2, 18) = .24, p = .79) 
or for service use (F(1, 9) = 2.19, p = .17).  
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RAVLT Scores Across Treatment
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Figure 3.3 Interaction Between Service Usage Groups on RAVLT Scores Across Treatment 
 
Contrary to hypotheses, there is not an interaction of assessment time and service 
use as they relate to NAB total score (F(2, 26) = .47, p = .63, Mse = 52.61).  Contrary to 
hypotheses, there was no main effect for NAB total scores over time (F(2, 26) = 1.74, p = 
.20) or for service use (F(1, 13) = .28, p = .61) (Tables 27 and 34). 
There is no interaction of assessment time and service use as they relate to RCFT 
Copy score (F(2, 60) = .19, p = .82, Mse = 18.89) or RCFT Recognition score (F(2, 60) = 
.63, p = .54, Mse = 11.58).  There is no main effect for RCFT Copy scores over time 
(F(2, 60) = 1.75, p = .18) or for RCFT Recognition scores over time (F(2, 60) = .55, p = 
.58).  Also there is no main effects for service use for RCFT Copy scores (F(1, 30) = .32, 
p = .58) or RCFT Recognition scores (F(1, 30) = .04, p = .85).   
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There is no interaction between assessment time and service use as they relate to 
RCFT Immediate Memory scores over time (F(2, 60) = 1.37, p = .26, Mse = 186.63).  As 
hypothesized, there is a main effect for RCFT Immediate Memory scores over time (F(2, 
60) = 4.62, p = .01), with no significant difference on scores from admission to six 
months however improvement in scores occurred at one year (LSD minimum mean 
difference = 6.83).  However, this pattern is only descriptive for those who used mental 
health services in adolescence.  A main effect for service use is not found (F(1, 30) = 
3.60, p = .07).  
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Figure 3.4 Time Main Effect for Service Usage Groups on RCFT Immediate Memory Scores 
Across Treatment 
 
There is no interaction between assessment time and service use as they relate to 
RCFT Delayed Memory scores over time (F(2, 60) = .13, p = .88, Mse = 30.90).  As 
hypothesized, there is a main effect for RCFT Delayed Memory scores over time (F(2, 
60) = 4.89, p = .01), with no significant difference on scores from admission to six 
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months and improvement in scores at one year (LSD minimum mean difference = 2.78).  
This pattern is descriptive for those who did and did not use services in adolescence.  A 
main effect for service use is not found (F(1, 30) = 1.69, p = .20).  Results of repeated 
measure ANOVAs and means and standard deviations can be found in Tables 28, and 39 
- 42.  
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Figure 3.5 Time Main Effect for Service Usage Groups on RCFT Delayed Memory Scores Across 
Treatment 
 
There is an interaction of assessment time and service use as they relate to Trails 
A performance (F(2, 110) = 3.38, p = .04, Mse = 165.13).  As hypothesized, the pattern 
of this interaction is that Trails A performance was slower, and thus worse, at admission  
than at 6 months and one year (which were equivalent to each another) (LSD minimum 
mean difference = 2.78) for those who used mental health services in adolescence.  
However, partial support is found for hypotheses for those who did not use mental health 
services prior to age 18, as their performance worsens from admission to six months, 
however improves from six to twelve months. At admission, those who did not use 
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mental health services prior to age 18 demonstrate poorer performance on Trails A than 
those who did not use mental health services in adolescence.. At six months, those who 
did not use services prior to age 18 demonstrate poorer performance than those who did 
use services prior to age 18, however, as hypothesized after one year of treatment 
differences in Trails A performance do not exist between the two groups. There is no 
overall main effect for Trails A over time (F(2, 110) = .51, p = .60) or for service use 
(F(1, 55) = .004, p = .95).    
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Figure 3.6 Interaction Between Service Usage Groups on Trails A Performance Across Treatment 
 
There is no interaction between assessment time and service use as they relate to 
Trails B performance (F(2, 110) = .53, p = .59.  Contrary to predictions, there is no 
overall main effect for Trails B over time and both groups do not demonstrate better 
performance over the course of treatment (F(2, 110) = .12, p = .89).  There is also no 
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main effect for service use (F(1, 55) = .20, p = .66).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 27, and 35-36. 
There is an interaction between assessment time and service use as they relate to 
COWAT/FAS score over time (F(2, 114) = 3.02, p = .05, Mse = 44.09).  Contrary to 
hypothesis, the pattern of this interaction is that although COWAT/FAS performance 
improves from six months to one year for those who did not use mental health services in 
adolescence, performance at one year is lower than at admission (LSD minimum mean 
difference = 1.41).  However, for those who did use mental health services in adolescence 
performance is equivalent from admission to six months, however improves from six to 
twelve months. While those who did not use services prior to age 18 perform better on 
the COWAT/FAS at admission, this difference does not exist at six months.  Contrary to 
hypotheses, after one year of treatment those who did use services prior to age 18 
demonstrate better performance than those who did not use services prior to age 18. Also, 
contrary to hypotheses there is no overall main effect for COWAT/FAS over time (F(2, 
114) = 1.91, p = .15) or for service use (F(1, 57) = .06, p = .82). Results of repeated 
measure ANOVAs and means and standard deviations can be found in Tables 27 and 37. 
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COWAT Scores Across Treatment
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Figure 3.7 Interaction Between Service Usage Groups on COWAT Scores Across Treatment 
 
There is an interaction of assessment time and service use as they relate to 
RBANS Total score (F(2, 108) = 3.65, p = .03, Mse = 51.18).  Partial support for 
hypotheses is found, as the pattern of this interaction is that RBANS Total score 
improves from admission to six months but does not improve from 6 months to one year 
for those who used mental health services prior to age 18, although scores at one year are 
better than at admission (LSD minimum mean difference = 3.82).  For those who did not 
use services prior to age 18, performance does not improve from admission to six 
months, however improves from six to twelve months.  As hypothesized, there is a main 
effect for overall RBANS Total score over time (F(2, 108) = 9.82, p < .001), with 
performance remaining the same from admission to six months but improving from six to 
twelve months of rehabilitation (LSD minimum mean difference = 2.70).  This pattern is 
only descriptive for those who did not use services in adolescence.  There is no overall 
main effect for service use (F(1, 54) = 1.67, p = .20).  Results of repeated measure 
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ANOVAs and means and standard deviations can be found in Tables 27 and 38. When 
planned comparisons were completed, as hypothesized and previously stated individuals 
without mental health service usage had higher RBANS scores at admission than those 
who used mental health services in adolescence.  However, contrary to hypotheses, 
differences existed between groups after one year of treatment.  Individuals without 
mental health service usage in adolescence had higher RBANS scores (M = 81.60) than 
for individuals who did not use services in adolescence (M=75.71), t (73) = 1.64, p = .05. 
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Figure 3.8 Time Main Effect and Interaction Between Service Usage Groups on RBANS Total Scores 
Across Treatment 
 
When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs 
are conducted using APP severity levels, no interactions, assessment time main effects, or 
APP severity level main effects are found for the following neurocognition measures: 
WCST Correct, WCST Perseverative Errors, WCST Random Errors, WCST 
Consolidation Index, NAB Screener Total score, RCFT Copy, RCFT Recognition, Trails 
A and B, and COWAT/FAS (all Fs < 2.66, all ps > .06).  Contrary to hypotheses, 
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increases in neurocognitive functioning over treatment as measured by the previously 
mentioned measures are not found when analyses included APP severity levels.  Also, 
contrary to hypotheses those with more severe levels of APP do not demonstrate poorer 
neurocognitive functioning on these measures at any assessment time.  However, as 
hypothesized differences do not remain amongst the groups after one year of treatment.  
Results of repeated measure ANOVAs utilizing APP severity levels and means and 
standard deviations can be found in Tables 44 - 59. 
There is an interaction between assessment time and APP severity level as they 
relate to RAVLT scores (F(4, 16) = 3.88, p = .02, Mse = 2.11).  No individuals in the low 
APP severity group completed RAVLT assessments and therefore are not included in 
analyses.  RAVLT performance for individuals with no APP does not change from 
admission to six months, however, performance increases from six to twelve months.  For 
individuals in the medium APP severity group, RAVLT performance does not change 
during treatment, whereas for those in the high APP severity group RAVLT performance 
increases from admission to six months but decreases from six to twelve months (which 
was equivalent to performance at admission) (LSD minimum mean difference = 2.27).  
RAVLT performance at admission is equal for the no APP group and medium APP group 
and for the medium and high APP groups, however contrary to hypotheses individuals in 
the high APP severity group demonstrate better performance than those in the no APP 
group on the RAVLT at admission.  At six months, contrary to hypotheses those in the 
high APP severity group demonstrate the highest performance on the RAVLT, followed 
by those in the medium APP severity group.  As hypothesized, these differences in 
RAVLT performance do not remain after one year of treatment. There is no main effect 
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for RAVLT over time (F(2, 16) = .15, p = .86) or for APP severity level (F(2, 8) = 1.06, p 
= .39). Results of repeated measure ANOVAs and means and standard deviations can be 
found in Tables 45, 50. 
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Figure 3.9 Interaction Between APP Severity Levels on RAVLT Scores Across Treatment 
 
There is no interaction between assessment time and APP severity levels as they 
relate to RCFT Immediate Memory scores (F(6, 56) = 1.76, p = .12, Mse = 175.91).  
There is an overall main effect for RCFT Immediate Memory scores over time (F(2, 56) 
= 5.66, p = .01), with no significant difference on scores from admission to six months 
and partial support for hypotheses as there are improvements in performance from six to 
twelve months. While performance for all APP severity groups remains the same from 
admission to six months, improvements in RCFT Immediate Memory scores from six to 
twelve months only occur for those in the low and high APP severity levels (LSD 
minimum mean difference = 6.70).  A main effect for APP severity level is not found 
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(F(3, 28) = 1.27, p = .31).  Results of repeated measure ANOVAs and means and 
standard deviations can be found in Tables 46, 57. 
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Figure 3.10 Time Main Effect for APP Severity Levels on RCFT Immediate Memory Scores Across 
Treatment 
 
There is no interaction between assessment time and APP severity levels as they 
relate to RCFT Delayed Memory scores (F(6, 56) = 2.14, p = .06, Mse = 27.06).  There is 
an overall main effect for RCFT Delayed Memory scores over time and partial support 
for hypotheses (F(2, 56) = 6.23, p < .01), with no significant difference on scores from 
admission to six months and improvements in performance from six to twelve months. 
This pattern of performance is only descriptive for no APP and high APP severity groups 
(LSD minimum mean difference = 2.63).  A main effect for APP severity level is not 
found (F(3, 28) = .55, p = .65).  Results of repeated measure ANOVAs and means and 
standard deviations can be found in Tables 46, 58. 
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Figure 3.11 Time Main Effect for APP Severity Levels on RCFT Delayed Memory Scores Across 
Treatment 
 
There is an interaction between assessment time and APP severity level as they 
relate to RBANS total scores (F(6, 104) = 2.40, p = .03, Mse = 49.84).  RBANS 
performance for individuals with no or low APP does not change from admission to six 
months, however performance increases from six to twelve months.  For individuals in 
the medium APP severity group, RBANS performance does not change during treatment, 
whereas for those in the high APP severity group RBANS performance increases from 
admission to six and twelve months (which were equivalent to each other) (LSD 
minimum mean difference = 5.34).  RBANS performance at admission is equal for the 
no, low, and medium APP groups; however as hypothesized, individuals in the high APP 
severity group have lower RBANS total scores than those in the no APP group at 
admission.  At six months, RBANS performance is equivalent for all APP severity 
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groups.  After one year of treatment, contrary to hypotheses, those in the no and low APP 
severity groups have higher RBANS total scores than those in the medium and high APP 
severity groups and those in the high APP severity group have higher RBANS total 
scores than those in the medium APP severity group. There is an overall main effect for 
RBANS total score over time (F(2, 104) = 6.37, p < .01) with RBANS performance 
remaining the same from admission to six months but improving by one year of 
treatment.  However, this main effect is only descriptive for individuals in the no and low 
APP severity groups.  There is not a main effect for APP severity level (F(3, 52) = .80, p 
= .50). Results of repeated measure ANOVAs and means and standard deviations can be 
found in Tables 45, 55. 
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Figure 3.12 Time Main Effect and Interaction Between APP Severity Levels on RBANS Total Scores 
Across Treatment 
 
In summary, results of analyses between those who used mental health services 
prior to age 18 and those who did not use services and neurocognitive functioning at 
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admission and over the course of treatment suggest that improvements in neurocognitive 
functioning are evident over the course of treatment on WCST Random Errors, for 
individuals who did not use services prior to age 18 on the RAVLT, for individuals who 
did use services in adolescence on RCFT Immediate Memory, for both groups on RCFT 
Delayed Memory, for individuals that used services in adolescence on Trails A, for those 
who used services on adolescence on COWAT/FAS, and for both groups on RBANS 
total.  Results of analyses between assessment time and APP severity level indicate 
improvements in neurocognitive functioning occur over the course of treatment on the 
RAVLT for those without APP, for those with low or high APP on RCFT Immediate 
Memory, for those with none or high APP on RCFT Delayed Memory, and for those in 
the none, low, or high groups on RBANS total performance.   
When analyses are conducted between those who used services in adolescence 
and those who did not use services in adolescence, as hypothesized no differences exist 
between groups after one year of psychiatric rehabilitation on the following measures: 
WCST Correct, WCST Perseverative Errors, WCST Random Errors, WCST 
Consolidation Index, RCFT Copy, RCFT Recognition, RCT Immediate and Delayed 
Memory, NAB total, RAVLT, and Trails A and B performance.  Contrary to hypotheses, 
individuals who used mental health services in adolescence demonstrate better 
performance on the COWAT/FAS after one year of treatment than individuals who did 
not user services in adolescence.  However, individuals who did not use services in 
adolescence demonstrate poorer performance on the RBANS total after one year of 
treatment than those who did use mental health services in adolescence. 
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Finally, when analyses are conducted utilizing APP severity level, as 
hypothesized no differences exist between groups after one year of psychiatric 
rehabilitation on the following measures: WCST Correct, WCST Perseverative Errors, 
WCST Random Errors, WCST Consolidation Index, RCFT Copy, RCFT Recognition, 
RCT Immediate and Delayed Memory, NAB total, RAVLT, and Trails A and B 
performance.  Contrary to hypotheses, individuals with high APP demonstrate better 
performance on the RAVLT at admission and six months, however as hypothesized this 
difference does not remain after one year of treatment.  As hypothesized, those 
individuals with high APP demonstrate poorer performance on the RBANS total at 
admission.  However, contrary to hypotheses difference remain between the groups at 
twelve months and those without APP or low APP perform better on the RBANS than 
those in the medium or high APP severity groups.   
 
 Social Cognitive Functioning Across Treatment 
 It is anticipated that individuals with and without mental health service usage in 
adolescence demonstrate an increase in functioning, a decrease in external locus of 
control, and a increase in internal locus of control.  Furthermore, when different levels of 
adolescent psychiatric pathology are considered, it is hypothesized as APP becomes more 
severe functioning decreases, however any differences will not remain between groups 
after one year of treatment.  A 2 (service use) x 3 (assessment time) repeated measure 
ANOVA was completed for each measure.   
There is not interaction between assessment time and service use as they relate to 
Hinting scores over time (F(2, 102) = .21, p = .81, Mse = 6.32) (Table 61, 63).  As 
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hypothesized, there is a main effect for Hinting scores over time (F(2, 102) = 8.32, p < 
.001), with improvement on scores from admission to six months and one year (which 
were equivalent to each other) (LSD minimum mean difference = .98).  This pattern was 
descriptive for both those with and without mental health service usage in adolescence.  
A main effect for service use is not found (F(1, 51) = .01, p = .93). 
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Figure 3.13 Time Main Effect for Service Usage Groups on Hinting Task Scores Across Treatment 
 
There is not an interaction between service use and assessment time as they relate 
to FKK Internal Locus of Control (F(2, 50) = .80, p = .46, Mse = 21.14).  Contrary to 
hypotheses, there is no main effect for FKK Internal Locus of Control scores over time 
and internal locus of control does not increase over treatment for either group (F(2, 50) = 
.27, p = .77).  There is also not a main effect for service use (F(1, 25) = .06, p = .82). 
There is not an interaction between service use and assessment time as they relate to FKK 
Self Concept scores (F(2, 50) = .71, p = .50, Mse = 12.23).  Contrary to hypotheses, there 
is no main effect for FKK Self Concept, a subscale of FKK Internal Locus of Control, 
scores over time (F(2, 50) = 1.14, p = .33).  There is not a main effect for service use 
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(F(1, 25) = .33, p = .57). There is not an interaction of assessment time and service use as 
they relate to FKK Self Efficacy scores (F(2, 50) = .48, p = .62, Mse = 44.46).  Contrary 
to hypotheses, there is no main effect for FKK Self Efficacy scores over time (F(2, 50) = 
.11, p = .90).  There is no main effect for service use (F(1, 25) = .25, p = .62). Results of 
repeated measure ANOVAs and means and standard deviations can be found in Tables 
60, and 64 - 66. 
There is not an interaction between assessment time and service use as they relate 
to FKK Powerful Others (F(2, 50) = .90, p = .41, Mse = 18.42).  Contrary to hypotheses 
that performance on this subscale of FKK External Locus of Control would decrease over 
time, there is no main effect for FKK Powerful Others scores over time (F(2, 50) = 1.04, 
p = .36).  There is also no main effect for service use (F(1, 25) = .33, p = .57).   
There is an interaction of assessment time and service use as they relate to FKK 
Chance scores (F(2, 50) = 5.29, p = .01, Mse = 19.93).  Partially supporting hypotheses, 
the pattern of this interaction is that FKK Chance scores remained the same across 
treatment for those without mental health service usage in adolescence, whereas as 
hypothesized FKK Chance scores were highest (more external locus of control) at 
admission than at 6 months to one year (which were equivalent to each other) for those 
who used mental health services in adolescence (LSD minimum mean difference = 3.47).  
While FKK Chance scores are equivalent to one another at admission for those with and 
without mental health service usage in adolescence, contrary to the hypothesis those 
without mental health service usage in adolescence have higher FKK Chance scores at 
six and twelve months than those who used mental health services in adolescence. 
Planned comparisons also found this result at six months, t (46) = 1.87, p = .03, and at 
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one year, t (34) = 1.72, p = .05. There is a main effect for overall FKK Chance score over 
time (F(2, 50) = 4.66, p = .01), as hypothesized FKK Chance scores are higher at 
admission than at six to twelve months of rehabilitation (which were equivalent to each 
other) (LSD minimum mean difference = 2.46).  This pattern is only descriptive for those 
who used mental health services in adolescence.  There is no overall main effect for 
service use (F(1, 25) = 1.13, p = .30).  Results of repeated measure ANOVAs and means 
and standard deviations can be found in Tables 60, 67 - 68. 
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Figure 3.14 Time Main Effect and Interaction Between Service Usage Groups on FKK Chance Subscale 
Scores Across Treatment 
 
There is an interaction of assessment time and service use as they relate to FKK 
External Locus of Control score over time (F(2, 50) = 3.87, p = .03, Mse = 51.98).  
Contrary to the hypothesis, the pattern of this interaction is that FKK External Locus of 
Control scores remain the same across treatment for those who did not use mental health 
services in adolescence, whereas as hypothesized FKK Chance scores are highest at 
admission than at 6 months to one year (which are equivalent to each other) for those 
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who did use mental health services in adolescence (LSD minimum mean difference = 
5.61).  While FKK External Locus of Control scores are equivalent to one another at 
admission for those with and without mental health service usage prior to age 18, 
contrary to the hypothesis those without service usage in adolscence had higher FKK 
External Locus of Control scores at six and twelve months than those with APP.  Planned 
comparisons only found this difference at six months, t (46) = 1.90, p = .03.  There is a 
main effect for overall FKK External Locus of Control score over time (F(2, 50) = 3.77, 
p = .03), as hypothesized FKK External Locus of Control scores are higher at admission 
than at six to twelve months of rehabilitation (which are equivalent to each other) (LSD 
minimum mean difference = 3.97).  This pattern is only descriptive for those who used 
mental health services in adolescence.  There is no overall main effect for service use 
(F(1, 25) = .74, p = .40).  Results of repeated measure ANOVAs and means and standard 
deviations can be found in Tables 60 and 69. 
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Figure 3.15 Time Main Effect and Interaction Between Service Usage Groups on FKK Externality Scale 
Scores Across Treatment 
 
 
82 
There is not an interaction of assessment time and service use as they relate to 
IPSAQ Internal Positive score (F(2, 30) = 2.85, p = .07, Mse = 5.67).  There is no main 
effect for IPSAQ Internal Positive scores over time (F(2, 30) = .39, p = .68) or for service 
use (F(1, 15) = 2.15, p = .16).  There is no interaction between assessment time and 
service use as they relate to IPSAQ Personal Positive scores over time (F(2, 30) = .93, p 
= .41, Mse = 2.25).  There is a main effect for IPSAQ Personal Positive scores over time 
(F(2, 30) = 4.00, p = .03), with no significant difference in scores from admission to six 
months and one year (which are equivalent to each other), however scores at 12 months 
are significantly less than at admission (LSD minimum mean difference = 1.0).  This 
result indicates at one year individuals are less likely to attribute positive events to 
themselves than at admission.  However, this pattern is descriptive for neither group and 
is therefore misleading as a general description.  A main effect for service use is not 
found (F(1, 15) = .51, p = .49).   
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Figure 3.16 Time Main Effect for Service Usage Groups on IPSAQ Personal Positive Scale Scores Across 
Treatment 
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There is not an interaction between assessment time and service use as they relate 
to IPSAQ Situational Positive (F(2, 30) = 2.18, p = .13, Mse = 5.05).  There is no main 
effect for IPSAQ Situational Positive scores over time (F(2, 30) = 2.32, p = .12) or for 
service use (F(1, 15) = 4.02, p = .06).  However, planned comparisons found contrary to 
hypothesis IPSAQ Situational Positive scores are higher for individuals without service 
usage in adolescence  after one year of treatment (M = 5.07) than for individuals without 
service usage in adolescence (M=3.55), t (23) = 1.68, p = .05.  Results of repeated 
measure ANOVAs and means and standard deviations can be found in Tables 62, and 70 
- 72. 
There is an interaction between assessment time and service use as they relate to 
IPSAQ Internal Negative scores (F(2, 30) = 3.41, p = .05, Mse = 5.97).  As hypothesized, 
the pattern of this interaction is that IPSAQ Internal Negative scores are highest at 
admission and six months (which are equivalent to each another (LSD minimum mean 
difference = 2.42) and decreases at twelve months for those without mental health service 
usage in adolescence This result indicates that individuals are more likely to attribute 
negative events to people or themselves after one year of treatment than at admission or 
six months. However, contrary to hypotheses, for those with mental health service usage 
in adolescence scores remain the same across treatment.  While IPSAQ Internal Negative 
scores are equivalent to each other for those with and without mental health service usage 
in adolescence at admission and six months, contrary to hypotheses at twelve months 
those with mental health service usage in adolescence have higher IPSAQ Internal 
Negative scores than those individuals who did not use services in adolescence, t (23) = -
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2.18, p = .02.. There is no overall main effect for IPSAQ Internal Negative scores over 
time (F(2, 30) = .39, p = .68) or for service use (F(1, 15) = 1.41, p = .25).  
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Figure 3.17 Interaction Between Service Usage Groups on IPSAQ Internal Negative Scale Scores Across 
Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to IPSAQ Personal Negative scores (F(2, 30) = .47, p = .63, Mse = 5.01).  There is no 
main effect for IPSAQ Personal Negative scores over time (F(2, 30) = .33, p = .72) or for 
service use (F(1, 15) = .63, p = .44).  There is not an interaction between assessment time 
and service use as they relate to IPSAQ Situational Negative scores (F(2, 30) = 2.14, p = 
.14, Mse = 5.18).  There is no main effect for IPSAQ Situational Negative scores over 
time (F(2, 30) = .45, p = .64) or for service use (F(1, 15) = .69, p = .42).  When planned 
comparisons were completed, contrary to hypothesis IPSAQ Situational Negative scores 
were lower for individuals with service usage in adolescence (M = 3.27) than for 
individuals who did not use services in adolescence (M=6.21), t (23) = 3.16, p < .01.  
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Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 62, and 73 - 75. 
There is not an interaction of assessment time and service use as they relate to 
CST Social Support scores (F(2, 40) = .74, p = .48, Mse = 44.41).  There is a main effect 
for overall CST Social Support scores over time (F(2, 40) = 4.83, p = .01).  As 
hypothesized CST Social Support scores are higher after one year of treatment than at 
admission or six months (which are equivalent to each other) (LSD minimum mean 
difference = 4.06). However, this pattern is only descriptive for individuals who used 
services in adolescence and is misleading. There is no main effect for service use (F(1, 
20) = .21, p = .65).   
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Figure 3.18 Time Main Effect for Service Usage Groups on CST Social Support Scores Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to CST Self-Controlling scores (F(2, 40) = .24, p = .79, Mse = 31.86).  There is no main 
effect for CST Self-Controlling scores over time (F(2, 40) = .14, p = .87).  There is a 
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main effect for service use (F(1, 20) = 7.05, p = .02). Contrary to hypotheses, those 
individuals without mental health service usage in adolescence have overall higher CST 
Self-Controlling scores than individuals with mental health service usage in adolescence 
and this pattern is consistent across assessment times.  However, when planned 
comparisons were completed individuals without mental health service usage in 
adolescence only demonstrate higher CST Self-Controlling scores after one year of 
treatment, t (35) = 1.77, p = .04.   
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Figure 3.19 Service Usage Group Main Effect for Service Usage Groups on CST Self-Controlling Scores 
Across Treatment 
 
There is not an interaction of assessment time and service use as they relate to 
CST Escape Avoidance scores (F(2, 40) = 1.92, p = .16, Mse = 35.23).  There is no main 
effect for CST Escape Avoidance scores over time (F(2, 40) = 1.74, p = .19) or for 
service use (F(1, 20) = .13, p = .72).  Also, there is not an interaction between assessment 
time and service use as they relate to CST Planful Problem Solving scores (F(2, 40) = 
.57, p = .57, Mse = 40.89).  There is no main effect for CST Planful Problem Solving 
 
87 
scores over time (F(2, 40) = .47, p = .63) or for service use (F(1, 20) = 1.16, p = .29).  
Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 61, 76 - 79. 
When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs 
are conducted no interactions, assessment time main effects, or APP severity level main 
effects are found for the following social cognition measures: FKK Internal Locus of 
Control, FKK Self Concept, FKK Self Efficacy, FKK Powerful Others, IPSAQ Internal 
Positive, IPSAQ Personal Positive, IPSAQ Personal Negative, IPSAQ Situational 
Negative, CST Social Support, CST Escape Avoidance, and CST Planful Problem 
Solving  (all Fs < 2.71, all ps > .06) (Tables 80 – 99). 
There is no interaction between assessment time and APP severity level as they 
relate to Hinting Task scores (F(6, 98) = .90, p = .50, Mse = 6.26) (Table 81, 83).  There 
is a main effect for Hinting scores over time as hypothesized (F(2, 98) = 5.87, p < .01), 
with improvement on scores from admission to six months and one year (which are 
equivalent to each other) (LSD minimum mean difference = .97).  This pattern is 
descriptive for those with no APP.  A main effect for APP severity level is not found 
(F(3, 49) = .80, p = .50).  
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Figure 3.20 Time Main Effect for APP Severity Levels on Hinting Task Scores Across Treatment 
 
There is an interaction between assessment time and APP severity level as they 
relate to FKK Chance score (F(6, 46) = 2.88, p = .02, Mse = 19.09).  Although contrary 
to hypotheses FKK Chance scores remain the same across treatment for those without 
APP, as hypothesized FKK Chance scores are highest (more external locus of control) at 
admission than at 6 months to one year (which are equivalent to each other) for those 
with low and medium APP (LSD minimum mean difference = 3.47).  For individuals in 
the high APP group, FKK Chance scores remain the same from admission to six months 
and from six months to one year, but scores at one year are lower than at admission as 
hypothesized.  While FKK Chance scores are equivalent to one another at admission 
amongst the groups, those without APP have higher FKK Chance scores at six months 
than those in the low and medium APP groups.  Individuals in the high APP group have 
higher FKK Chance scores at six months than those in the low and medium APP groups. 
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However, there is partial support for hypotheses as those individuals with more severe 
symptomatology have higher FKK Chance scores (more external locus of control) at six 
months than those with medium APP.  At one year, FKK Chance scores for those in the 
low, medium, and high APP severity groups are equivalent while those in the no APP 
group have higher FKK Chance scores than those in the low and high APP groups.  There 
is a main effect for overall FKK Chance score over time (F(2, 46) = 7.81, p = .001).  As 
hypothesized FKK Chance scores are higher at admission than at six to twelve months of 
rehabilitation (which are equivalent to each other) (LSD minimum mean difference = 
2.40).  This pattern is only descriptive for those with low APP.  There is no overall main 
effect for APP severity level (F(3, 23) = .35, p = .79). Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 80, 84 - 89. 
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Figure 3.21 Time Main Effect and Interaction between APP Severity Levels on FKK Chance Scores Across 
Treatment 
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There is an interaction between assessment time and APP severity level as they 
relate to FKK External Locus of Control score (F(6, 46) = 2.30, p = .05, Mse = 50.17).  
Although, the pattern of this interaction is that FKK External Locus of Control scores 
remain the same across treatment for those without APP, partial support for hypotheses is 
demonstrated as FKK Chance scores are highest at admission than at 6 months to one 
year (which are equivalent to each other) for those with low or medium APP (LSD 
minimum mean difference = 7.79).  For individuals with high APP, FKK External Locus 
of Control scores at one year are lower than at admission or six months (which are 
equivalent to each other). This result still supports hypothesizes that those in the high 
APP group demonstrate a decrease in external locus of control after one year of 
treatment. While FKK External Locus of Control scores are equivalent to one another at 
admission and one year for those with and without APP, contrary to the hypothesis those 
without APP have higher FKK External Locus of Control scores at six months than those 
with low or medium APP.  However, partial support for hypotheses is found as 
individuals in the high APP group have higher FKK External Locus of Control scores at 
six months than individuals with low or medium APP.  There is a main effect for overall 
FKK External Locus of Control score over time (F(2, 46) = 5.47, p = .01).  As 
hypothesized FKK External Locus of Control scores are higher at admission than at six to 
twelve months of rehabilitation (which are equivalent to each other) (LSD minimum 
mean difference = 3.90).  This pattern is only descriptive for those with low or medium 
APP.  There is no overall main effect for APP severity level (F(3, 23) = .29, p = .83).  
Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 80 and 89. 
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FKK Externality Scores Across Treatment
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Figure 3.22 Time Main Effect and Interaction between APP Severity Levels on FKK Externality Scores 
Across Treatment 
There is not an interaction between assessment time and APP severity level as 
they relate to IPSAQ Situational Positive scores (F(6, 26) = 1.77, p = .15, Mse = 4.74).  
There is no main effect for IPSAQ Situational Positive scores over time (F(2, 26) = 1.05, 
p = .37).  There is a main effect for APP severity level (F(1, 13) = 4.23, p = .03). Overall 
IPSAQ Situational Positive scores, attributing positive events to situational factors, are 
highest for those without APP and with high APP (which are equivalent to each other) 
than for individuals in medium APP groups.  Individuals in the low APP groups have the 
lowest overall IPSAQ Situational Positive scores (LSD minimum mean difference = 
1.40).  Results of repeated measure ANOVAs and means and standard deviations can be 
found in Tables 82 and 92. 
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IPSAQ Situational Positive Subscale Scores Across Treatment
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Figure 3.23 APP Severity Levels Main Effect on IPSAQ Situational Positive Subscale Scores Across 
Treatment 
 
There is an interaction between assessment time and APP severity level as they 
relate to IPSAQ Internal Negative scores (F(6, 26) = 3.21, p = .02, Mse = 4.85).  The 
pattern of this interaction is that IPSAQ Internal Negative scores remain the same across 
treatment for those with no APP and medium APP (LSD minimum mean difference = 
3.15).  IPSAQ Internal Negative scores for those in the low APP group remain the same 
from admission and six months but increase by one year.  For individuals with high APP, 
scores increase from admission to six and twelve months (which are equivalent to each 
other), indicating as treatment progresses those in the high APP severity group are more 
likely to attribute negative events to themselves or others than at admission.  While 
IPSAQ Internal Negative scores are equivalent to each other for those with and without 
APP at admission, at six months those with no APP have higher scores than those in the 
low APP group.  Those in the medium and high APP groups have higher scores at sixth 
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months than those in the low APP group.  Contrary to hypotheses, by one year of 
treatment, those in the low, medium, and high APP groups have higher scores than those 
in the no APP group. There is no overall main effect for IPSAQ Internal Negative scores 
over time (F(2, 26) = 1.20, p = .32) or for APP severity level (F(3, 13) = .66, p = .59).  
Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 82 and 93. 
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Figure 3.24 Interaction between APP Severity Levels on IPSAQ Internal Negative Subscale Scores Across 
Treatment 
 
There is not an interaction between assessment time and APP severity as they 
relate to CST Self-Controlling scores (F(6, 36) = 1.81, p = .13, Mse = 27.52).  There is no 
main effect for CST Self-Controlling scores over time (F(2, 36) = .48, p = .62).  There is 
a main effect for APP severity level (F(3, 18) = 3.39, p = .04). Those individuals without 
APP have overall higher CST Self-Controlling scores than individuals with low, medium, 
and high APP.  Contrary to hypotheses, those with high APP have lower overall CST 
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Self-Controlling scores, indicating these individuals may utilize other coping strategies.  
However, this pattern is not consistent across treatment times except for after one year of 
treatment (Tables 81 and 97). 
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Figure 3.25 APP Severity Levels Main Effect on CST Self-Controlling Subscale Scores Across Treatment 
 
In summary, results of analyses between those who used mental health services 
prior to age 18 and those who did not use services and socialcognitive functioning over 
the course of treatment suggest that improvements in sociocognitive functioning are 
evident for both groups over the course of treatment on the Hinting Task and for those 
with mental health service usage on CST Social Support.  Contrary to hypotheses, there is 
not a decrease in FKK Powerful Others (a subscale of FKK External Locus of Control) 
over treatment.  Furthermore, contrary to hypotheses there is not an increase in FKK 
Internal Locus of Control or FKK Self Concept or FKK Self Efficacy (both subscales of 
FKK Internal Locus of Control) over the course of treatment.  As hypothesized, FKK 
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External Locus of Control and FKK Chance, a subscale of FKK External Locus of 
Control, do decrease over treatment; however, this only occurred for those who used 
mental health services in adolescence.   Additionally, IPSAQ Internal Negative scores, 
part of a personalizing bias, decrease across treatment for those without mental health 
service usage in adolescence; however, this remains constant across treatment for those 
who used mental health services in adolescence. 
Results of analyses between assessment time and APP severity level indicate 
improvements in sociocognitive functioning are over the course of treatment on the 
Hinting Task. Contrary to hypotheses, there is not a decrease in FKK Powerful Others (a 
subscale of FKK External Locus of Control) over treatment.  Furthermore, contrary to 
hypotheses there is not an increase in FKK Internal Locus of Control or FKK Self 
Concept or FKK Self Efficacy (both subscales of FKK Internal Locus of Control) over 
the course of treatment.  As hypothesized, FKK External Locus of Control decrease over 
treatment, however this only occurs for those in the low, medium, and high groups.  For 
FKK Chance, a subscale of FKK External Locus of Control, decreases over treatment 
only occur for those with low or medium APP.   Additionally, IPSAQ Internal Negative 
scores, part of a personalizing bias, increase across treatment for those with low or high 
APP and remain constant across treatment for those with medium or no APP. 
As hypothesized, when analyses are conducted between those without and 
without mental health service usage in adolescence, no differences exist between groups 
after one year of psychiatric rehabilitation on the following measures: Hinting Task, FKK 
Internal Locus of Control, FKK Self Concept, FKK Self Efficacy, FKK Powerful Others, 
IPSAQ Internal Positive, IPSAQ Situational Positive, IPSAQ Personal Negative, IPSAQ 
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Situational Negative, CST Social Support, CST Escape Avoidance, and CST Planful 
Problem Solving.  Contrary to hypotheses, individuals without mental health service 
usage prior to age 18 demonstrate higher scores on the FKK Chance scale and FKK 
External Locus of Control measures after one year of treatment than those without mental 
health service usage in adolescence.  Also, contrary to hypotheses those without mental 
health service usage demonstrate lower scores after one year of treatment on the IPSAQ 
Internal Negative and higher scores on the CST Social Support scale than those with 
APP. 
Finally, as hypothesized, when analyses are conducted utilizing APP severity 
level, as hypothesized no differences exist between groups after one year of psychiatric 
rehabilitation on the following measures: Hinting Task, FKK Internal Locus of Control, 
FKK Self Concept, FKK Self Efficacy, FKK Powerful Others, FKK External Locus of 
Control, IPSAQ Internal Positive, IPSAQ Personal Positive, IPSAQ Personal Negative, 
IPSAQ Situational Negative, CST Social Support, CST Escape Avoidance, CST Self 
Controlling, and CST Planful Problem Solving.  Contrary to hypotheses, individuals 
without APP demonstrate higher scores on the FKK Chance scale after one year of 
treatment than those with low or high APP.  Also, contrary to hypotheses those without 
APP demonstrate lower IPSAQ Internal Negative scores after twelve months than 
individuals with low, medium, or high APP (which are all equivalent). 
 
Insight Over the Course of Treatment 
 It is anticipated that adults with SMI who had mental health services before the 
age of 18 have more insight into their mental illness over the course of treatment than 
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those that did not have mental health services prior to the age of 18. Furthermore, it is 
predicted that difference in insight across treatment will not remain after one year of 
treatment. A 2 (service use) x 3 (time) repeated measure ANOVA with follow-up 
analyses using the LSD procedure (p = .05) was completed for each measure.  Analyses 
utilizing 2 (service use) x 3 (assessment time) repeated measure ANOVAs and 4 (APP 
Severity Level) x 3 (assessment time) repeated measure ANOVAs were attempted for 
each SAIQ subscale.  However, based on when this assessment was administered at CTP, 
no group based on these distinctions had more than 10 people and one group had as few 
as zero.  Therefore, no repeated measures analyses were undertaken based on SAIQ 
subscales and only analyses of the Insight Scale and its subscales will be discussed 
below.  
There is an interaction between assessment time and service use on Insight Scale 
total score (F(2, 114) = 3.26, p = .04, Mse = 6.82). Insight total score remain the same 
over treatment for those individuals who used mental health services in adolescence, 
whereas for those individuals who did not use services prior to age 18 Insight Total 
scores are highest at admission and six months (which are equivalent to each other) and 
decrease after one year of treatment (LSD minimum mean difference = 1.36). Partial 
support for hypotheses is found, as those who did not use mental health services prior to 
age 18 have higher Insight Total scores at admission and six months and scores become 
equivalent for both groups after one year of treatment.  However, contrary to hypotheses, 
those that had contact with mental health services before age 18 do not receive higher 
Insight Total scores at admission than those who did not use services prior to age 18.  
There is no main effect for Insight Total scores over time (F(2, 114) = 2.37, p = .10).   
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There is a significant main effect for service use (F(1, 57) = 5.47, p = .02). Individuals 
who did not use mental health services in adolescence have higher overall Insight Total 
scores across treatment than individuals who did use mental health services in 
adolescence; however, this pattern is only descriptive for both groups at admission and 
six months (LSD minimum mean difference = .96).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 100 and 104. 
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Figure 3.26 Service Main Effect and Interaction between Service Usage Groups on Birchwood Insight 
Total Scores Across Treatment 
 
There is an interaction between assessment time and service use on Insight 
Relabel scale score (F(2, 114) = 3.98, p = .02, Mse = .97).  Insight Relabel scale scores 
are highest at admission and six months (which are equivalent to each other) and decrease 
at one year for individuals without mental health service usage in adolescence, whereas 
for those individuals with mental health service usage in adolescence Insight Relabel 
scale scores remain the same over treatment (LSD minimum mean difference = .51).  
Contrary to hypotheses, no differences are found between individuals with and without 
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mental health service usage in adolescence on Insight Relabel scale scores at admission, 
and six months. As hypothesized, no differences are found between groups after twelve 
months. There is no main effect for Insight Relabel scale scores over time (F(2, 114) = 
2.40, p = .10) or for service use (F(1, 57) = .52, p = .48).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 100 and 101. 
Birchwood Relabel Symptoms Scale Scores Across Treatment
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Figure 3.27 Interaction between Service Usage Groups on Birchwood Relabel Symptoms Scores Across 
Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to Insight Awareness scale scores (F(2, 114) = 2.52, p = .09, Mse = 1.25).  There is no 
main effect for Insight Awareness scale scores over time (F(2, 114) = 1.37, p = .26).  
Contrary to hypotheses, individuals with mental health service usage in adolescence do 
not have higher IS Awareness scores at admission than those without mental health 
service usage in adolescence.  There is a main effect for service use (F(1, 57) = 8.42, p = 
.01).  Individuals without mental health service usage in adolescence have higher overall 
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Insight Awareness scale scores across treatment than individuals with mental health 
service usage in adolescence, however this pattern is only descriptive for both groups at 
admission and six months (LSD minimum mean difference = .42).   When planned 
comparisons were completed, Insight Awareness scores were lower for individuals with 
service usage in adolescence (M = 1.93) than for individuals who did not use services in 
adolescence (M = 2.41), t (125) = 2.16, p = .02.  Results of repeated measure ANOVAs 
and means and standard deviations can be found in Tables 100 and 102. 
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Figure 3.28 Service Usage Group Main Effect on Birchwood Relabel Symptoms Scores Across Treatment 
 
There is not an interaction of assessment time and service use as they relate to 
Insight Need for Treatment scale scores (F(2, 114) = 1.96, p = .15, Mse = 1.12).  There is 
a main effect for overall Insight Need for Treatment scale scores over time (F(2, 114) = 
3.22, p = .04).  Overall Insight Need for Treatment scale scores remain the same from 
admission to six months and from six months to one year of treatment, however overall 
scores after one year of treatment are lower than at admission (LSD minimum mean 
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difference = .39). However, this pattern is descriptive for neither group and is therefore 
misleading. There is no main effect for service use (F(1, 57) = 2.77, p = .10).  Results of 
repeated measure ANOVAs and means and standard deviations can be found in Tables 
100 and 103. 
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Figure 3.29 Time Main Effect for Service Usage Groups on Birchwood Need For Treatment Scores Across 
Treatment 
 
In addition, 4 (APP Severity Level) x 3 (assessment time) repeated measure 
ANOVAs were conducted for each insight measure.  There is an interaction between 
assessment time and APP severity level on Insight Scale total score (F(6, 110) = 3.38, p = 
.004, Mse = 6.31). Insight total score remain the same over treatment for those 
individuals with high APP, whereas for those individuals without APP Insight Total 
scores remain the same from admission to six months and decrease after one year of 
treatment to scores consistent with those at admission (LSD minimum mean difference = 
1.85). Insight total scores for individuals with low APP decrease from admission to six 
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and twelve months (LSD minimum mean difference = 1.85).  Insight scores for 
individuals with medium APP increase from admission to six and twelve months (which 
are equivalent to each other).  At admission, those with medium APP have lower Insight 
total scores than those without APP or low APP.  After six months, individuals without 
APP have the highest Insight totals (all other groups have scores equivalent to each 
other).  As hypothesized, after one year of psychiatric rehabilitation all groups have 
equivalent Insight total scores.  There is no main effect for Insight Total scores over time 
(F(2, 110) = 1.98, p = .14).   There is not a significant main effect for APP severity level 
(F(3, 55) = .43, p = .73).  Results of repeated measure ANOVAs and means and standard 
deviations can be found in Tables 105 and 109. 
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Figure 3.30 Interaction between APP Severity Levels on Birchwood Insight Total Scores Across Treatment 
 
There is an interaction between assessment time and APP severity level on Insight 
Relabel scale score (F(6, 110) = 2.90, p = .01, Mse = .93). Insight Relabel scale scores 
 
103 
are highest at admission and six months (which are equivalent to each other) and decrease 
at one year for individuals without APP, whereas for those individuals with high APP 
Insight Relabel scale scores remain the same over treatment (LSD minimum mean 
difference = .71). Insight Relabel scale scores for individuals with low APP are highest at 
admission, contrary to hypotheses, and decrease from six to twelve months (which are 
equivalent to each other). At admission, individuals in the low APP group have higher 
scores than those in the medium APP group.  As hypothesized, no differences are found 
between individuals without APP and various severities of APP on Insight Relabel scale 
scores at six and twelve months. There is no main effect for Insight Relabel scale scores 
over time (F(2, 110) = .91, p = .41) or for APP severity level (F(3, 55) = .43, p = .73).   
Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 105 and 106. 
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Figure 3.31 Interaction between APP Severity Levels on Birchwood Relabel Symptoms Scale Scores 
Across Treatment 
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There is an interaction between assessment time and APP severity level as they 
relate to Insight Awareness scale scores (F(6, 110) = 2.48, p = .03, Mse = 1.20).  Insight 
Awareness scores remain the same across treatment for those without APP and 
individuals in the medium and high APP group.  Insight Awareness scores for individuals 
with low APP are higher at admission than at six to twelve months (which are equivalent 
to each other) (LSD minimum mean difference = .81).  At admission, contrary to 
hypotheses, those with low APP have higher Insight Awareness scores than those with 
medium or high APP.  At six months, those without APP have higher Insight Awareness 
scores than individuals with low or high APP.  As hypothesized, by one year of treatment 
all groups have equivalent Insight Awareness scores.  There is no main effect for Insight 
Awareness scale scores over time (F(2, 110) = 2.16, p = .12).  There is a main effect for 
APP severity level (F(3, 55) = 2.89, p = .04).  Individuals without APP have higher 
overall Insight Awareness scale scores across treatment than individuals with each 
severity of APP, whereas individuals with low or high APP (which are equivalent to each 
other) have higher overall Insight Awareness scores than individuals with medium APP.  
However this pattern is not descriptive for any assessment time and is therefore 
misleading (LSD minimum mean difference = .61).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 105 and 107. 
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Birchwood Awareness Scale Scores Across Treatment
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Figure 3.32 APP Severity Level Main Effect and Interaction between APP Severity Levels on Birchwood 
Awareness Scale Scores Across Treatment 
 
There is not an interaction of assessment time and APP severity level as they 
relate to Insight Need for Treatment scale scores (F(6, 110) = 1.79, p = .11, Mse = 1.10).  
There is a main effect for overall Insight Need for Treatment scale scores over time (F(2, 
110) = 3.14, p = .04).  Overall Insight Need for Treatment scale scores are highest at 
admission and decrease at six months and from six months to one year of treatment (LSD 
minimum mean difference = .39). However, this pattern is not completely descriptive for 
any group APP at all assessment times and is therefore misleading. There is no main 
effect for APP severity level (F(3, 55) = .91, p = .44).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 105 and 109. 
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Figure 3.33 Time Main Effect for APP Severity Levels on Birchwood Need For Treatment Scale Scores 
Across Treatment 
 
In summary, results of analyses on insight measures at admission and over the 
course of treatment suggest that hypothesized improvements in insight did not occur over 
the course of treatment for the all of the CTP population.  Contrary to the hypothesis 
those adults who used mental health services in adolescence do not endorse differing 
Insight Totals or ability to relabel symptoms scores over the course of treatment.  
Furthermore, individuals without mental health service usage in adolescence endorse 
lower Insight Total scores and their ability to relabel symptoms as part of their illness 
decreases over the course of treatment.  Furthermore, in general the CTP participants 
endorse lower Insight Need For Treatment scores across treatment.  While differences do 
not exist after one year of treatment between those with and without service usage in 
adolescence on insight measures, this suggests neither groups’ insight changed more than 
the others after participating in psychiatric rehabilitation.  
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When results of analyses on insight measures at admission and over the course of 
treatment utilize APP severity levels, results suggest that contrary to the hypothesis only 
individuals with low APP endorse increases in Insight Totals over the course of 
treatment.  Insight Totals for individuals with no or low APP decrease over treatment 
while Insight Total scores remain the same across treatment for those with high APP.  As 
hypothesized, ability to relabel symptoms increases over treatment for those with medium 
APP but remains the same for those with high APP.  In contrast, individuals with no or 
low APP experience decreases in Insight Relabel scores across treatment.  Insight 
Awareness scores remain the same across treatment for those with no, medium, or high 
APP while it decreases for those with low APP.  Furthermore, insight into need for 
treatment decreases across treatment for individuals with no, low, or high APP but 
remains stable across treatment for those with medium APP.  However, as hypothesized, 
there are no differences between those with no, low, medium, and high APP on Insight 
measures after one year of psychiatric rehabilitation. 
 
 Behavioral Functioning Across Treatment  
 It is hypothesized that as a result of psychiatric rehabilitation, there will be an 
increase in behavioral functioning for all CTP participants over the course of psychiatric 
rehabilitation.  Although differences across treatment are hypothesized, it is predicted 
that differences will not remain after one year.  A 2 (service use) x 3 (assessment time) 
repeated measure ANOVA was completed for each measure.  There is not an interaction 
between assessment time and service use as they relate to NOSIE Daily Schedule 
Competence scores, F(2, 188) = .57, p = .57, Mse = 14.53.  As hypothesized, the 2 
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(service) x 3 (time) repeated measures ANOVA reveals a significant main effect for time 
on the NOSIE Daily Schedule Competence scale scores, F (2, 188) = 26.86, p < .001 
indicating that, overall, improvements in NOSIE Daily Schedule Competence occur with 
treatment for both individuals with and without mental health service usage in 
adolescence (LSD minimum mean difference = 1.10).  There is no main effect for service 
use, F(1, 94) = 2.54, p = .11 (Tables 110 and 111). Planned comparisons indicate after six 
months of treatment NOSIE Daily Schedule Competence scores were lower for 
individuals with service usage in adolescence (M = 32.65) than for individuals who did 
not use services in adolescence (M=34.83), t (115) = 1.84, p = .03. 
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Figure 3.34 Time Main Effect for Service Usage Groups on NOSIE Daily Schedule Competence Scores 
Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Social Interest scores, F(2, 188) = 1.30, p = .28, Mse = 14.73.  As 
hypothesized, repeated measures ANOVA reveal a significant main effect for time on the 
NOSIE Social Interest scale scores, F (2, 188) = 39.51, p < .001 indicating that, overall, 
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improvements in NOSIE Social Interest scores occur with treatment for both individuals 
with and without mental health service usage in adolescence (LSD minimum mean 
difference = 1.10).  There is no main effect for service use, F(1, 94) = .06, p = .80 (Tables 
110 and 111). 
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Figure 3.35 Time Main Effect for Service Usage Groups on NOSIE Social Interest Scores Across 
Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Neatness scores, F(2, 188) = .33, p = .72, Mse = 8.19.  As hypothesized, 
analyses reveal a significant main effect for time on the NOSIE Neatness scale scores, F 
(2, 188) = 20.89, p < .001 indicating that, overall, improvements in NOSIE Neatness 
scores occur with treatment for both individuals with and without mental health service 
usage in adolescence (LSD minimum mean difference = .82).  There is no main effect for 
service use, F(1, 94) = 1.20, p = .28.  Results of repeated measure ANOVAs and means 
and standard deviations can be found in Tables 110 and 111. 
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Figure 3.36 Time Main Effect for Service Usage Groups on NOSIE Neatness Scores Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Irritability scores, F(2, 188) = .15, p = .86, Mse = 16.27.  Analyses reveal a 
significant main effect for time on the NOSIE Irritability scale scores, F (2, 188) = 3.78, 
p = .03 indicating partial support for hypotheses.  NOSIE Irritability scores increase from 
admission to six months and, as hypothesized, scores decrease from six months to one 
year of treatment for individuals with and without mental health service usage during 
adolescence (LSD minimum mean difference = 1.15).  There is no main effect for service 
use, F(1, 94) = 1.38, p = .24.  Results of repeated measure ANOVAs and means and 
standard deviations can be found in Tables 110 and 111. 
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Figure 3.37 Time Main Effect for Service Usage Groups on NOSIE Irritability Scores Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Psychoticism scores, F(2, 188) = .96, p = .38, Mse = 3.56.  Contrary to 
hypotheses, results reveal a significant main effect for time on the NOSIE Psychoticism 
scale scores, F (2, 188) = 7.47, p = .001 indicating that, overall, NOSIE Psychoticism 
scores increase from admission to six months and one year of treatment (LSD minimum 
mean difference = .54).  There is no main effect for service use, F(1, 94) = .87, p = .35 
(Tables 110, 111). 
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Figure 3.38 Time Main Effect for Service Usage Groups on NOSIE Psychoticism Scores Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Motor Retardation scores, F(2, 188) = .34, p = .72, Mse = 7.03.  As 
hypothesized, results reveal a significant main effect for time on the NOSIE Motor 
Retardation scale scores, F (2, 188) = 15.93, p < .001 indicating that, overall, NOSIE 
Motor Retardation scores are not significantly different from admission to six months, 
however scores decrease by one year of treatment (LSD minimum mean difference = 
.76).  There is no main effect for service use, F(1, 94) = 1.50, p = .22.  Results of 
repeated measure ANOVAs and means and standard deviations can be found in Tables 
110 and 111. 
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Figure 3.39 Time Main Effect for Service Usage Groups on NOSIE Motor Retardation Scores Across 
Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Total Assets scores, F(2, 188) = .21, p = .81, Mse = 206.89.  As hypothesized, 
results reveal a significant main effect for time on the NOSIE Total Assets scores, F (2, 
188) = 21.68, p < .001 indicating that, overall, improvements in NOSIE Total Assets 
scores occur with treatment for both individuals with and without mental health service 
usage in adolescence (LSD minimum mean difference = 4.11).  There is no main effect 
for service use, F(1, 94) = 1.97, p = .16 (Tables 110 and 111). 
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Figure 3.40 Time Main Effect for Service Usage Groups on NOSIE Total Scores Across Treatment 
 
Results were also analyzed using a 4 (APP Severity Level) x 3 (assessment time) 
repeated measure ANOVA for each NOSIE measure.  Results indicate there is not an 
interaction between assessment time and APP severity level as they relate to NOSIE 
Daily Schedule Competence scores, F(6, 184) = .85, p = .54, Mse = 14.54.  As 
hypothesized, the 4 (APP severity level) x 3 (time) repeated measures ANOVA reveals a 
significant main effect for time on the NOSIE Daily Schedule Competence scale scores, 
F (2, 184) = 23.33, p < .001 indicating that, overall, improvements in NOSIE Daily 
Schedule Competence occur with treatment (LSD minimum mean difference = 1.09) 
(Tables 112, 113).  This pattern is descriptive for all groups except individuals with high 
APP, for which scores decrease from admission to six months but are highest at one year.  
There is no main effect for APP severity level, F(3, 92) = 1.10, p = .35. 
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Figure 3.41 Time Main Effect for APP Severity Levels on NOSIE Daily Schedule Competence Scores 
Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to NOSIE Social Interest scores, F(6, 184) = 1.83, p = .10, Mse = 14.40.  As 
hypothesized, results reveal a significant main effect for time on the NOSIE Social 
Interest scale scores, F (2, 184) = 36.58, p < .001 indicating that, overall, improvements 
in NOSIE Social Interest scores occur with treatment (LSD minimum mean difference = 
1.08).  There is no main effect for APP severity level, F(3, 92) = .73, p = .54. Results of 
repeated measure ANOVAs and means and standard deviations can be found in Tables 
112 and 113. 
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Figure 3.42 Time Main Effect for APP Severity Levels on NOSIE Social Interest Scores Across Treatment 
 
There is an interaction between assessment time and APP severity level as they 
relate to NOSIE Neatness scores, F(6, 184) = 3.14, p = .01, Mse = 7.62. For individuals 
without APP, NOSIE neatness scores remain the same from admission to six months but 
improve from six months to one year, whereas for individuals with low or medium APP 
scores continue to improve throughout treatment (LSD minimum mean difference = 
1.58).  For individuals with high APP, scores decrease from admission to six months but 
improve from six months to one year of treatment.  At admission, individuals with high 
APP have the highest NOSIE neatness scores followed by those without APP.  At six 
months, individuals without APP have higher scores than those with low or high APP.  
As hypothesized, after one year of treatment all groups have equivalent NOSIE neatness 
scores. As hypothesized, results reveal a significant main effect for time on the NOSIE 
Neatness scale scores, F (2, 184) = 19.85, p < .001 indicating that, overall, scores remain 
the same from admission to six months but improvements in NOSIE Neatness scores 
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occur from six months to one year (LSD minimum mean difference = .79).  However, 
this pattern is only descriptive for those without APP and is therefore misleading. There 
is no main effect for APP severity level, F(3, 92) = .73, p = .54.  Results of repeated 
measure ANOVAs and means and standard deviations can be found in Tables 112 and 
113. 
NOSIE Neatness Scores Across Treatment
0
5
10
15
20
25
30
Time 1 Time 2 Time 3
Assessment Time
NO
SIE
 N
ea
tne
ss
 Sc
or
e No APP
Low APP
Med APP
High APP
 
Figure 3.43 Time Main Effect and Interaction between APP Severity Levels on NOSIE Neatness Scores 
Across Treatment 
 
There is not an interaction between assessment time and APP severity level as 
they relate to NOSIE Irritability scores, F(6, 184) = .40, p = .88, Mse = 16.44.  As 
hypothesized, results reveal a significant main effect for time on the NOSIE Irritability 
scale scores, F (2, 184) = 3.40, p = .04 indicating that, overall, NOSIE Irritability scores 
increase from admission to six months and decrease from six months to one year of 
treatment (LSD minimum mean difference = 1.16) (Tables 112, 113).  This pattern is 
descriptive for all groups except the high APP group, for which NOSIE Irritability scores 
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remain the same across treatment. There is no main effect for APP severity level, F(3, 92) 
= 1.30, p = .28. 
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Figure 3.44 Time Main Effect for APP Severity Levels on NOSIE Irritability Scores Across Treatment 
 
 There is not an interaction between assessment time and APP severity level as 
they relate to NOSIE Psychoticism scores, F(6, 184) = 1.58, p = .16, Mse = 3.49.  
Analyses reveal a significant main effect for time on the NOSIE Psychoticism scale 
scores, F (2, 184) = 8.07, p < .001 indicating that, overall, NOSIE Psychoticism scores 
increase from admission to six months and one year of treatment (which are equivalent to 
each other) (LSD minimum mean difference = .53).  However, this pattern is only 
descriptive for those with low APP (Tables 112, 113). There is no main effect for APP 
severity level, F(3, 92) = .36, p = .78. 
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Figure 3.45 Time Main Effect for APP Severity Levels on NOSIE Psychoticism Scores Across Treatment 
 
There is not an interaction between assessment time and APP severity level as 
they relate to NOSIE Motor Retardation scores, F(6, 184) = 2.03, p = .06, Mse = 6.76.  
Results reveal a significant main effect for time on the NOSIE Motor Retardation scale 
scores, F (2, 184) = 13.55, p < .001 indicating that, overall, NOSIE Motor Retardation 
scores are not significantly different from admission to six months, however as 
hypothesized scores decrease across treatment (LSD minimum mean difference = .74).  
However, this pattern is only descriptive for individuals with high APP and is misleading. 
There is no main effect for APP severity level, F(3, 92) = 1.63, p = .19.  Results of 
repeated measure ANOVAs and means and standard deviations can be found in Tables 
112 and 113. One tailed planned comparisons indicate contrary to hypotheses NOSIE 
Motor Retardation scores were higher for individuals with service usage in adolescence 
(M = 5.35) than for individuals who did not use services in adolescence (M=4.18), t (94) 
= -1.66, p = .05. 
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Figure 3.46 Time Main Effect for APP Severity Levels on NOSIE Motor Retardation Scores Across 
Treatment 
 
There is an interaction between assessment time and APP severity level as they 
relate to NOSIE Total Assets scores, F(6, 184) = 2.20, p = .05, Mse = 197.68.  NOSIE 
Total Assets scores increase across treatment for individuals with low or medium APP 
(LSD minimum mean difference = 8.04).  For individuals without APP, scores do not 
change from admission to six months and from six months to one year, at which time 
scores are greater than at admission (Table 112, 113).  NOSIE Total Assets score for 
individuals with high APP do not change from admission to six months but increase from 
six months to one year (which is equivalent to scores at admission).  At admission, 
NOSIE Total Assets scores are equivalent for those without APP and those with high 
APP.  However, those without APP or with high APP have higher NOSIE Total Assets 
than individuals with low or medium APP.  At six months, individuals without APP or 
medium APP have higher scores than those with low or high APP.  As hypothesized, 
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after one year of treatment no differences between groups exist on NOSIE Total Assets. 
As hypothesized, the 4 (APP severity level) x 3 (time) repeated measures ANOVA reveal 
a significant main effect for time on the NOSIE Total Assets scores, F (2, 184) = 22.23, p 
< .001 indicating that, overall, improvements in NOSIE Total Assets scores occur with 
treatment (LSD minimum mean difference = 4.02).  There is no main effect for APP 
severity level, F(3, 92) = 1.48, p = .23.  Results of repeated measure ANOVAs and 
means and standard deviations can be found in Tables 112 and 113. 
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Figure 3.47 Time Main Effect for APP Severity Levels on NOSIE Total Scores Across Treatment 
 
Overall, these results suggest that improvements in behavioral functioning do 
occur across treatment on almost all NOSIE subscales and NOSIE Total Assets for those 
with and without mental health service usage.  However, partial support for hypotheses is 
found for NOSIE Irritability and NOSIE Psychoticism.  When service use is utilized in 
analyses, all participants’ NOSIE Irritability scores contrary to hypotheses increase from 
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admission to six months but, as hypothesized, do decrease by 12 months of treatment.  
Furthermore, contrary to hypotheses NOSIE Psychoticism scores for all participants 
continued to increase over the course of treatment.  When results are analyzed with 
regards to APP severity level, the above results are again found.  However, NOSIE Motor 
Retardation scores improve for all APP severity levels.  Finally as predicted, no 
differences exist on NOSIE measures amongst groups after one year of psychiatric 
rehabilitation.  
   
 Symptomatology Across Treatment 
 It is hypothesized that as a result of psychiatric rehabilitation, improvements will 
occur in symptomatology across treatment.  While differences may exist amongst groups 
at admission or six months, it is predicted that individuals who used mental health 
services in adolescence demonstrate higher symptomatology after one year of treatment.  
However, when different levels of APP are used in analyses, it is predicted that as APP 
becomes more severe there will be more severe symptomatology. A 2 (service use) x 3 
(assessment time) repeated measure ANOVA and a 4 (APP Severity Level) x 3 
(assessment time) repeated measure ANOVA was completed for each measure.   
There is not an interaction between assessment time and service use as they relate 
to BPRS Total scores, F(2, 128) = .86, p = .43, Mse = 97.89.  There is no main effect for 
BPRS Total scores over time (F(2, 128) = 1.23, p = .30) or for service use (F(1, 64) = 
.23, p = .64) (Table 114, 116).   
There is an interaction between assessment time and service use on BPRS 
Psychotic Disorganization Factor score, F(2, 128) = 3.17, p = .05, Mse = 3.87. BPRS 
 
123 
Psychotic Disorganization Factor scores remain stable over treatment except for those 
who used mental health services in adolescence whose score at one year of treatment are 
lower than at admission as hypothesized (LSD minimum mean difference = .96). 
Individuals with mental health service usage in adolescence have higher BPRS Psychotic 
Disorganization Factor scores at admission than individuals without mental health service 
usage in adolescence. However, contrary to hypotheses this difference does not persist at 
6 months to one year of treatment. There is no main effect for BPRS Psychotic 
Disorganization Factor scores over time (F(2, 128) = 2.16, p = .32) or for service use 
(F(1, 64) = 1.20, p = .28).  Results of repeated measure ANOVAs and means and 
standard deviations can be found in Tables 114 and 117. 
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Figure 3.48 Interaction Between Service Usage Groups on BPRS Psychotic Disorganization Factor Scores 
Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to BPRS Hallucination/Delusions Factor scores, F(2, 134) = .85, p = .43, Mse = 7.97.  
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There is no main effect for BPRS Hallucinations/Delusions Factor scores over time (F(2, 
134) = .82, p = .44) or for service use (F(1, 67) = .47, p = .50) (Tables 114, 118).  Also, 
there is not an interaction between assessment time and service use as they relate to 
BPRS Paranoia Factor scores, F(2, 134) = .05, p = .95, Mse = 6.88.  There is no main 
effect for BPRS Paranoia Factor scores over time (F(2, 134) = .04, p = .96) or for service 
use (F(1, 67) = 1.75, p = .19) (Tables 114, 119).   
There is not an interaction between assessment time and service use as they relate 
to BPRS Emotional Blunting Factor scores, F(2, 134) = .19, p = .83, Mse = 4.41.  There 
is no main effect for BPRS Emotional Blunting Factor scores over time (F(2, 134) = 
1.03, p = .36) or for service use (F(1, 67) = 1.20, p = .28).  However, planned 
comparisons indicate BPRS Emotional Blunting Factor scores are higher at six months of 
treatment for individuals with service usage in adolescence (M = 6.17) than for 
individuals who did not use services in adolescence (M =5.22), t (119) = -1.85, p = .03. 
In addition, there is not an interaction between assessment time and service use as 
they relate to BPRS Anxiety/Depression Factor scores, F(2, 134) = .27, p = .77, Mse = 
6.82.  There is no main effect for BPRS Anxiety/Depression Factor scores over time 
(F(2, 134) = .50, p = .61) or for service use (F(1, 67) = .64, p = .43).  However, planned 
comparisons indicate BPRS Anxiety/Depression Factor scores are higher at six months of 
treatment for individuals with service usage in adolescence (M = 9.20) than for 
individuals who did not use services in adolescence (M =7.82), t (118) = -2.09, p = .02. 
Finally there is not an interaction between assessment time and service use as they 
relate to BPRS Agitation/Elation Factor scores, F(2, 134) = 1.08, p = .34, Mse = 1.51.  
There is no main effect for BPRS Agitation/Elation Factor scores over time (F(2, 134) = 
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.06, p = .94) or for service use (F(1, 67) = .02, p = .90).  Results of repeated measure 
ANOVAs and means and standard deviations can be found in Tables 114, 120 - 122. 
Because isolated differences between groups on individual BPRS items are found 
at admission, those analyses are repeated here to determine whether there is a consistent 
pattern over time on any particular BPRS items.  No interactions, assessment time main 
effects, or service use main effects are found for the following BPRS items: Somatic 
Concern, Anxiety, Depression, Guilt, Hostility, Elevated Mood, Grandiosity, 
Suspiciousness, Disorientation, Conceptual Disorganization, Blunted Affect, Emotional 
Withdrawal, Tension, Uncooperativeness, Excitement, Distractibility, Motor 
Hyperactivity, and Mannerisms and Posturing (all Fs < 3.71, all ps > .06). 
However, planned comparisons indicate several differences between individuals 
who used services in adolescence and those without a history of adolescent service usage.  
Results indicate BPRS Depression item scores are higher at six months of treatment for 
individuals with service usage in adolescence (M = 2.28) than for individuals who did not 
use services in adolescence (M =1.85), t (119) = -1.89, p = .03. Results also indicate 
BPRS Guilt item scores are higher at six months of treatment for individuals with service 
usage in adolescence (M = 2.10) than for individuals who did not use services in 
adolescence (M =1.55), t (118) = -2.49, p < .01.  Additionally, planned comparisons 
indicate BPRS Hostility item scores are higher at six months of treatment for individuals 
with service usage in adolescence (M = 2.81) than for individuals who did not use 
services in adolescence (M = 2.32), t (119) = -1.89, p = .04.  As previously stated, t-tests 
at admission found a difference between groups on BPRS Grandiosity item scores.  This 
result is also found after one year of treatment, when again results indicate scores are 
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lower for individuals with service usage in adolescence (M = 1.57) than for individuals 
who did not use services in adolescence (M = 2.26), t (77) = 1.71, p = .05.  Results 
indicate BPRS Blunted Affect item scores are higher at six months of treatment for 
individuals with service usage in adolescence (M = 2.77) than for individuals who did not 
use services in adolescence (M = 2.32), t (119) = -1.91, p = .03.   Analyses also indicate 
BPRS Tension item scores are lower after one year of treatment for individuals with 
service usage in adolescence (M = 1.33) than for individuals who did not use services in 
adolescence (M = 1.76), t (77) = 2.07, p = .02.  Finally, results indicate BPRS Motor 
Hyperactivity item scores are lower after one year of treatment for individuals with 
service usage in adolescence (M = 1.18) than for individuals who did not use services in 
adolescence (M = 1.51), t (77) = 1.72, p = .05.  The previously stated results obtained 
from planned comparisons indicate analyses utilizing ANOVAs over the course of 
treatment sometimes did not have enough power to detect significant differences amongst 
the groups. 
There is not an interaction between assessment time and service use as they relate 
to BPRS Suicidality scores, F(2, 136) = .14, p = .87, Mse = .64.  There is no main effect 
for BPRS Suicidality scores over time (F(2, 136) = .55, p = .58).  As hypothesized, there 
is a main effect for service use (F(1, 68) = 6.62, p = .01), with individuals with mental 
health service usage in adolescence receiving higher overall BPRS Suicidality scores than 
those without mental health service usage in adolescence at all assessment times (Table 
124).  When planned comparisons were completed, results indicate BPRS Suicidality 
item scores are higher at six months of treatment for individuals with service usage in 
adolescence (M = 1.73) than for individuals who did not use services in adolescence (M = 
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1.16), t (119) = -3.35, p < .001.  Additionally, after one year of treatment results indicate 
contrary to hypothesis BPRS Suicidality item scores remain higher for individuals with 
service usage in adolescence (M = 2.28) than for individuals who did not use services in 
adolescence (M = 1.85), t (77) = -.87, p = .01. 
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Figure 3.49 Service Usage Group Main Effect on BPRS Suicidality Item Scores Across Treatment 
 
There is an interaction between assessment time and service use on BPRS 
Hallucinations item score, F(2, 136) = 3.97, p = .02, Mse = 1.87.  BPRS Hallucination 
items scores remain stable over treatment for those without mental health service usage in 
adolescence, whereas BPRS Hallucination items scores, contrary to hypotheses, decrease 
over treatment for those with mental health service usage in adolescence (LSD minimum 
mean difference = .59). As hypothesized, individuals with mental health service usage in 
adolescence have higher BPRS Hallucination item scores at admission than individuals 
without mental health service usage in adolescence; however, contrary to hypotheses, this 
difference does not persist at 6 months to one year of treatment. There is no main effect 
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for BPRS Hallucination item scores over time (F(2, 136) = .08, p = .93) or for service use 
(F(1, 68) = .61, p = .44).  Results of repeated measure ANOVAs and means and standard 
deviations can be found in Tables 124. 
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Figure 3.50 Interaction Between Service Usage Groups on BPRS Hallucinations Item Scores Across 
Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to BPRS Unusual Thought Content item scores, F(2, 134) = .51, p = .60, Mse = 1.57.   
There is a main effect for assessment time, F(2, 134) = 4.14, p = .02.  Scores remain the 
same from admission to six months, and from six months to one year, however as 
hypothesized scores after one year of treatment generally decrease from scores at 
admission.  However, this pattern is only descriptive for individuals who used mental 
health service use in adolescence. There is no main effect for service use, F(1, 67) = .57, 
p = .45 (Table 124). 
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Figure 3.51 Time Main Effect for Service Usage Groups on BPRS Unusual Thought Content Item Scores 
Across Treatment 
 
There is an interaction between assessment time and service use on BPRS Bizarre 
Behavior item score, F(2, 136) = 3.24, p = .04, Mse = 1.22. BPRS Bizarre Behavior items 
scores remain stable over treatment for those with and without mental health service 
usage in adolescence; however BPRS Bizarre Behavior items scores at one year are less 
than scores at admission for those who used mental health services in adolescence (LSD 
minimum mean difference = .52). Individuals who used mental health services in 
adolescence have higher BPRS Bizarre Behavior item scores at admission than 
individuals without mental health service usage in adolescence; however, contrary to 
hypotheses, this difference does not persist at 6 months to one year of treatment. There is 
no main effect for BPRS Bizarre Behavior item scores over time (F(2, 136) = 1.00, p = 
.37) or for service use (F(1, 68) = 1.99, p = .16) (Table 124).  
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BPRS Bizarre Behavior Item Scores Across Treatment
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Figure 3.52 Interaction Between Service Usage Groups on BPRS Bizarre Behavior Item Scores Across 
Treatment 
 
There is an interaction between assessment time and service use on BPRS Self 
Neglect item score, F(2, 136) = 4.46, p = .01, Mse = .61. As hypothesized, BPRS Self 
Neglect items scores remain stable from admission to six months and then decrease for 
individuals who used mental health services in adolescence.  However, contrary to 
hypotheses, scores increase from admission to six and twelve months (which are 
equivalent to each other) for those without mental health service usage in adolescence 
(LSD minimum mean difference = .37).  As hypothesized, individuals who used mental 
health services in adolescence have higher BPRS Self-Neglect item scores at admission 
than individuals without mental health service usage in adolescence; however, contrary to 
hypotheses, this difference does not persist at 6 months to one year of treatment. There is 
an overall main effect for BPRS Self Neglect item scores over time, F(2, 136) = 5.68, p < 
.01.  Self Neglect items scores increase from admission to six months and then decrease 
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at one year of treatment (LSD minimum mean difference = .26).  However, this pattern is 
not descriptive for those with or without mental health service usage in adolescence and 
is therefore misleading.  There is no main effect for service use, F(1, 68) = .07, p = .80.  
Results of repeated measure ANOVAs and means and standard deviations can be found 
in Tables 124. 
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Figure 3.53 Time Main Effect and Interaction Between Service Usage Groups on BPRS Self-Neglect Item 
Scores Across Treatment 
 
There is not an interaction between assessment time and service use as they relate 
to BPRS Motor Retardation item scores, F(2, 134) = .11, p = .90, Mse = .61.  There is a 
main effect for assessment time, F(2, 134) = 4.65, p = .01.  Scores decrease from 
admission to six months and one year (which are equivalent to each other) for individuals 
with and without mental health service usage in adolescence (LSD minimum mean 
difference = .26). There is no main effect for service use, F(1, 67) = .77, p = .38 (Table 
124). 
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Figure 3.54 Time Main Effect for Service Usage Groups on BPRS Motor Retardation Item Scores Across 
Treatment 
 
When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs 
were conducted using APP severity levels, no interactions, assessment time main effects, 
or APP severity level main effects are found for the following assessments: BPRS Total, 
BPRS Psychotic Disorganization Factor, BPRS Hallucinations/Delusions Factor, BPRS 
Paranoia Factor, BPRS Emotional Blunting Factor, BPRS Anxiety/Depression Factor, 
BPRS Agitation/Elation Factor, BPRS Somatic Concern item, BPRS Anxiety item, BPRS 
Depression item, BPRS Guilt item, BPRS Hostility item, BPRS Elevated Mood item, 
BPRS Grandiosity item, BPRS Suspiciousness item, BPRS Hallucinations item, BPRS 
Unusual Thought Content item, BPRS Conceptual Disorganization item, BPRS Blunted 
Affect item, BPRS Emotional Withdrawal item, BPRS Tension item, BPRS 
Uncooperativeness item, BPRS Excitement item, BPRS Distractibility item, BPRS Motor 
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Hyperactivity item, and BPRS Mannerisms and Posturing item (all Fs < 2.51, all ps > 
.06).   
Results of repeated measure ANOVAs and means and standard deviations can be 
found in Tables 115, 123, and 125.  Again, there are several significant differences on 
BPRS items when analyses assess differences amongst APP severity levels. There is not 
an interaction between assessment time and APP severity level as they relate to BPRS 
Suicidality scores, F(6, 132) = .51, p = .80, Mse = .64.  There is no main effect for BPRS 
Suicidality scores over time, F(2, 132) = .89, p = .41.  There is a main effect for APP 
severity level, F(3, 66) = 4.64, p = .01, with individuals with each level of APP having 
equivalent overall BPRS Suicidality scores, however as hypothesized those with high 
APP have higher overall BPRS Suicidality scores than those with no or low APP.  This 
pattern is descriptive for all assessment times (Table 125). 
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Figure 3.55 APP Severity Levels Main Effect on BPRS Suicidality Item Scores Across Treatment 
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There is an interaction between assessment time and APP severity level on BPRS 
Bizarre Behavior item score, F(6, 132) = 2.19, p = .05, Mse = 1.20. BPRS Bizarre 
Behavior items scores remain stable over treatment for those with no, low, and medium 
APP whereas for individuals with high APP Bizarre Behavior item scores at one year are, 
as hypothesized, less than scores at admission (LSD minimum mean difference = .73). 
Individuals without APP and with medium APP have lower BPRS Bizarre Behavior item 
scores at admission than those in the low and high APP groups (which are equivalent to 
each other).  At six months, BPRS Bizarre Behavior item scores are equivalent for each 
group.  After one year of treatment, contrary to hypotheses, Bizarre Behavior item scores 
are highest for individuals with low APP, with those with no, medium, and high APP 
receiving equivalent BPRS Bizarre Behavior scores.  There is no main effect for BPRS 
Bizarre Behavior item scores over time (F(2, 132) = .17, p = .84) or for APP severity 
level (F(3, 66) = 1.22, p = .31).  Means and standard deviations are in Tables 125. 
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Figure 3.56 Interaction between APP Severity Levels on BPRS Bizarre Behavior Item Scores Across 
Treatment 
 
135 
There is an interaction between assessment time and APP severity level on BPRS 
Self Neglect item score, F(6, 132) = 2.56, p = .02, Mse = .60. BPRS Self Neglect items 
scores remain stable from admission to six months and then, as hypothesized, these 
scores decrease for individuals with high APP.  Contrary to hypotheses, scores increase 
from admission to six months and remain the same from six to twelve months for those 
without APP (LSD minimum mean difference = .52).  BPRS Self Neglect item scores 
remain the same across treatment for individuals with low or medium APP.    No 
differences are found between groups on BPRS Self-Neglect item scores at admission or 
at six months, however as hypothesized individuals with high APP have lower BPRS Self 
Neglect scores than all other groups after one year or treatment. There is not an overall 
main effect for BPRS Self Neglect item scores over time (F(2, 132) = 1.43, p =.24) or for 
APP severity level (F(3, 66) = .50, p = .68) (Table 125).  
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Figure 3.57 Interaction between APP Severity Levels on BPRS Self-Neglect Item Scores Across Treatment 
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There is not an interaction between assessment time and APP severity level as 
they relate to BPRS Disorientation item scores, F(6, 130) = .58, p = .75, Mse = .41.  
There is not a main effect for assessment time, F(2, 130) = .31, p = .74.  There is an 
overall main effect for APP severity level, F(3, 65) = 4.97, p < .01. Overall, contrary to 
hypotheses individuals with low APP have higher BPRS Disorientation item scores than 
those with no, medium, or high APP at all assessment times (LSD minimum mean 
difference = .52) (Table 125). 
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Figure 3.58 APP Severity Levels Main Effect on BPRS Disorientation Item Scores Across Treatment 
 
There is not an interaction between assessment time and APP severity level as 
they relate to BPRS Motor Retardation item scores, F(6, 130) = .34, p = .92, Mse = .62.  
There is a main effect for assessment time, F(2, 130) = 3.12, p = .05.  Scores remain the 
same from admission to six months and from six months to one year.  However, as 
hypothesized scores at one year are lower than scores at admission (LSD minimum mean 
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difference = .27). However, this pattern is only descriptive for individuals with high APP 
and is therefore misleading. There is no main effect for APP severity level, F(3, 65) = 
1.04, p = .38. 
BPRS Motor Retardation Item Scores Across Treatment
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Figure 3.59 Time Main Effect for APP Severity Levels on BPRS Motor Retardation Item Scores Across 
Treatment 
 
Overall, results of analyses using the BPRS total, BPRS factor scores, and BPRS 
items suggest that differences amongst groups exist for several symptomatology 
measures as they relate to assessment time and service use.  Contrary to hypotheses, 
symptomatology for individuals with and without mental health service usage in 
adolescence does not improve over the course of treatment as measured by BPRS Total 
Assets, BPRS Hallucination/Delusions factor, BPRS Paranoia factor, BPRS Emotional 
Blunting factor, BPRS Anxiety/Depression factor, and BPRS Agitation/Elation factor.  
Partial support for hypotheses is found with the BPRS Psychotic Disorganization factor, 
as improvements across treatment are only descriptive for those who used mental health 
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services in adolescence.  As hypothesized, individuals with mental health service usage in 
adolescence demonstrate more symptomatology at admission on the BPRS Psychotic 
Disorganization factor, however no other differences between groups at admission exist 
for other BPRS factor scores.  In addition, contrary to hypotheses, individuals with 
mental health service usage in adolescence do not demonstrate more symptomatology 
after one year of treatment on the BPRS Total Assets score and BPRS factor scores.  
When BPRS items are analyzed across time, partial support for hypotheses is found.  For 
individuals who used mental health services in adolescence, scores on BPRS 
Hallucinations/Delusion item, BPRS Unusual Thought Content item, BPRS Bizarre 
Behavior item, and BPRS Self-Neglect item improve by one year of treatment.  However, 
scores on these same measures remain the same across treatment for those without mental 
health service usage in adolescence.  However, as hypothesized, BPRS Motor 
Retardation scores improve over the course of treatment for those with and without 
mental health service usage in adolescence.  As hypothesized, individuals who did use 
mental health services in adolescence demonstrate more symptomatology at admission on 
the BPRS Suicidality item, BPRS Hallucination/Delusions item, BPRS Bizarre Behavior 
item, and BPRS Self-Neglect item.  However, by one year of treatment the only 
difference that remains between groups is that individuals who used mental health 
services in adolescence receive higher suicidality scores than those without mental health 
service usage in adolescence.  
In summary, when analyses were conducted between APP severity level and 
BPRS total, BPRS factor scores, and BPRS items only significant differences emerge on 
individual BPRS items.  Again, partial support for hypotheses is found.  Improvement in 
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symptomatology across treatment is found only for those with high APP on BPRS Self-
Neglect item, BPRS Bizarre Behavior item, and BPRS Motor Retardation item.  As 
hypothesized, differences exist between the groups at various assessment times.  As 
hypothesized, individuals with high APP demonstrate more symptomatology at 
admission on the BPRS Bizarre behavior item, however individuals with high APP 
demonstrate equivalent scores to those with low APP at admission.  As hypothesized, 
individuals with high APP exhibit more symptomatology after one year of treatment on 
BPRS Suicidality item and BPRS Self-Neglect item.  However, contrary to hypotheses 
individuals with low APP receive the highest BPRS Bizarre Behavior item and BPRS 
Disorientation item scores after one year of treatment and therefore demonstrate more 
symptomatology on these measures compared to those with high APP.   
 
Hypothesis 2 
Outcome 
 A pattern of differential outcome was hypothesized for those who used services 
during adolescence versus individuals who did not use services and for each APP severity 
level.  Specifically, it is predicted that that discharge disposition differs between the two 
groups in that individuals with severe adolescent psychiatric pathology are discharged to 
a more restrictive setting.  In addition, it is predicted that there is a greater rate of 
rehospitalization for those who used mental health services in adolescence than those 
without mental health services in adolescence.  Furthermore, when analyses are 
conducted between the different APP severity groups, it is predicted that those 
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individuals in the medium and highest APP severity groups have a greater rate of 
rehospitalization than those in the low to no APP severity groups.   
Also, it is predicted that those in the highest APP severity group have the greatest 
rate of rehospitalization, as these individuals may represent a subgroup experiencing 
more severe and refractory symptoms that can be potential barriers to living in the 
community for extended periods.  
 Discharge Location 
 It was predicted that people who used services during adolescence are discharged 
to more restrictive levels of care than those who did not use services.  Chi square 
analyses reveal there is no significant relationship between the level of restrictiveness of 
discharge setting and service use in adolescence, X2 (3) = 1.85, p =0.60 (See Table 126).   
It was also predicted that when APP severity level is examined, discharge 
disposition differs between the groups in that individuals with severe adolescent 
psychiatric pathology are discharged to a more restrictive setting than individuals in the 
no, low, or medium APP groups. Chi square analyses reveal there is no significant 
relationship between the level of restrictiveness of discharge setting and APP severity 
level, X2 (9) = 5.86, p =0.75 (See Table 127).  Contrary to the hypothesis, those 
individuals with severe adolescent psychiatric pathology are not discharged to more 
restrictive settings than individuals with less severe adolescent pathology. 
 Rehospitalization Rate 
 Following discharge, CTP participants spent an average of 94.86% of days during 
the first six months after discharge in the community rather than in the hospital, 95.20% 
of days within the first year, 93.22% of days within eighteen months, and 93.20% of days 
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within the first two years after discharge.  Ninety-three of the 123 people, or 75.6%, with 
rehospitalization data available are not rehospitalized from the time of discharge through 
the time the outcome data was collected.  There are no significant differences between 
those who did or did not use services during adolescence on the percentage of days in the 
first six months after CTP discharge spent in the community (F(1,122) = .03, p = 0.86), 
the percentage of days in the first year after CTP discharge spent in the community 
(F(1,109) = .22, p = 0.64), the percentage of days within eighteen months after CTP 
discharge spent in the community (F(1, 88) = .30, p = 0.58), or the percentage of days 
within two years after CTP discharge spent in the community (F (1, 73) = .02, p = 0.90).   
Furthermore, when APP severity level is examined, there are no significant 
differences between APP severity level on the percentage of days in the first six months 
after CTP discharge spent in the community (F(3,122) = .72, p = 0.54), the percentage of 
days in the first year after CTP discharge spent in the community (F(3,109) = 1.02, p = 
0.39), the percentage of days within eighteen months after CTP discharge spent in the 
community (F(3, 88) = .67, p = 0.58), or the percentage of days within two years after 
CTP discharge spent in the community (F (3, 73) = .55, p = 0.65).   
 As described in the methods section, the rehospitalization data is skewed and 
could not be transformed or windsorized into an acceptable skewness range.  This is 
largely a function of the large proportion of people who were never rehospitalized during 
the follow-up period.  In order to substantiate the above results since the data used in the 
above analyses is skewed, categorical variables of “rehospitalized” and “not 
rehospitalized” were created based on all or none cutoff levels.    Chi square analysis 
reveals no significant relationship between whether or not someone used services in 
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adolescence and rehospitalization categorization, X2(1) = .62, p = .43.  Likewise, 
rehospitalization categorizations were made based on rehospitalization in six-month 
intervals following discharge.  At six months post-discharge, there is not a significant 
relationship between service use and rehospitalization categorization, X2(1) = .62, p = .43.  
At 12 months post-discharge, again no significant relationships between service use and 
rehospitalization categorization are found, X2(1) = .30, p = .59.  Again, at 18 months post-
discharge, there remains no relationship between the two variables, X2(1) = .88, p = .35.  
Finally, at 24 months post-discharge, there remains no relationship between the two 
variables, X2(1) = .05, p = .82. 
When APP severity level is examined, Chi square analysis again reveals no 
significant relationship between APP severity level and whether or not they are 
rehospitalized after discharge from CTP, X2(3) = 2.87, p = .41.  Likewise, 
rehospitalization categorizations for each APP severity level are made based on 
rehospitalization in six-month intervals following discharge.  At six months post-
discharge, there is not a significant relationship between the various APP severity levels 
and rehospitalization categorization, X2(3) = 3.32, p = .35.  At 12 months post-discharge, 
again no significant relationships between APP severity level and rehospitalization 
categorization are found, X2(3) = 4.03, p = .26.  Again, at 18 months post-discharge, there 
remains no relationship between the two variables, X2(3) = 4.21, p = .24.  Finally, at 24 
months post-discharge, there remains no relationship between the two variables, X2(3) = 
5.21, p = .16. 
In summary, results of analyses of outcome data with regard to service use 
indicate that at the time of discharge and during the follow-up period after discharge, no 
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differences between individuals who used services in adolescence and those who did not 
use services are evident.  Moreover, no differences between APP severity groupings are 
noted. Contrary to all outcome hypotheses, there is no evidence that APP severity levels 
differ in terms of rehospitalization outcomes. 
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CHAPTER 5 – DISCUSSION 
The primary purpose of this study was to assess the relationship of adolescent 
psychiatric pathology with insight before, during, and after treatment.  In addition, a 
secondary relationship between adolescent psychiatric pathology and functioning in a 
variety of domains before, during, and after treatment were assessed.  The participants 
with adolescent psychiatric pathology were compared to those without to determine if 
any differences existed.  Also, when adolescent psychiatric pathology was separated into 
three separate groups by the amount and type of services utilized during adolescence, 
these three different levels of adolescent psychiatric pathology were also be compared to 
those without.  Univariate and multivariate analyses were conducted within and between 
the two groups and four groups with respect to overall functioning using multiple 
measures described below. To date, only one study on this topic is known to exist 
(Wynne, 2009).  Because of the paucity of research in this area, this study was highly 
exploratory in nature, giving a first look at the clinical correlates across treatment 
between individuals with and without adolescent psychiatric pathology.  Furthermore, 
these clinical correlates across treatment in adulthood were also studied between 
individuals with various severities of adolescent psychiatric pathology.   
Overall, there was mixed support for the hypotheses of the study.  In summary 
results suggest individuals with service use during adolescence were found to be younger 
at admission to CTP, have slightly lower levels of education, and have an earlier age of 
onset and more previous hospitalizations, as expected.  The results are consistent with 
earlier work (Herron, 1962) on the process reactive distinction in schizophrenia.  The 
process reactive distinction analyzed the developmental sequence of schizophrenia 
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spectrum disorders.  Specifically, research in this area is concerned with individuals’ 
premorbid patterns, the timeline preceding the onset of the disorder, the precipitant(s) that 
may engender the onset of the disorder, and symptom presentation during the course of 
the disorder.  Results from this study indicate those who used services in adolescence, as 
specifically the medium and high APP groups closely resemble the traditional 
psychopathology “process” group from research in the 1950s-1980. Process type has 
been associated with an insidious onset, gradual emotional blunting, and withdrawing 
from daily activities.  Research found individuals identified in the process group had poor 
performance in school, deterioration in functioning in a variety of domains including 
neurocognitive, hospitalization during adolescence, poor response to treatment, 
awareness of change in self, and a family history of mental illness.  Individuals without 
mental health service usage in adolescence may represent the reactive type again from 
research in the 1950s-1980s. Reactive type is usually characterized by a sudden onset of 
the disorder after the person experiences a particular stressor, have an onset later in life, 
functioning within normal limits in most domains in life prior to onset, good academic 
performance in school, good response to treatment, and “no sensation of change” (Haas 
& Sweeney, 1992).  While it is interesting to note analyses utilizing the service use prior 
to age 18 vs. no service use prior to age 18 found similar results to research using 
process-reactive distinctions, utilizing either of these promotes a dichotomous typology 
rather than analyzing adults with SMI on a continuum.  Thus, further research utilizing 
APP severity levels may be able to further delineate differences in premorbid 
functioning, onset of illness, clinical correlates, and influence favorable treatment 
outcomes for each individual at all levels of the continuum.    
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A relationship between Axis I and Axis II diagnoses and service use was 
identified.  Those diagnosed with Schizophrenia, Chronic/Undifferentiated Type, 
Schizoaffective Disorder, and “other” appear more likely to have used mental health 
services during adolescence than those diagnosed with Schizophrenia, Paranoid Type.  
Those diagnosed with Paranoid Personality Disorder appear less likely to have received 
services during adolescence than those diagnosed with Borderline Personality Disorder; 
whereas those diagnosed with Borderline Personality Disorder appear more likely to have 
received services during adolescence.  Those who used services and did not use services 
were more likely to be diagnosed with “other” than to have a diagnosis of Borderline 
Personality Disorder. Those diagnosed with Borderline Personality Disorder appear more 
likely to have received services during adolescence than not whereas those without an 
Axis II diagnosis were more likely to have not used services during adolescence.  The 
differences between groups corroborate previous findings and indicate that exploration of 
these differences in participant characteristics needs to continue to be explored in future 
studies.  The finding that Axis I and Axis II diagnoses are associated with service use 
may be a sign those that receive mental health services during adolescence may be more 
likely to develop comorbid disorders that greatly influence their functioning in adulthood.  
This may also indicate that those individuals who did not receive services during 
adolescence were experiencing less severe symptomatology than those who received 
services and thus these individuals may not have been perceived as high risk or needing 
services during adolescence by mental health professionals.  This finding may have 
important implications for screening tools used by mental health professionals serving 
adolescents transitioning into adulthood. 
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Contrary to all hypotheses, participants with service usage in adolescence do not 
significantly differ from those without at the time of admission, with respect to 
neurocognitive, social cognitive functioning, or insight.  In addition, there do not appear 
to be substantial differences in neurocognitive functioning, social cognitive functioning, 
or insight at admission for the various APP severity levels.  Overall, results of NOSIE 
analyses do not support hypotheses that those with service use in adolescence 
demonstrate poorer behavioral functioning upon admission than those without, nor were 
hypotheses supported that differences in behavioral functioning at admission existed 
between the different APP severity groups.  Although a significant difference occurred on 
the NOSIE Motor Retardation subscale, results were opposite to hypothesized and the 
high APP severity group received lower scores than individuals in the low and medium 
APP severity groups.    
It was anticipated that individuals with service usage in adolescence would have a 
higher level of symptomatology at admission than those without, and specifically those 
individuals with the most severe APP would demonstrate a higher level of 
symptomatology than those with less severe APP.   Individuals with service usage in 
adolescence received higher suicidality and hopelessness scores at admission than those 
without.  Indeed, as research has indicated, symptoms such as suicidality and depression 
may all influence or be manifestations or outcomes of various levels of insight (Amador 
et al., 1991; Amador et al., 1993; Amador et al., 1996; Caldwell & Gottesman, 1990; 
Lysaker et al., 2005; McGlashan et al., 1975).  These results indicate future studies may 
utilize cluster analysis in order to study the unique differences amongst groups in 
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variables, as a consistent pattern of differences in performance was not found by the 
current study.   
 When analyses were conducted between APP severity levels two significant 
differences emerged.  Again as hypothesized, those individuals with medium or high APP 
received higher suicidality scores on multiple measures than those without APP or in the 
low APP severity group. Individuals without service use in adolescence were rated as 
more uncooperative than individuals with various levels of APP severity, indicating that 
prior contact with services may actually aid in working with treatment providers upon 
rehospitalization.  
Results of analyses between those who used mental health services prior to age 18 
and those who did not use services and neurocognitive functioning over the course of 
treatment suggest that improvements in neurocognitive functioning are evident over the 
course of treatment on strategic planning and organized searching, for individuals without 
service use in adolescence on a measure of verbal memory, for individuals with service 
use in adolescence on a measure of visuocontructional ability and nonverbal memory, for 
both groups in nonverbal memory, for individuals with service use in adolescence on a 
task assessing attention and information processing, for those with service use in 
adolescence on verbal fluency and word generating ability, and for both groups on a 
neurocognitive screening assessment measuring overall cognitive functioning.   
Results of analyses between assessment time and APP severity level indicate 
improvements in neurocognitive functioning are over the course of treatment on a task of 
verbal memory for those without APP, for those with low or high APP on a task of 
immediate nonverbal memory and visuocontructional ability, for those with none or high 
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APP on delayed nonverbal memory, and for those in the none, low, or high groups on a 
neurocognitive screener measuring overall cognitive functioning.   
As hypothesized, when analyses were conducted between those without service 
usage before age 18 and those with service usage in adolescence, no differences existed 
between groups on most measures of neurocognitive functioning.  Contrary to 
hypotheses, individuals with service usage in adolescence were better able to rapidly 
generate and organize verbal information after one year of treatment than those without 
service usage in adolescence.  However, individuals without APP demonstrated poorer 
overall cognitive functioning after one year of treatment than those with APP. 
Finally, as hypothesized, when analyses were conducted utilizing APP severity 
level, as hypothesized no differences existed between groups after one year of psychiatric 
rehabilitation on most neurocognitive measures.  Contrary to hypotheses, individuals with 
high APP demonstrated better verbal memory performance at admission and six months, 
however as hypothesized this difference did not remain after one year of treatment.  As 
hypothesized, those individuals with high APP demonstrated poorer overall cognitive 
functioning at admission.  However, contrary to hypotheses differences remained 
between the groups at twelve months and those without APP or low APP performed 
better on a measure of overall cognitive functioning than those in the medium or high 
APP severity groups.  
Improvements in sociocognitive functioning were also evident over the course of 
treatment on participant’s ability and facility of comprehension and interpretation of 
social limitations and for those with service usage prior to age 18 on social support 
coping cognitions.  Contrary to hypotheses, there was not a decrease in participant’s 
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beliefs being effected by their beliefs that others are powerful, a component of external 
locus of control. Furthermore, contrary to hypotheses there was not an increase in internal 
locus of control, in individual’s self-concept of their own competence or participant’s 
self-efficacy (both components of internal locus of control) over the course of treatment.  
As hypothesized, overall external locus of control and the role of chance in determining 
one’s fate, a subscale of external locus of control, did decrease over treatment. However, 
this only occurred for those with service usage in adolescence.    
When social cognitive was assessed amongst the various APP severity groups 
results indicate improvements in sociocognitive functioning are inconsistent over the 
course of treatment on theory of mind abilities. As previously indicated, there was not a 
decrease in participant’s beliefs in powerful others over treatment.  Furthermore, contrary 
to hypotheses there was not an increase in internal locus of control or participant’s self-
concept or self-efficacy over the course of treatment amongst the various APP severity 
groups.  As hypothesized, external locus of control decreased over treatment, however 
this only occurred for those in the low, medium, and high groups.  For beliefs that chance 
controls one’s fate, decreases over treatment only occurred for those with low or medium 
APP.    
Contrary to the hypothesis those adults with service usage in adolescence did not 
endorse differing overall insight or ability to relabel symptoms scores over the course of 
treatment. However, as hypothesized, there were no differences between those with and 
without service usage in adolescence on any measure of insight after one year of 
psychiatric rehabilitation. Furthermore, individuals without service usage prior to age 18 
endorsed lower overall insight total scores and their ability to relabel symptoms as part of 
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their illness decreased over the course of treatment.  In general, the CTP participants 
endorsed lower insight into need for treatment scores across treatment, possibly 
indicating an increased desire to be discharged as length of stay increased.   
When results of analyses on insight measures at admission and over the course of 
treatment utilize APP severity levels, results suggest that differences in insight across 
treatment existed between groups.  However, contrary to hypotheses only individuals 
with low APP endorsed increases in total insight over the course of treatment.  Total 
insight for individuals with no or low APP decreased over treatment while total insight 
scores remained the same across treatment for those with high APP.  As hypothesized, 
ability to relabel symptoms increased over treatment for those with medium APP but 
remained the same for those with high APP.  Individuals with no or low APP experienced 
decreased ability to relabel symptoms across treatment.  Insight awareness scores 
remained the same across treatment for those with no, medium, or high APP while it 
decreased for those with low APP.  Furthermore, insight into need for treatment again 
decreased across treatment for individuals with no, low, or high APP groups but 
remained stable across treatment for those with medium APP.  However, as 
hypothesized, there were no differences between those with and without APP on insight 
measures after one year of psychiatric rehabilitation. 
Overall, results suggest that improvements in behavioral functioning do occur 
across treatment in almost all domains measured within the current study for those with 
and without service usage in adolescence.  However, partial support for hypotheses was 
found for irritability and psychoticism scores.  When service use was utilized in analyses, 
all participants’ irritability scores increased from admission to six months but decreased 
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by 12 months of treatment.  Furthermore, contrary to hypotheses psychoticism scores for 
all participants continued to increase over the course of treatment.  When results were 
analyzed with regards to APP severity level, the above results were again found.  
However, motor retardation improved for all APP severity levels.  However, as predicted, 
no differences existed amongst groups after one year of psychiatric rehabilitation.  
Results also suggest that differences amongst groups exist for several 
symptomatology measures as they relate to assessment time and service use.  Contrary to 
hypotheses, symptomatology for individuals with and without service usage in 
adolescence did not improve over the course of treatment.  Partial support for hypotheses 
was found with the BPRS Psychotic Disorganization factor, as improvements across 
treatment were only descriptive for those with service usage in adolescence.  As 
hypothesized, individuals with service usage prior to age 18 demonstrated more 
symptomatology at admission on the BPRS Psychotic Disorganization factor, however no 
other differences between groups at admission existed for other BPRS factor scores.  
Also contrary to hypotheses, individuals with service usage in adolescence did not 
demonstrate more symptomatology after one year of treatment.  When specific 
symptomatology items were analyzed across time, partial support was found.  For 
individuals with mental health service usage in adolescence, items assessing 
hallucinations/delusions, unusual thought content, bizarre behavior, and self-neglect 
improved by one year of treatment.  However, on scores on these same measures 
remained the same across treatment for those without service usage in adolescence.  
However, as hypothesized, BPRS Motor Retardation scores improved over the course of 
treatment for those with and without service usage in adolescence.  As hypothesized, 
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individuals with service usage in adolescence demonstrated more suicidality, 
hallucinations/delusions, bizarre behavior, and self-neglect.  However, by one year of 
treatment the only difference that remained between groups was that individuals with 
service usage in adolescence received higher suicidality scores than those without service 
usage in adolescence.  
Results also suggest that differences amongst groups exist for several 
symptomatology measures as they relate to assessment time and APP severity level.  
Again, partial support for hypotheses were found.  Improvement in symptomatology 
across treatment was found only for those with high APP on items measuring self-
neglect, bizarre behavior, and motor retardation.  As hypothesized, differences existed 
between the groups at various assessment times.  As hypothesized, individuals with high 
APP demonstrated more symptomatology at admission on items assessing bizarre 
behavior, however individuals with high APP demonstrated equivalent scores to those 
with low APP at admission.  As hypothesized, individuals with high APP exhibited more 
suicidality and self-neglect.  However, contrary to hypotheses individuals with low APP 
received the highest bizarre behavior and disorientation item ratings after one year of 
treatment.   
Differences in level of discharge restrictiveness and rehospitalization rates were 
predicted for those with and without service usage in adolescence and for the various 
APP severity levels. Contrary to the hypothesis, those individuals with severe adolescent 
psychiatric pathology were not discharged to more restrictive settings than individuals 
with less severe adolescent pathology. There were no significant differences between 
those who did or did not use services during adolescence on the percentage of days spent 
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in the community in the first six, twelve, eighteen, and twenty-four months after CTP 
discharge.  Furthermore, when APP severity level is examined, there are no significant 
differences between APP severity level on the percentage of days in the first six, twelve, 
eighteen, and twenty-four months after CTP discharge spent in the community.   
Again, contrary to hypotheses, analyses revealed no significant relationship 
between whether or not someone used services in adolescence and rehospitalization 
categorization.  Likewise, rehospitalization categorizations were made based on 
rehospitalization in six-month intervals following discharge.  At six, twelve, eighteen, 
and twenty-four months post-discharge, there was not a significant relationship between 
service use and rehospitalization categorization. 
When APP severity level was examined, analyses again revealed no significant 
relationship between whether or not someone used services in adolescence and whether 
or not they were rehospitalized after discharge from CTP at all assessment time periods.  
Thus, contrary to all outcome hypotheses, there is no evidence that with or with APP 
differ in terms of rehospitalization outcomes or discharge location restrictiveness. 
Overall, similar discharge patterns between those with and without APP were 
found with discharges from CTP.  Treatment teams may be aware of the social history of 
each person and it is likely that failure at previous discharge locations impact future 
discharge planning.  Of note, several measures of symptomatology and behavioral 
functioning (i.e. those with service usage in adolescence were rated higher on items of 
self-neglect and suicidality) were unable to maintain adequate self-care or an appropriate 
level of care needed for some discharge locations.  Based on past rates of 
rehospitalization, treatment teams may be more likely to discharge to locations seen as 
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transitional, or intermediate levels of care.  Perhaps even more likely, discharges may be 
dictated by the community providers themselves based on prior working with participants 
from the program.  Therefore, participants from CTP may only be accepted by a limited 
range of providers leading to the non-significant discharge findings.     
 The second part of the outcome hypothesis pertained to rate of rehospitalization.  
Results of this study cannot be used to fully substantiate nor disprove the notion that 
people with APP have higher rates of rehospitalization and that those with high APP may 
represent a more population with more treatment refractory symptoms.  A possible 
confound was the community agencies for which rehospitalization data was available.  
Records were not available if individuals resided or were hospitalized in another state, if 
they did not use the local CMHC, or if they were rehospitalized anywhere else besides 
the state hospital.  This may have significantly skewed the rehospitalization data that was 
available, therefore more qualitative analyses or case studies regarding rehospitalization 
rate for those with and without APP may be warranted to further evaluate this hypothesis. 
The inconsistent pattern of results and partial support of hypotheses in this study 
may be explained by the nature of the population from which the sample was drawn.  
Because of the severity and chronicity of psychiatric disorder within the CTP population, 
some of the non-significant differences between groups can be attributable to the overall 
high level of impairment present in the population at CTP, thus creating a “leveling 
effect” that may obscure some findings that would occur in other treatment environments.  
The CTP participants represent a particularly treatment-refractory population and 
differences in functioning between groups with various amount and types of service use 
during adolescence may be less apparent than they would be in a less severe or less 
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chronic psychiatric population with more variability.  Discriminating between any groups 
within the CTP population may require not only the existence of differences, but 
substantial differences.  That is not to say that there is not considerable heterogeneity 
within this group, but it may mean that fine, subtle differences between groups may be 
hard to detect, and these differences may or may not be meaningful.  This conclusion is 
congruent with studies which have had difficulty detecting treatment effects between 
groups in the CTP setting (Spaulding, Reed, Sullivan, Richarson, & Weiler, 1999; 
Wynne, 2009).  A similar study across treatment settings and/or populations may be 
warranted. 
   
Limitations of the Present Study 
The goal of identifying between a developmental conceptualization of insight 
based on contact with adolescent psychiatric pathology and various domains of 
functioning while hospitalized and outcomes in the community resulted in a myriad of 
findings.  The lack of consistent patterns of differences between groups may be because 
of varied conceptualizations of the construct of insight, constitutes service use during 
adolescence, and the unknown quality of services received.  One weakness of this study 
is that included measures of insight that do not reflect recent advances in 
multidimensional insight assessments.  Furthermore, insight assessments may be 
influenced by practice effects, as participants are given the same self-report form over the 
course of treatment.  Since this study utilized archival clinical data, only measures that 
are part of routine assessment at CTP were available.  While poor cognitive functioning 
has been linked to insight (e.g., Amador et al., 1991; Frith, 1992; Lysaker et al., 1994; 
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Lysaker et al., 1995; McGlynn & Schacter, 1989; Prigatano & Schacter, 1991 as cited in 
Rusch and Corrigan, 2002) and this study found inconsistent results between groups on 
neurocognitive functioning.  It may be that a more global measurement of insight 
reflecting current conceptualizations of insight, or a variable derived of various domains 
from assessments in other domains, would better capture the relationship between service 
use during adolescence and changes in insight and neurocognitive functioning across 
treatment.  
The current archival database does not lend itself to pre-post analyses.  Future 
studies may consider reformatting the archival database so as to have an admission data 
point and a discharge data point (or the assessment closest to discharge) as an 
approximation of pre- and post- rehabilitation functioning.  Furthermore, the use of a 
flexible assessment battery with this clinical population meant there was an unusually 
large amount of missing data that prevented some use of appropriate statistical analyses.  
The amount of significant results was also close to that expected to occur by chance, thus 
lowering confidence in complete interpretation of results.  For most analyses examining 
the between-group differences and within group difference there was enough power to 
detect differences. Effect size estimates were examined in addition to the statistical 
significance tests to determine there was enough power to detect all differences. 
At any rate, this study explored the relationship between various domains of 
functioning during the course of psychiatric rehabilitation and service use, APP severity 
and insight such that future studies in this area can make more informed research 
hypotheses using stricter constraints in research design to circumvent problems related to 
possible confounds.  
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Future Directions 
 Areas of needed research have already been alluded to in the above discussion.  
Specifically, a replication or study similar to the one undertaken here, with more defined 
hypotheses and changes in assessment measures is needed to further clarify the 
characteristics of those with various amounts of service use during adolescence and the 
differences in several domains of functioning across treatment after the age of 18 and 
once discharged into the community.  Likewise, a similar study in a broader population 
would allow for more generalizability of results.  Finally, a study or a series of case 
studies examining different events and service use during adolescence, possibly a 
longitudinal study following subjects from adolescence to adulthood, is necessary to 
better understand why some people improve their insight across treatment and others do 
not given the different trajectories or trends in insight scores and other domains of 
functioning across treatment for the various severity levels of APP. 
While the Birchwood Insight Scale is theoretically based on a multidimensional 
view of insight (David, 1990), this measure may not be indicative of current 
multidimensional conceptualizations of insight, or other conceptualizations such as the 
view that insight is the degree to which an individual agrees with their treatment 
provider, or insight as a coping mechanism.  The current study sought to determine 
relationships between individual’s insight and domains of functioning, however a 
consistent pattern could not be established.  Therefore, using measures of insight to 
identify correlates to clinical functioning, or insight across treatment, is unresolved until a 
relationship between the psychological construct of insight and other biopsychosocial 
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measures is better understood.  Studies identifying correlates of insight to various clinical 
variables have not been conducted within a population whose historical use of services 
during adolescence has been investigated.  Or, if they have, the effect of contact with 
mental health providers earlier in life on insight into treatment after the onset of illness 
has not been considered in analyses.  Such a study might simply include different 
biopsychosocial measures within a population such as the one in this study to determine 
if the measures make distinctions or can predict different APP severity level groups 
across treatment. 
 In general, more empirical, as opposed to theoretical investigations, of the 
concepts found within the prodromal research and service use during adulthood are 
needed in order to prevent or decrease the revolving door phenomenon commonly found 
in mental health settings.  The current study continues to take essential steps towards 
identifying the relationship between the access to and use of mental health services by 
adolescents and the subsequent clinical functioning of those individuals with an onset of 
mental illness later after transitioning into adulthood.   
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CTP Information Gathering Sheet pg. 1 
Name:____________________________________ 
ID number (please write down if you find they have more than 1 ID #):____________ 
Date(s) the file was looked at:_________________ 
Clinical Assistant who checked file:________________ 
 
 
Please write down any information about mental health services the patient received 
before the age of 18 (therapy, medicine, services from other mental health practitioners 
such as social works, etc; being in-patient hospitalized, whether they were in adolescent 
services here at the regional center or in another state, etc): 
 
Prior Therapy before the age of 18: 
 
 
 
 
 
 
 
 
 
 
Medicine before the age of 18: 
 
 
 
 
 
 
 
 
 
 
 
Services form other mental health providers (social workers, OT, psychiatrists, etc.): 
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CTP Information Gathering Sheet pg. 2 
 
Were they in-patient hospitalized before the age of 18? 
 
 
 
 
 
 
 
 
 
 
 
Any other information that is useful for determining how many and what type of mental 
health services they received prior to the age of 18? 
 
 
 
 
 
 
 
 
Is more information needed to determine the amount or type?  If so, what do you feel is 
needed? 
 
 
 
 
 
 
 
 
 
 
 
 
Was there any vague information that did not allow you to accurately rate the amount of 
previous mental health services?  If so describe the information.                                              
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Table 1 
Demographic and Clinical Characteristics of Participants  
Demographic and Clinical Variables N Mean (SD) or Percentage 
Age (range: 18 to 71) 308 37.91 (12.62) 
Education, # of years in school (range: 6 to 20 years)  283 12.23 (2.03) 
Length of stay at CTP in days (range:57-2545) 137 637.28 (452.97) 
Age of onset (range: 4 to 63 )  248 19.92 (8.60) 
Number of hospitalizations in lifetime (range: 0 to 105) 298 9.69 (9.77) 
Gender (n=317)   
     Male 203 64.0% 
     Female 114 36.0% 
Race/Ethnicity (n=288)   
     Caucasian 238 82.6% 
     African American 30 10.4% 
     Hispanic 6 2.1% 
     Native American 4 1.4% 
     Asian American 2 0.7% 
     Other 8 2.8% 
Marital Status (n=272)   
     Single 171 62.9% 
     Married 21 7.7% 
     Divorced 69 25.4% 
     Widowed 4 1.5% 
     Separated 7 2.6% 
Legal Status (n=280)   
     Mental Health Board Commitment (MHB) 220 78.6% 
     Voluntary per guardian (VpG) 34 12.1% 
     Not responsible by reason of insanity (NRRI) 22 7.9% 
     Voluntary (V) 4 1.4% 
Primary Axis I Diagnosis (n=282)   
     Schizophrenia, Paranoid Type 77 27.3% 
     Schizophrenia, Chronic/Undifferentiated Type 66 23.4% 
     Schizoaffective 78 27.7% 
     Bipolar 35 12.4% 
     Psychotic Disorder NOS 4 1.4% 
     Dementia / Organic Brain Disease 4 1.4% 
     Impulse Control Disorder 6 2.1% 
     Other 12 4.3% 
Axis II Diagnoses (n=284)   
     None 105 37.0% 
     Borderline 20 7.0% 
     Paranoid 46 16.2% 
     Antisocial 13 4.6% 
     Schizoid 4 1.4% 
     Borderline Intellectual Functioning / Mild Mental Retardation  19 6.7% 
     NOS 30 10.6% 
     Other 47 16.5% 
 
175 
Table 2 
Demographic and Clinical Characteristics of Participants according to Service 
Use During Adolescence  
 
No Service Use 
 
 
Service Use 
Demographic and Clinical Variables 
N Mean (SD) or Percentage N 
Mean (SD) 
or 
Percentage 
Age (range: 19 to 71) 145 42.55 (12.35) 163 33.77 (11.40) 
Education, # of years in school (range: 6 to 20 years)  134 12.84 (1.98) 149 11.69 (1.92) 
Length of stay at CTP in days (range:11-2545) 72 581.39 (411.34) 65 699.20 (490.81) 
Age of onset (range: 4 to 63 )  118 24.20 (9.07) 130 16.03 (5.92) 
Number of hospitalizations in lifetime (range: 0 to 105) 139 8.42 (7.47) 159 
10.81 
(11.31) 
Gender (n=317)     
     Male 94 63.1% 109 64.1% 
     Female 53 35.6% 61 35.9% 
Race/Ethnicity (n=288)     
     Caucasian 111 74.5% 127 82.5% 
     African American 15 10.1% 15 9.7% 
     Hispanic 1 0.7% 5 3.2% 
     Native American 2 1.3 2 1.3% 
     Asian American 1 0.7% 1 0.6% 
     Other 4 2.7% 4 2.6% 
Marital Status (n=272)     
     Single 75 58.6% 96 66.7% 
     Married 10 7.8% 11 7.6% 
     Divorced 34 26.6% 35 24.3% 
     Widowed 3 2.3% 1 0.7% 
     Separated 6 4.7% 1 0.7% 
Legal Status (n=280)     
     Mental Health Board Commitment (MHB) 103 69.1% 117 77.5% 
     Voluntary per guardian (VpG) 12 8.1% 22 14.6% 
     Not responsible by reason of insanity (NRRI)     11 7.4% 11 7.3% 
     Voluntary (V) 3 2.0% 1 0.7% 
Primary Axis I Diagnosis (n=282)     
     Schizophrenia, Paranoid Type 51 38.3% 26 17.4% 
     Schizophrenia, Chronic/Undifferentiated Type 23 17.3% 43 28.9% 
     Schizoaffective 35 26.3% 43 28.9% 
     Bipolar 15 11.3% 20 13.4% 
     Psychotic Disorder NOS 1 0.8% 3 2.0% 
     Dementia / Organic Brain Disease 2 1.5% 2 1.3% 
     Impulse Control Disorder 3 2.3% 3 2.0% 
     Other 3 2.3% 9 6.1% 
Axis II Diagnoses (n=284)     
     None 58 43.3% 47 31.3% 
     Borderline 4 3.0% 16 10.7% 
     Paranoid 20 14.9% 26 17.3% 
     Antisocial 4 3.0% 9 6.0% 
     Schizoid 1 0.7% 3 2.0% 
     Borderline Intellectual Functioning to Mild Mental Retardation  6 4.4% 13 8.1% 
     NOS 14 10.4% 16 10.7% 
     Other 27 20.1% 20 13.3% 
 
176 
Table 3 
Demographic and Clinical Characteristics of Participants according to APP 
Severity Level    
 
 
 
No APP 
 
 
Low APP 
 
Med APP 
 
High APP 
Demographic and Clinical 
Variables 
N 
Mean (SD)  
or 
Percentage 
N 
Mean (SD)  
or 
 Percentage 
N 
Mean (SD)  
or  
Percentage 
N 
Mean 
(SD) or 
Percentag
e 
Age (range: 19 to 71) 145 42.55  (12.35) 23 
40.04  
(10.68) 34 
33.04  
(10.23) 106 
32.64 
(11.53) 
Education, # of years in school  
(range: 6 to 20 years)  134 
12.84  
(1.98) 22 
12.23  
(1.77) 31 
11.87  
(1.82) 96 
11.51 
(1.97) 
Length of stay at CTP in days 
 (range:11-2545) 72 
581.39 
(411.34) 19 
781.68 
(633.89) 17 
698.18 
(382.86) 29 
645.76 
(448.31) 
Age of onset  
(range: 4 to 63 )  118 
24.20  
(9.07) 20 
20.20  
(6.41) 31 
17.68  
(6.91) 79 
14.33 
(4.60) 
Number of hospitalizations in 
lifetime (range: 0 to 105) 139 
8.42 
(7.47) 22 
11.00  
(7.57) 33 
7.45  
(6.32) 104 
11.83 
(12.95) 
Gender (n=317)         
     Male 94 63.1% 13 56.5% 27 77.1% 69 61.6% 
     Female 53 35.6% 10 43.5% 8 22.9% 43 38.4% 
Race/Ethnicity (n=288)         
     Caucasian 111 74.5% 18 81.8% 31 93.9% 78 78.8% 
     African American 15 10.1% 1 4.5% 1 3.0% 13 13.1% 
     Hispanic 1 0.7% 1 4.5% 1 3.0% 3 3.0% 
     Native American 2 1.3 - - - - 2 2.0% 
     Asian American 1 0.7% 1 4.5% - - - - 
     Other 4 2.7% 1 4.5% - - 3 3.0% 
Marital Status (n=272)         
     Single 75 58.6% 11 55.0% 19 61.3% 66 71.0% 
     Married 10 7.8% 1 5.0% 5 16.1% 5 5.4% 
     Divorced 34 26.6% 8 40.03% 6 19.4% 21 22.6% 
     Widowed 3 2.3% - - 1 3.2% - - 
     Separated 6 4.7% - - - - 1 1.1% 
Legal Status (n=280)         
 Mental Health Board 
Commitment (MHB) 103 69.1% 15 68.2% 22 66.7% 80 83.3% 
     Voluntary per guardian (VpG) 12 8.1% 6 27.3% 9 27.3% 7 7.3% 
Not responsible by reason of 
insanity (NRRI)     11 7.4% 1 4.5% 2 6.1% 8 8.3% 
     Voluntary (V) 3 2.0% - - - - 1 1.0% 
Primary Axis I Diagnosis (n=282)         
     Schizophrenia, Paranoid Type 51 38.3% 3 13.6% 8 25.0% 15 15.8% 
Schizophrenia,Chronic/ 
Undifferentiated Type 23 17.3% 9 40.9% 12 37.5% 22 23.2% 
     Schizoaffective 35 26.3% 10 45.5% 2 6.3% 31 32.6% 
     Bipolar 15 11.3% - - 3 9.4% 17 17.9% 
     Psychotic Disorder NOS 1 0.8% - - 1 3.1% 2 2.1% 
Dementia/Organic Brain Disease 2 1.5% - - - - 2 2.1% 
     Impulse Control Disorder 3 2.3% - - 2 5.9% 1 1.1% 
     Other 3 2.3% - - 4 12.5% 5 5.3% 
Axis II Diagnoses (n=284)         
     None 58 43.3% 7 31.8% 8 25.8% 32 33.0% 
     Borderline 4 3.0% - - 2 6.5% 14 14.4% 
     Paranoid 20 14.9% 6 27.3 9 29.0% 11 11.3% 
     Antisocial 4 3.0% 2 9.1% 1 3.2% 6 6.2% 
     Schizoid 1 0.7% - - - - 3 3.1% 
Borderline Intellectual 
Functioning – Mild Mental  
Retardation  
6 4.4% 1 4.5% 3 9.7% 9 9.3% 
     NOS 14 10.4% 2 9.1% 2 6.5% 12 12.4% 
     Other 27 20.1% 4 18.2% 6 19.3% 10 10.3% 
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Table 4 
Relationship Between Axis I Diagnosis and Service Use (N=282) 
 
  
Axis I Diagnosis No Service Service Use Total 
 
Schizophrenia, Paranoid Type 51 26 77 
 
Schizophrenia, Chronic/Undifferentiated Type 23 43 66 
 
Schizoaffective 35 43 78 
 
Other2 24 37 61 
 
Total 133 149 282 
 
                                               
2 Other includes diagnoses such as, but not limited to, the following: Bipolar Disorder, Dementia, Psychotic 
Disorder NOS, Pervasive Developmental Disorder, Impulse Control Disorder, and Asperger’s. 
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Table 5 
Relationship Between Axis II Diagnosis and Service Use (N=284) 
 
  
Axis II Diagnosis No Service 
Service 
Use Total 
 
Borderline 4 16 20 
 
Paranoid 20 26 46 
 
Antisocial 4 9 13 
 
Other4 34 36 70 
NOS 14 16 30 
No Axis II diagnosis (None) 58 47 105 
 
Total 134 150 284 
                                               
4 Other includes diagnoses such as, but not limited to, the following: Histrionic Personality Disorder, 
Schizoid, and Borderline Intellectual Functioning. 
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Table 6 
Relationship Between Race and Service Use (N=288) 
 
                                                        
Race No Service Service Use Total 
 
Caucasian 111 127 238 
 
Non-white 23 27 50 
 
Total 134 154 288 
 
 
Table 7 
Relationship Between Marital Status and Service Use (N=272) 
 
                                                        
Marital Status No Service Service Use Total 
 
Single 75 96 171 
Married 10 11 21 
Divorced 34 35 69 
Widowed 3 1 4 
 
Separated 6 1 7 
 
Total 128 144 272 
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Table 8 
Mean Scores and Standard Deviations for Demographic and Clinical Variables as a 
Function of Service Use 
 
 No Service Service Use 
 M SD M SD 
Age* 42.55 12.35 33.77 11.38 
Length of Stay 581.39 411.34 699.20 490.81 
Years of Education* 12.84 1.98 11.69 1.92 
Age of Onset* 24.20 9.07 16.03 5.92 
Number of Previous 
Hospitalizations* 8.42 7.47 10.81 11.31 
   * P<.05 
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Table 9 
Bivariate Correlations for Neurocognitive Variables  
 1a 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 - RAVLT Trial 
5 
-              
2 – NAB Total .74 
 
-   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
3 - COGLAB 
Total Correct 
.10 
 
-a -            
4 - Card Sort 
Random Errors 
-.41 
** 
-.15 
 
-.41 
** 
-           
5 - Card Sort 
Perseverative 
Errors 
-.36 
** 
-.05 
 
-.43 
** 
.58 
** 
-          
6 – Card Sort 
Consolidation 
Index 
.23 -1.0 
** 
-.10 -.13 .12 -         
7 - RCFT Copy 1.0 
** 
.24 a -.30 
* 
-.03 .53 -        
8 - RCFT 
Immediate 
Memory 
1.0 
**. 
.55 
** 
a -.53 
** 
-.42 
** 
-.26 
 
.38 
** 
-       
9 - RCFT 
Delayed 
Memory 
. 1.0 
** 
.66 
** 
a -.48 
** 
-.40 
** 
-.16 
 
.41 
** 
.95 
** 
-      
10 - RCFT 
Recognition 
-1.0 
** 
.36 a -.29 
* 
-.17 -.45 -.05 
 
.48 
** 
.50 
** 
-     
11 - Trails A .10 -.54 
** 
a .22 
 
.29 
* 
-.25 .01 -.23 
* 
-.30 
* 
-.06 -    
12 -Trails B -.45 
 
-.61 a .33 
** 
.32 
* 
 
.20 -.14 
 
-.32 
** 
-.38 
** 
-.03 
 
.54 
** 
-   
13 – 
COWAT/FAS 
-.56 
 
.56 
** 
a -.38 
** 
-.23 -.17 .35 
** 
.37 
** 
.34 
** 
.08 -.32 
** 
-.27 
** 
-  
14 - RBANS 
Total 
.30 .53 
* 
a -.31 
* 
-.22 .06 
 
.48 
** 
.52 
** 
.55 
** 
.25 
* 
-.15 
 
-.29 
** 
.41 
** 
- 
 
a Note: The RAVLT was phased out of regular use at CTP when the Rey Complex Figure Test and RBANS battery 
were added.  As can be seen here, there were no participants with assessments from both time periods from which to 
compute correlations. 
** Correlation is significant at the 0.01 level (1-tailed). 
* Correlation is significant at the 0.05 level (1-tailed).  
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Table10 
Service Use by Neurocognitive Variables  at Admission 
 One-Way Analyses of Variance (ANOVAs) 
 
 
Univariate  
Neurocognitive Variables M(SD) F df p 
RAVLT  
     No Service 
     Service Use 
 
8.07 (3.73) 
8.47 (3.30) 
.18 1, 55 .68 
NAB Total  
     No Service 
     Service Use 
82.10 (17.06) 
79.08 (18.00) 
.53 1, 76 .47 
WCST Correct 
    No Service 
    Service Use 
 
24.63 (2.01) 
24.75 (1.02) 
.09 1, 60 .77 
WCST Perseverative Errors  
   No Service 
   Service Use 
 
22.13 (13.01) 
20.51 (12.26) 
.44 1, 106 .51 
WCST Random Errors  
   No Service 
   Service Use 
 
23.58 (16.65) 
22.85 (18.27) 
.05 1, 106 .83 
WCST Consolidation Index  
   No Service 
   Service Use 
3.46 (4.64) 
2.57 (4.31) 
.61 1, 60 .44 
RCFT Copy  
   No Service 
   Service Use  
29.03 (7.21) 
29.33 (6.00) 
.04 1, 71 .84 
RCFT Immediate Memory  
   No Service 
   Service Use 
12.76 (7.09) 
14.32 (9.60) 
.63 1, 71 .43 
RCFT Delayed Memory  
   No Service 
   Service Use 
12.68 (6.68) 
13.80 (9.55) 
.34 1, 71 .56 
RCFT Recognition  
   No Service 
   Service Use 
20.54 (6.16) 
18.17 (4.87) 
3.33 1, 71 .07 
Trails A  
   No Service 
   Service Use 
41.71 (14.59) 
42.99 (25.71) 
.11 1, 114 .74 
Trails B  
   No Service 
   Service Use 
105.14 (47.61) 
125.24 (81.07) 
2.65 1, 114 .11 
COWAT/FAS  
   No Service 
   Service Use 
30.97 (11.19) 
29.32 (10.57) 
.66 1, 113 .42 
RBANS Total  
   No Service 
   Service Use 
75.50 (16.89) 
69.74 (14.06) 
3.13 1, 92 .08 
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Table 11 
APP Severity Level by Neurocognitive Variables  at Admission 
 One-Way Analyses of Variance (ANOVAs) 
 
 Univariate 
Neurocognitive Variables M(SD) F df p 
RAVLT  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
8.07 (3.73) 
8.71 (4.07) 
9.57 (2.76) 
7.88 (3.22) 
.45 3, 53 .72 
NAB Total  
     No APP 
     Low APP 
     Med APP 
     High APP 
82.10 (17.06) 
70.00 (13.11) 
87.25 (18.66) 
78.95 (18.25) 
.73 3, 74 .54 
WCST Correct  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
24.63 (2.01) 
25.00 (0.00) 
25.00 (0.00) 
24.50 (1.41) 
.29 3, 58 .83 
WCST Perseverative Errors  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
22.13 (13.01) 
21.50 (11.02) 
17.25 (14.87) 
21.45 (11.68) 
.49 3, 104 .69 
WCST Random Errors  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
23.58 (16.65) 
23.88 (7.79) 
13.25 (11.23) 
26.09 (20.98) 
1.66 3, 104 .18 
WCST Consolidation Index  
     No APP 
     Low APP 
     Med APP 
     High APP 
3.46 (4.64) 
1.31 (1.23) 
4.50 (6.58) 
2.03 (3.38) 
1.04 3, 58 .38 
RCFT Copy  
     No APP 
     Low APP 
     Med APP 
     High APP 
29.03 (7.21) 
30.07 (3.40) 
28.06 (8.38) 
29.57 (5.84) 
.15 3, 69 .93 
RCFT Immediate Memory  
     No APP 
     Low APP 
     Med APP 
     High APP 
12.76 (7.09) 
14.21 (4.72) 
18.56 (16.09) 
12.74 (7.36) 
1.15 3, 69 .34 
RCFT Delayed Memory  
   No APP 
     Low APP 
     Med APP 
     High APP 
 
12.68 (6.68) 
12.14 (4.72) 
17.56 (16.10) 
12.91 (7.39) 
 
 
.85 
 
 
3, 69 
 
 
.47 
RCFT Recognition  
     No APP 
20.54 (6.16) 
18.14 (3.08) 2.18 3, 69 .10 
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     Low APP 
     Med APP 
     High APP 
21.13 (8.11) 
17.05 (3.28) 
Trails A  
     No APP 
     Low APP 
     Med APP 
     High APP 
41.71 (14.59) 
52.25 (25.14) 
35.08 (15.67) 
45.71 (30.05) 
1.72 3, 112 .17 
Trails B  
     No APP 
     Low APP 
     Med APP 
     High APP 
105.14 (47.61) 
122.75 (80.44) 
111.21 (70.12) 
134.48 (88.39) 
1.36 3, 112 .26 
COWAT/FAS  
     No APP 
     Low APP 
     Med APP 
     High APP 
30.97 (11.19) 
28.11 (9.61) 
30.67 (12.93) 
28.87 (9.50) 
.36 3, 111 .78 
RBANS Total  
     No APP 
     Low APP 
     Med APP 
     High APP 
75.50 (16.89) 
75.00 (15.04) 
70.91 (14.80) 
67.35 (13.43) 
1.53 3, 90 .21 
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Table 12 
Bivariate Correlations for Socialcognitive Variables  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 - Hinting 
Task  
-                 
2 – FKK 
Internal  
 
-.03 
 
-   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
3 - FKK Self 
Concept  
 
.06 
 
.28 
* 
-               
4 - FKK Self 
Efficacy  
 
..01 
 
.86 
** 
 
.73 
** 
-              
5 - FKK 
Powerful 
Others  
 
.09 
 
.07 
 
-.11 
 
-.01 
 
-             
6 – FKK 
Chance  
 
-.01 .09 
 
-.45 
** 
-.21 .66 
** 
-            
7 - FKK 
Externality  
 
.05 
 
.08 -.33 
** 
-.12 .92 
** 
.91 
** 
-           
8 - IPSAQ 
Internal 
Positive  
 
-.00 
 
.25 
* 
.25 
* 
.31 
* 
.09 
 
.02 
 
.06 
 
-          
9 - IPSAQ 
Personal 
Positive  
 
. 
.26 
* 
-.15 
 
-.12 -.17 
 
.15 
 
.22 
 
.20 
 
-.13 
 
-         
10 - IPSAQ 
Situational 
Positive  
 
.19 
 
.22 .19 .26 
* 
 
.08 -.05 
* 
.02 
 
-.39 
** 
-.30 
* 
-        
11 - IPSAQ 
Internal 
Negative  
 
-.03 .10 
 
-.18 -.03 
 
.05 .24 
* 
.16 .48 
** 
.09 
 
-.22 -       
12 - IPSAQ 
Personal 
Negative  
 
.30 
* 
.004 .30 
* 
.17 
 
-.09 
 
-.17 -.14 
 
.16 
 
.41 
** 
-.09 
 
-.37 
** 
-      
13 – IPSAQ 
Situational 
Negative  
 
.02 
 
.31 
* 
.23 .34 
** 
.32 
* 
.07 .21 
 
-.03 
 
-.22 
 
.56 
** 
-.35 
** 
-.24 
 
-     
14 - CST 
Social 
Support 
Seeking  
  
.03 
 
-.03 
 
 
-.11 
 
-.08 
 
 
-.18 
 
-.12 
 
-.17 
 
.06 
 
 
.19 
 
 
-.10 .18 
 
-.12 
 
 
-.01 
 
- 
 
   
 
15 - CST 
Self-
Controlling  
 
.04 .05 .41 
** 
.26 
* 
.01 -.22 -.12 .26 
* 
-.01 -.12 -.07 .13 .15 -.11 - 
 
  
16 - CST 
Escape 
Avoidance  
 
.16 .08 .28 
* 
.20 -.39 
** 
-.47 
** 
-.47 
** 
-.21 .05 .14 -.16 .10 .03 .10 .37 
** 
- 
 
 
17 - CST 
Planful 
Problem 
Solving  
 
-.01 .09 .40 
** 
.28 
* 
-.13 -.45 
** 
-.31 
* 
.02 .12 .15 -.23 .16 .31 
* 
.34 
* 
.43 
** 
.30 
* 
- 
 
 
** Correlation is significant at the 0.01 level (1-tailed). 
* Correlation is significant at the 0.05 level (1-tailed).  
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 Table 13 
Service Use by Theory of Mind, Social Cognition  at Admission One-Way Analyses of Variance (ANOVAs) 
 
 M(SD) F df p 
Theory of Mind Measure     
Hinting Task  
    No Service 
    Service Use 
 
15.12 (3.32) 
14.36 (3.81) 
1.06 1, 92 .31 
Socialcognition Measures      
FKK Internal  
   No Service 
   Service Use 
34.41 (7.18) 
34.00 (5.33) 
.04 1, 43 .84 
FKK Self Concept  
   No Service 
   Service Use 
33.56 (4.71) 
32.94 (5.16) 
.17 1, 43 .68 
FKK Self Efficacy  
   No Service 
   Service Use 
67.96 (9.95) 
66.94 (7.80) 
.13 1, 43 .72 
FKK Powerful Others  
   No Service 
   Service Use 
25.96 (8.80) 
24.78 (6.51) 
.24 1, 43 .63 
FKK Chance  
   No Service 
   Service Use 
23.48 (7.20) 
25.17 (7.80) 
.55 1, 43 .46 
FKK Externality  
   No Service 
   Service Use 
 
49.44 (15.53) 
49.94 (11.60) 
.01 1, 43 .91 
IPSAQ Internal Positive  
   No Service 
   Service Use 
8.19 (3.50) 
7.89 (2.78) 
.09 1, 43 .77 
IPSAQ Personal Positive  
   No Service 
   Service Use 
3.52 (2.39) 
3.56 (1.92) 
.00 1, 43 .96 
IPSAQ Situational Positive  
   No Service 
   Service Use 
3.26 (2.35) 
3.78 (2.90) 
.44 1, 43 .51 
IPSAQ Internal Negative  
   No Service 
   Service Use 
5.89 (3.77) 
5.89 (2.93) 
.00 1, 43 1.0 
IPSAQ Personal Negative  
   No Service 
   Service Use 
4.89 (3.48) 
4.89 (2.83) 
.00 1, 43 1.0 
IPSAQ Situational Negative  
   No Service 
   Service Use 
4.07 (2.80) 
4.50 (3.13) 
.23 1, 43 .64 
CST Social Support Seeking  
   No Service 
   Service Use 
35.58 (9.99) 
36.61 (10.03) 
.11 1, 42 .74 
CST Self-Controlling  
   No Service 
   Service Use 
52.65 (6.97) 
48.44 (10.44) 
2.58 1, 42 .12 
CST Escape Avoidance  
   No Service 
   Service Use 
37.12 (6.73) 
35.44 (4.53) 
.84 1, 42 .36 
CST Planful Problem Solving  
   No Service 
   Service Use 
42.08 (8.85) 
41.89 (10.02) 
.00 1, 42 .95 
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Table 14 
APP Level by Theory of Mind and Social Cognitive Functioning at Admission  
One-Way Analyses of Variance (ANOVAs)  
 M(SD) F df p 
Theory of Mind Measure     
Hinting Task  
    No APP 
     Low APP 
     Med APP 
     High APP 
 
15.12 (3.32) 
13.71 (1.98) 
15.00 (3.46) 
14.31 (3.55) 
0.52 3, 90 .67 
Socialcognition Measures      
FKK Internal  
     No APP 
     Low APP 
     Med APP 
     High APP 
34.41 (7.18) 
34.43 (5.56) 
34.67 (5.75) 
32.60 (5.41) 
.12 3, 41 .95 
FKK Self Concept  
     No APP 
     Low APP 
     Med APP 
     High APP 
33.56 (4.71) 
32.71 (5.19) 
33.17 (5.95) 
33.00 (5.34) 
.06 3, 41 .98 
FKK Self Efficacy  
     No APP 
     Low APP 
     Med APP 
     High APP 
67.96 (9.95) 
67.14 (7.71) 
67.83 (9.66) 
65.60 (6.99) 
.10 3, 41 .96 
FKK Powerful Others  
     No APP 
     Low APP 
     Med APP 
     High APP 
25.96 (8.80) 
25.71 (4.54) 
25.17 (8.31) 
23.00 (7.58) 
.19 3, 41 .90 
FKK Chance  
     No APP 
     Low APP 
     Med APP 
     High APP 
23.48 (7.20) 
24.29 (8.32) 
26.00 (9.59) 
25.40 (6.11) 
.23 3, 41 .87 
FKK Externality  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
49.44 (15.53) 
50.00 (10.61) 
51.17 (16.51) 
48.40 (7.57) 
.04 3, 41 .99 
IPSAQ Internal Positive  
     No APP 
     Low APP 
     Med APP 
     High APP 
8.19 (3.50) 
9.00 (3.32) 
6.83 (2.64) 
7.60 (1.95) 
.53 3, 41 .67 
IPSAQ Personal Positive  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
3.52 (2.39) 
2.71 (2.22) 
4.50 (2.07) 
3.60 (0.55) 
 
 
.70 
 
 
3, 41 
 
 
.56 
IPSAQ Situational Positive  
     No APP 
     Low APP 
     Med APP 
     High APP 
3.26 (2.35) 
3.29 (2.43) 
3.67 (4.27) 
4.60 (1.67) 
.39 3, 41 .76 
IPSAQ Internal Negative  
     No APP 
     Low APP 
     Med APP 
     High APP 
5.89 (3.77) 
6.00 (3.37) 
5.67 (3.33) 
6.00 (2.35) 
.01 3, 41 1.0 
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IPSAQ Personal Negative  
     No APP 
     Low APP 
     Med APP 
     High APP 
4.89 (3.48) 
4.29 (3.04) 
4.50 (3.27) 
6.20 (1.92) 
.38 3, 41 .77 
IPSAQ Situational Negative  
     No APP 
     Low APP 
     Med APP 
     High APP 
4.07 (2.80) 
4.43 (4.35) 
5.17 (2.71) 
3.80 (1.64) 
.27 3, 41 .85 
CST Social Support Seeking  
     No APP 
     Low APP 
     Med APP 
     High APP 
35.58 (9.99) 
37.29 (8.40) 
37.17 (13.17) 
35.00 ( 10.03) 
.09 3, 40 .96 
CST Self-Controlling  
     No APP 
     Low APP 
     Med APP 
     High APP 
52.65 (6.97) 
51.00 (5.60) 
51.17 (6.08) 
41.60 (16.99) 
2.49 3, 40 .07 
CST Escape Avoidance  
     No APP 
     Low APP 
     Med APP 
     High APP 
37.12 (6.73) 
34.86 (2.19) 
36.50 (5.58) 
35.00 (6.21) 
.36 3, 40 .78 
CST Planful Problem Solving  
     No APP 
     Low APP 
     Med APP 
     High APP 
42.08 (8.85) 
40.57 (3.99) 
45.67 (14.50) 
39.20 (10.31) 
.51 3, 40 .68 
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Table 15 
Bivariate Correlations for Insight Variables  
 
1 2 3 4 5 6 7 
1- Total Insight -       
2 - Ability to relabel                    
psychotic experiences 
.73 
** 
-      
3 - Awareness of Illness .89 
** 
.45 
** 
-     
4 - Need for Treatment .83 
** 
.39 
** 
.72 
** 
-    
5 - SAIQ Need for Treatment .80 
** 
.76 
** 
.76 
** 
.57 
** 
-   
6 - SAIQ Worry -.80 
** 
-.77 
** 
-.77 
** 
-.57 
** 
-.95 
** 
-  
7 - SAIQ Presence/Outcome of 
Illness 
-.80 
** 
-.77 
** 
-.77 
** 
-.58 
** 
-.98 
** 
.95 
** 
- 
      ** Correlation is significant at the 0.01 level (1-tailed). 
      *  Correlation is significant at the 0.05 level (1-tailed). 
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Table 16 
Service Use by Insight Measures at Admission One-Way Analyses of Variance (ANOVAs) 
 
Insight Measures M(SD) F df p 
IS Relabel Symptoms Scale  
   No Service 
   Service Use 
2.46 (1.11) 
2.42 (1.15) 
.05 1, 107 .82 
IS Awareness of Illness Scale  
   No Service 
   Service Use 
 
2.34 (1.37) 
2.25 (1.28) 
.14 1, 107 .71 
IS Need for Treatment Scale  
   No Service 
   Service Use 
2.37 (1.17) 
2.27 (1.19) 
.17 1, 107 .68 
IS Total Score  
   No Service 
   Service Use 
7.17 (3.11) 
6.86 (2.91) 
.29 1, 107 .59 
SAIQ Need for Treatment  
   No Service 
   Service Use 
6.10 (6.67) 
1.71 (4.54) 
2.27 1, 15 .15 
SAIQ Worry  
   No Service 
   Service Use 
 
26.90 (8.63) 
31.71 (8.69) 
1.27 1, 15 .28 
SAIQ Presence/Outcome of Illness  
   No Service 
   Service Use 
12.20 (3.05) 
14.29 (1.89) 
2.56 1, 15 .13 
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Table 17 
APP Level by Insight Measures at Admission One-Way Analyses of Variance (ANOVAs) 
 
Insight Measures M(SD) F df p 
IS Relabel Symptoms Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
2.46 (1.11) 
2.44 (1.60) 
1.80 (.92) 
2.59 (1.05) 
1.29 3, 105 .28 
IS Awareness of Illness Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
2.34 (1.37) 
2.67 (1.32) 
1.60 (1.26) 
2.32 (1.25) 
1.19 3, 105 .32 
IS Need for Treatment Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
2.37 (1.17) 
2.72 (.97) 
1.75 (.79) 
2.31 (1.30) 
1.17 3, 105 .32 
IS Total Score  
     No APP 
     Low APP 
     Med APP 
     High APP 
7.17 (3.11) 
7.83 (3.30) 
5.15 (1.76) 
7.10 (2.94) 
1.59 3, 105 .20 
SAIQ Need for Treatment  
     No APP 
     Low APP 
     Med APP 
     High APP 
6.10 (6.67) 
6.00 (8.49) 
0.00 (0) 
0.00 (0) 
1.20 3, 13 .35 
SAIQ Worry  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
26.90 (8.63) 
23.50 (16.26) 
35.00 (0.0) 
35.00 (0.0) 
1.32 3, 13 .31 
SAIQ Presence/Outcome of Illness  
     No APP 
     Low APP 
     Med APP 
     High APP 
12.20 (3.05) 
12.50 (3.54) 
15.00 (0.0) 
15.00 (0.0) 
1.21 3, 13 .35 
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Table 18 
Bivariate Correlations of NOSIE subscales  
 
1 2 3 4 5 6 7 
1 – NOSIE Daily Schedule  
Competence -       
2 – NOSIE Social Interest .46** -      
3 – NOSIE Neatness .79 ** .50** -     
4 – NOSIE Irritability -.65** -.29** -.49** -    
5 – NOSIE Psychoticism -.51** -.24** -.39** .50** -   
6 – NOSIE Motor Retardation -.73** -.52** -.68** .25** .21* -  
7 – NOSIE Total .88** .67** .84** -.69** -.54** -.74** - 
** Correlation is significant at the 0.01 level (2-tailed). 
  * Correlation is significant at the 0.05 level (2-tailed). 
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Table 19 
Service Use by NOSIE scales scores at Admission One-Way Analyses of Variance 
(ANOVAs) 
 
NOSIE Subscales M (SD) F df p 
Daily Schedule Competence      
   No Service 33.57 (6.81) 
   Service Use 31.84 (6.72) 1.98 1, 119 .16 
Social Interest      
   No Service 15.66 (6.45) 
   Service Use 15.53 (6.92) .01 1, 119 .92 
Neatness      
   No Service 23.77 (5.50) 
   Service Use 22.50 (5.77) 1.54 1, 119 .22 
Irritability      
   No Service 4.00 (5.10) 
   Service Use 5.48 (6.52) 1.95 1, 119 .17 
Psychoticism      
   No Service 1.41 (2.66) 
   Service Use 1.66 (2.61) .28 1, 119 .60 
Motor Retardation      
   No Service 5.93 (4.13) 1.29 1, 119 .26 
   Service Use 6.82 (4.53)    
NOSIE Total Score      
   No Service 157. 68 (24.13) 
   Service Use 150.50 (26.26) 
2.46 
 
1, 119 
 
.12 
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Table 20 
APP Level by NOSIE scale scores at Admission One-Way Analyses of Variance 
(ANOVAs) 
 
NOSIE Subscales M (SD) F df p 
Daily Schedule Competence      
     No APP 33.57 (6.81) 
     Low APP 31.79 (8.59) 
     Med APP 30.96 (5.96) 
     High APP 32.50 (5.89) 
.82 3, 117 .49 
Social Interest      
     No APP 15.66 (6.45) 
     Low APP 14.72 (6.92) 
     Med APP 14.97 (6.79) 
     High APP 16.49 (7.18) 
.29 3, 117 .83 
Neatness      
     No APP 23.77 (5.50) 
     Low APP 21.60 (6.67) 
     Med APP 20.73 (5.23) 
     High APP 24.40 (5.08) 
2.18 3, 117 .09 
Irritability      
     No APP 4.00 (5.10) 
     Low APP 5.67 (7.15) 
     Med APP 4.00 (5.09) 
     High APP 6.38 (7.01) 
1.21 3, 117 .31 
Psychoticism      
     No APP 1.41 (2.66) 
     Low APP 1.57 (2.40) 
     Med APP 1.84 (3.48) 
     High APP 1.60 (2.12) 
.13 3, 117 .94 
Motor Retardation      
     No APP 5.93 (4.13) 
     Low APP 7.61 (5.84) 
     Med APP 8.42 (4.40) 
     High APP 5.14 (2.90) 
2.70 
 
3, 117 
 
.05 
 
NOSIE Total Score      
     No APP 157. 68 (24.13) 
     Low APP 144.50 (32.32) 
     Med APP 148.40 (21.92) 
     High APP 156.24 (24.17) 
1.60 
 
3, 117 
 
.19 
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Table 21 
Bivariate Correlations of BPRS Total Scores, BPRS Factor Scores, and Symptomatology 
Measures  
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. BPRS Total 
-              
22   2. Psychotic        
Disorganization .75 ** -             
  3. 
Hallucinations/ 
         Delusions 
.75 
** 
.53*
* -            
4. Paranoia .75 
** 
.48*
* 
.52 
** -           
5. Emotional 
Blunting .19 * .07 -.04 -.05 -          
6.Anxiety/ 
Depression .56 ** .12 
.24 
** 
.40 
** -.05 -         
7. Agitation/ 
Elation .44 
** 
.32*
* 
.29 
** 
.27 
** 
-.33 
** 
.35 
** -        
8. BHS Total .32 
** .07 .14 .18 
.25 
* 
.35 
** -.13 -       
9. BDI-II Total .26 
* .15 .13 .09 .20 
.28 
* -.16 
.70 
** -      
10. SPS Total .46 
** .26* 
.30 
* 
.28 
* .21 
.29 
* .15 
.59 
** 
.62 
** -     
11. SPS  
Hopelessness 
Scale 
.37 
** .15 
.26 
* .21 .17 
.30 
* .02 
.43 
** 
.63 
** 
.80 
** -    
12. SPS  
Suicidality 
Scale 
.40 
** .27* .23 .19 .19 
.25 
* .08 
.32 
** 
.55 
** 
.66 
** 
.74 
** -   
13. SPS 
Negative Self-
Evaluation 
Scale 
.11 .14 .10 .08 .08 -.02 -.09 .37 ** 
.27 
** 
.50 
** 
.38 
** 
.49 
** -  
14. SPS 
Hostility Scale  .21 .08 .12 .03 .19 .16 .13 .36 ** 
.48 
** 
.64 
** 
.71 
** 
.60 
** 
.42 
** - 
 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
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Table 22 
Service Use by BPRS Factor Scores, BPRS Total, and Symptomatology Measures at Admission  
One-Way Analyses of Variance (ANOVAs) 
 M (SD) F df p 
BPRS Total  
     No Service 
     Service Use 
 
47.60 (12.15) 
48.29 (14.62) 
.10 1, 154 .75 
BPRS Factor Scores     
Psychotic Disorganization  
     No Service 
     Service Use 
6.35 (2.76) 
6.84 (3.37) 
.99 1, 154 .32 
Emotional Blunting  
     No Service 
     Service Use 
 
5.96 (3.65) 
6.07 (3.29) 
.04 1, 155 .85 
Paranoia  
     No Service 
     Service Use 
 
9.00 (3.21) 
8.14 (3.36) 
2.65 1, 155 .11 
Anxiety/Depression  
     No Service 
     Service Use 
 
9.03 (3.46) 
9.90 (4.12) 
2.03 1, 155 .16 
Hallucinations/Delusions  
     No Service 
     Service Use 
6.71 (4.08) 
6.39 (4.17) 
.23 1, 155 .63 
Agitation/Elation  
     No Service 
     Service Use 
3.49 (1.55) 
3.82 (1.79) 
1.51 1, 155 .22 
BHS Total  
     No Service 
     Service Use 
4.24 (4.55) 
5.58 (5.19) 
 
2.22 
 
1, 118 .14 
BDI-II Total  
     No Service 
     Service Use 
9.33 (10.10) 
12.96 (13.82) 
 
2.20 
 
1, 99 
 
.14 
SPS Total  
     No Service 
     Service Use 
56.02 (10.19) 
61.02 (10.22) 
 
7.41 
 
1, 122 
 
.01 
SPS Hopelessness Scale  
     No Service 
     Service Use 
53.33 (10.42) 
57.48 (13.09) 
 
3.76 
 
 
1, 122 
 
 
.05 
 
SPS Suicidality Scale  
     No Service 
     Service Use 
51.41 (8.74) 
54.35 (13.65) 
 
1.97 
 
1, 122 .16 
SPS Negative Self-Evaluation Scale 
     No Service 
     Service Use 
 
59.48 (9.79) 
58.60 (12.56) 
 
 
.19 
 
 
1, 121 
 
 
.67 
SPS Hostility Scale  
     No Service 
     Service Use 
52.81 (10.57) 
56.88 (13.81) 
3.30 1, 121 .07 
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Table 23 
APP Level by BPRS Factor Scores, BPRS Total, and Symptomatology Measures at 
Admission One-Way Analyses of Variance (ANOVAs) 
 M (SD) F df p 
BPRS Total  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
47.60 (12.15) 
45.96 (11.94) 
46.91 (14.91) 
49.34 (15.28) 
.32 3, 152 .81 
BPRS Factor Scores     
Psychotic Disorganization  
     No APP 
     Low APP 
     Med APP 
     High APP 
6.35 (2.76) 
6.70 (3.59) 
6.52 (2.94) 
6.98 (3.51) 
.43 3, 152 .73 
Emotional Blunting  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
5.97 (3.65) 
6.92 (2.71) 
5.47 (2.76) 
6.06 (3.58) 
.44 3, 153 .72 
Paranoia  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
9.00 (3.21) 
7.58 (3.83) 
8.14 (3.52) 
8.28 (3.24) 
1.03 3, 153 .38 
Anxiety/Depression  
     No APP 
     Low APP 
     Med APP 
     High APP 
 
9.03 (3.46) 
8.42 (2.95) 
9.94 (4.64) 
10.25 (4.18) 
1.48 3, 153 .22 
Hallucinations/Delusions  
     No APP 
     Low APP 
     Med APP 
     High APP 
6.71 (4.08) 
6.15 (3.48) 
5.97 (3.53) 
6.59 (4.56) 
.19 3, 153 .91 
Agitation/Elation  
     No APP 
     Low APP 
     Med APP 
     High APP 
3.49 (1.55) 
3.23 (1.20) 
4.15 (1.89) 
3.86 (1.88) 
1.26 3, 153 .29 
BHS Total  
     No APP 
     Low APP 
     Med APP 
     High APP 
4.24 (4.55) 
5.69 (6.20) 
7.38 (3.93) 
4.98 (5.18) 
 
1.54 
 
3, 116 .21 
BDI-II Total  
     No APP 
     Low APP 
     Med APP 
 
9.33 (10.10) 
11.71 (14.84) 
18.91 (15.75) 
 
1.84 
 
3, 97 
 
.14 
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     High APP 11.37 (12.43) 
SPS Total  
     No APP 
     Low APP 
     Med APP 
     High APP 
56.02 (10.19) 
58.43 (11.32) 
64.50 (8.40) 
60.68 (10.31) 
 
3.34 
 
3, 120 
 
.02 
SPS Hopelessness Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
53.33 (10.42) 
56.71 (13.63) 
60.29 (12.95) 
56.74 (13.16) 
 
1.57 
 
 
3, 120 
 
 
.20 
 
SPS Suicidality Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
51.41 (8.74) 
54.64 (10.95) 
54.00 (15.51) 
54.37 (14.17) 
 
.65 
 
3, 120 .58 
SPS Negative Self-Evaluation 
Scale 
     No APP 
     Low APP 
     Med APP 
     High APP  
 
 
59.48 (9.79) 
58.14 (9.67) 
57.00 (15.58) 
59.32 (12.64) 
 
 
.20 
 
 
3, 119 
 
 
.89 
SPS Hostility Scale  
     No APP 
     Low APP 
     Med APP 
     High APP 
52.81 (10.57) 
57.71 (10.77) 
59.92 (16.73) 
55.53 (13.89) 
1.53 3, 119 .21 
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Table 24 
Service Use by BPRS Items at admission One-Way Analyses of Variance (ANOVAs) 
BPRS Items M (SD) F df p 
Somatic Concern No Service 
Service Use 
2.50 (1.63) 
2.36 (1.57) 
.30 1, 156 .59 
Anxiety No Service 
Service Use 
2.63 (1.40) 
2.72 (1.62) 
.14 1, 156 .71 
Depression No Service 
Service Use 
2.19 (1.19) 
2.52 (1.53) 
2.19 1, 156 .14 
Suicidality No Service 
Service Use 
1.23 (0.62) 
1.79 (1.37) 
10.36 1, 156 .002* 
Guilt No Service 
Service Use 
1.84 (1.24) 
2.19 (1.37) 
2.85 1, 156 .09 
Hostility No Service 
Service Use 
2.53 (1.59) 
2.70 (1.74) 
.42 1, 156 .52 
Elevated Mood No Service 
Service Use 
1.51 (0.96) 
1.61 (1.25) 
.32 1, 156 .57 
Grandiosity No Service 
Service Use 
2.13 (1.82) 
1.63 (1.52) 
3.54 1, 156 .06 
Suspiciousness No Service 
Service Use 
2.77 (1.80) 
2.33 (1.58) 
2.63 1, 156 .11 
Hallucinations No Service 
Service Use 
1.87 (1.55) 
2.41 (1.97) 
3.66 1, 156 .06 
Unusual Thought Content No Service 
Service Use 
2.71 (1.99) 
2.35 (1.96) 
1.29 1,156 .23 
Bizarre Behavior No Service 
Service Use 
1.93 (1.49) 
2.25 (1.61) 
1.60 1, 156 .21 
Self-Neglect No Service 
Service Use 
2.05 (0.94) 
2.39 (1.24) 
3.55 1, 156 .06 
Disorientation No Service 
Service Use 
1.33 (0.70) 
1.45 (0.90) 
.92 1, 155 .34 
Conceptual Disorganization No Service 
Service Use 
2.06 (1.40) 
1.88 (1.43) 
.65 1, 155 .42 
Blunted Affect No Service 
Service Use 
2.54 (1.48) 
2.59 (1.30) 
.04 1, 155 .84 
Emotional Withdrawal No Service 
Service Use 
2.25 (1.41) 
2.18 (1.21) 
.11 1, 155 .74 
Motor Retardation No Service 
Service Use 
2.00 (1.17) 
2.01 (1.19) 
.01 1, 155 .94 
Tension No Service 
Service Use 
1.75 (1.16) 
1.55 (0.85) 
1.53 1, 155 .22 
Uncooperativeness No Service 
Service Use 
1.83 (1.23) 
1.49 (0.91) 
3.91 1, 155 .05* 
Excitement No Service 
Service Use 
1.63 (1.12) 
1.40 (0.93) 
1.99 1, 155 .16 
Distractibility No Service 
Service Use 
1.78 (1.15) 
1.93 (1.33) 
.54 1, 155 .46 
Motor hyperactivity No Service 
Service Use 
1.37 (0.88) 
1.30 (0.73) 
.23 1, 155 .63 
Mannerisms and Posturing No Service 
Service Use 
1.17 (0.55) 
1.20 (0.58) 
.11 1, 155 .74 
*p<.05  
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Table 25 
APP Severity Level by BPRS Items at admission One-Way Analyses of Variance 
(ANOVAs) 
 
BPRS Items M (SD) F df p 
Somatic Concern No APP 
Low APP 
Med APP 
High APP 
2.50 (1.63) 
1.77 (0.93) 
2.12 (1.55) 
2.58 (1.67) 
1.18 3, 154 .32 
Anxiety No APP 
Low APP 
Med APP 
High APP 
2.63 (1.40) 
2.19 (1.15) 
2.74 (2.06) 
2.84 (1.56) 
.68 3, 154 .57 
Depression No APP 
Low APP 
Med APP 
High APP 
2.19 (1.19) 
2.35 (1.55) 
2.38 (1.57) 
2.60 (1.54) 
.91 3, 154 .44 
Suicidality No APP 
Low APP 
Med APP 
High APP 
1.23 (0.62) 
1.15 (0.56) 
1.94 (1.35) 
1.90 (1.49) 
5.34 3, 154 .002* 
Guilt No APP 
Low APP 
Med APP 
High APP 
1.84 (1.24) 
1.77 (1.09) 
2.29 (1.56) 
2.26 (1.37) 
1.49 3, 154 .22 
Hostility No APP 
Low APP 
Med APP 
High APP 
2.53 (1.59) 
2.00 (1.29) 
2.68 (1.88) 
2.88 (1.77) 
1.11 3, 154 .35 
Elevated Mood No APP 
Low APP 
Med APP 
High APP 
1.51 (0.96) 
1.35 (0.75) 
1.76 (1.47) 
1.62 (1.29) 
.45 3, 154 .72 
Grandiosity No APP 
Low APP 
Med APP 
High APP 
2.13 (1.82) 
1.54 (1.39) 
1.65 (1.69) 
1.65 (1.52) 
1.18 3, 154 .32 
Suspiciousness No APP 
Low APP 
Med APP 
High APP 
2.77 (1.80) 
2.42 (1.66) 
2.24 (1.52) 
2.34 (1.61) 
.90 3, 154 .45 
Hallucinations No APP 
Low APP 
Med APP 
High APP 
1.87 (1.55) 
1.92 (1.80) 
2.29 (1.90) 
2.57 (2.05) 
1.70 3, 154 .17 
Unusual Thought Content No APP 
Low APP 
Med APP 
High APP 
2.71 (1.99) 
2.69 (1.97) 
2.03 (2.04) 
2.37 (1.96) 
.71 3,153 .55 
Bizarre Behavior No APP 
Low APP 
Med APP 
High APP 
1.93 (1.49) 
2.35 (1.75) 
2.12 (1.69) 
2.26 (1.58) 
.59 3, 154 .63 
Self-Neglect No APP 
Low APP 
Med APP 
High APP 
2.05 (0.94) 
2.08 (0.95) 
2.71 (1.23) 
2.36 (1.30) 
2.01 3, 154 .11 
Disorientation No APP 
Low APP 
Med APP 
High APP 
1.33 (0.70) 
2.08 (1.50) 
1.21 (0.47) 
1.38 (0.76) 
3.73 3, 153 .01* 
Conceptual Disorganization No APP 
Low APP 
Med APP 
High APP 
2.06 (1.40) 
2.23 (1.59) 
1.88 (1.46) 
1.79 (1.39) 
.55 3, 153 .65 
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Blunted Affect No APP 
Low APP 
Med APP 
High APP 
2.54 (1.48) 
3.00 (1.29) 
2.38 (1.17) 
2.55 (1.34) 
.53 3, 153 .66 
Emotional Withdrawal No APP 
Low APP 
Med APP 
High APP 
2.25 (1.41) 
2.38 (1.12) 
2.03 (1.07) 
2.17 (1.28) 
.22 3, 153 .88 
Motor Retardation No APP 
Low APP 
Med APP 
High APP 
2.00 (1.17) 
2.15 (1.07) 
1.82 (1.03) 
2.04 (1.28) 
.22 3, 153 .89 
Tension No APP 
Low APP 
Med APP 
High APP 
1.75 (1.16) 
1.54 (0.88) 
1.56 (.97) 
1.56 (.81) 
.50 3, 153 .68 
Uncooperativeness No APP 
Low APP 
Med APP 
High APP 
1.83 (1.23) 
1.62 (1.12) 
1.53 (1.13) 
1.45 (0.78) 
1.38 3, 153 .25 
Excitement No APP 
Low APP 
Med APP 
High APP 
1.63 (1.12) 
1.23 (0.45) 
1.53 (1.18) 
1.40 (0.94) 
.86 3, 153 .46 
Distractibility No APP 
Low APP 
Med APP 
High APP 
1.78 (1.15) 
1.54 (0.78) 
1.56 (0.86) 
2.14 (1.52) 
1.64 3, 153 .18 
Motor hyperactivity No APP 
Low APP 
Med APP 
High APP 
1.37 (0.88) 
1.31 (0.63) 
1.41 (1.00) 
1.27 (0.65) 
.21 3, 153 .89 
Mannerisms and Posturing No APP 
Low APP 
Med APP 
High APP 
1.17 (0.55) 
1.31 (0.63) 
1.06 (0.24) 
1.23 (0.64) 
.58 3, 152 .63 
*p<.05  
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Table 26 
Service Use by WCST Repeated Measures ANOVAs 
 Measures 
 
WCST 
Correct 
WCST 
Perseverative 
Errors 
WCST 
Random 
Errors 
WCST 
Consolidation 
Index 
Variable 
F (2,72) F (2,112) F (2, 112) F (2, 72) 
Main Effect 
     Assessment Time .66 2.53 3.66* 1.92 
Main Effect 
     Service Use 1.35 5.13* .71 .71 
Interaction        
Assessment Time * Service Use .64 1.36 .84 .10 
*p<.05, **p<.01, ***p<.001 
 
Table 27 
Service Use by Neurocognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
RAVLT NAB 
Total Trails A Trails B 
COWAT/ 
FAS 
RBANS 
Total 
Variable 
F (2,18) F (2,26) F (2, 110) F (2, 112) F (2, 114) F (2, 108) 
Main Effect 
     Assessment Time .24 1.74 .51 .12 1.91 9.82*** 
Main Effect 
     Service Use 2.19 .28 .004 .20 .06 1.67 
Interaction        
     Assessment Time *  
     Service Use 
5.25* .47 3.38* .53 3.02* 3.65* 
*p<.05, **p<.01, ***p<.001 
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Table 28 
Service Use by RCFT Repeated Measures ANOVAs 
 Measures 
 
RCFT  
Copy 
RCFT 
Immediate 
Copy 
RCFT 
Delayed 
Memory 
RCFT  
Recognition 
Variable 
F (2,60) F (2,60) F (2, 60) F (2, 60) 
Main Effect 
     Assessment Time 1.75 4.62** 4.89** .55 
Main Effect 
     Service Use .32 3.60 1.69 .04 
Interaction        
    Assessment Time *  
     Service Use 
.19 1.37 .13 .63 
*p<.05, **p<.01, ***p<.001 
 
 
 
 
Table 29 
Mean Scores and Standard Deviations for WCST Correct Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 WCST Correct Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 24.35 (2.67) 23.41 (4.23) 23.94 (3.31) 
     Service Use 24.86 (.66) 24.81 (.87) 24.33 (2.83) 
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Table 30 
Mean Scores and Standard Deviations for WCST Perseverative Errors Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 WCST Perseverative Errors Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 24.52 (13.52) 30.70 (18.50) 24.93 (15.98) 
     Service Use 22.10 (11.41) 21.52 (12.09) 17.94 (11.23) 
 
Table 31 
Mean Scores and Standard Deviations for WCST Random Errors Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 WCST Random Error Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 27.89 (15.98) 29.81 (18.19) 21.74 (18.47) 
     Service Use 24.90 (18.71) 25.26 (17.51) 20.23 (17.51) 
 
Table 32 
Mean Scores and Standard Deviations for WCST Consolidation Index Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 WCST Consolidation Index Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 4.59 (5.77) 4.58 (8.42) 11.87 (32.49) 
     Service Use 2.84 (4.90) 2.74 (3.21) 7.43 (19.47) 
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Table 33 
Mean Scores and Standard Deviations for RAVLT  Scores at Admission, 6 Months, and 
12 Months as a Function of Service Use Before Age 18 
 RAVLT Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 6.80 (3.19) 5.80 (3.11) 8.20 (3.27) 
     Service Use 9.00 (2.19) 10.33 (3.14) 8.50 (2.51) 
 
Table 34 
Mean Scores and Standard Deviations for NAB Total Scores at Admission, 6 Months, and 
12 Months as a Function of Service Use Before Age 18 
 NAB Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 70.00 (10.23) 75.00 (3.74) 77.75 (9.32) 
     Service Use 75.91 (15.98) 80.09 (14.96) 78.27 (14.16) 
 
 
Table 35 
Mean Scores and Standard Deviations for Trails A Scores at Admission, 6 Months, and 
12 Months as a Function of Service Use Before Age 18 
 Trails A Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 42.88 (14.57) 50.30 (19.59) 43.03 (14.97) 
     Service Use 47.04 (28.23) 42.76 (30.58) 45.24 (38.51) 
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Table 36 
Mean Scores and Standard Deviations for Trails B Scores at Admission, 6 Months, and 
12 Months as a Function of Service Use Before Age 18 
 Trails B Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 107.84 (48.26) 112.83 (58.77) 112.03 (93.06) 
     Service Use 126.91 (84.19) 112.66 (94.25) 117.02 (86.00) 
 
 
 
 
 
Table 37 
Mean Scores and Standard Deviations for COWAT/FAS Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 COWAT/FAS Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 30.71 (9.45) 26.75 (12.70) 28.82 (8.87) 
     Service Use 26.74 (9.27) 27.68 (9.86) 30.32 (9.62) 
 
Table 38 
Mean Scores and Standard Deviations for RBANS Total Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 RBANS Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 73.77 (15.39) 73.19 (13.49) 80.84 (16.03) 
     Service Use 68.32 (13.57) 72.60 (13.45) 73.04 (14.62) 
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Table 39 
Mean Scores and Standard Deviations for RCFT Copy Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 RCFT Copy Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 29.85 (6.85) 28.46 (5.52) 29.85 (5.97) 
     Service Use 28.42 (5.95) 26.92 (7.38) 29.55 (6.38) 
 
Table 40 
Mean Scores and Standard Deviations for RCFT Immediate Memory Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 RCFT Immediate Memory Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 11.58 (5.20) 12.31 (5.53) 16.12 (6.85) 
     Service Use 15.82 (1.68) 15.76 (9.97) 29.92 (29.46) 
 
Table 41 
Mean Scores and Standard Deviations for RCFT Delayed Memory Scores at Admission, 
6 Months, and 12 Months as a Function of Service Use Before Age 18 
 RCFT Delayed Memory Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 12.12 (4.98) 11.88 (5.14) 15.23 (6.69) 
     Service Use 15.17 (11.66) 15.39 (9.43) 19.71 (11.14) 
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Table 42 
Mean Scores and Standard Deviations for RCFT Recognition Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 RCFT Recognition Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 19.08 (2.53) 18.92 (1.71) 19.08 (2.84) 
     Service Use 18.21 (6.00) 19.68 (7.10) 19.95 (2.70) 
 
 
 
Table 43 
APP Severity Level by WCST Repeated Measures ANOVAs 
 Measures 
 
WCST 
Correct 
WCST 
Perseverative 
Errors 
WCST 
Random 
Errors 
WCST 
Consolidation 
Index 
Variable F (6,68) F (6,108) F (6, 108) F (6, 68) 
Main Effect 
     Assessment Time .20 .73 1.81 .77 
Main Effect 
     APP Severity Level .54 2.66 1.87 .40 
Interaction        
Assessment Time *  
APP Severity Level 
.26 1.09 1.30 .08 
*p<.05, **p<.01, ***p<.001 
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Table 44 
APP Severity Level by Neurocognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
RAVLT NAB 
Total Trails A Trails B 
COWAT/ 
FAS 
RBANS 
Total 
Variable 
F (4,16) F (4,24) F (6, 106) F (6, 106) F (6, 110) F (6, 104) 
Main Effect 
     Assessment Time .15 .39 .20 .56 1.16 6.37** 
Main Effect 
     APP Severity Level 1.06 .30 1.58 .84 .09 .80 
Interaction        
     Assessment Time *  
     APP Severity Level 
3.88* 1.40 1.28 .55 1.67 2.40* 
*p<.05, **p<.01, ***p<.001 
 
 
 
Table 45 
Service Use by RCFT Repeated Measures ANOVAs 
 Measures 
 
RCFT 
Copy 
RCFT 
Immediate 
Copy 
RCFT 
Delayed 
Memory 
RCFT 
Recognition 
Variable F (6,56) F (6,56) F (6, 56) F (6, 56) 
Main Effect 
     Assessment Time 2.20 5.66* 6.23** 1.33 
Main Effect 
     Service Use .80 1.27 .55 1.19 
Interaction        
     Assessment Time *  
     Service Use 
.25 1.76 2.14 1.46 
*p<.05, **p<.01, ***p<.001 
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Table 46 
Mean Scores and Standard Deviations for WCST Correct Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 WCST Correct Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  24.35 (2.67) 23.41 (4.23) 23.94 (3.31) 
     Low APP 25.00 (.00) 25.00 (.00) 25.00 (.00) 
     Medium APP  25.00 (.00) 25.00 (.00) 24.80 (.45) 
     High APP 24.75 (.87) 24.67 (1.16) 23.92 (3.75) 
 
 
Table 47 
Mean Scores and Standard Deviations for WCST Perseverative Errors Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 WCST Perseverative Errors Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  24.52 (13.52) 30.70 (18.50) 24.93 (15.98) 
     Low APP 22.50 (11.79) 26.25 (6.19) 19.50 (12.77) 
     Medium APP 18.29 (11.80) 10.00 (6.56) 16.14 (14.68) 
     High APP 23.35 (11.52) 24.60 (12.14) 18.25 (10.18) 
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Table 48 
Mean Scores and Standard Deviations for WCST Random Errors Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 WCST Random Error Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 27.89 (15.98) 29.81 (18.19) 21.74 (18.47) 
     Low APP 23.00 (8.29) 40.50 (10.76) 22.00 (8.41) 
     Medium APP 14.00 (12.74) 9.71 (10.42) 17.71 (20.23) 
     High APP 29.10 (20.68) 27.65 (16.95) 20.75 (18.45) 
 
 
 
Table 49 
Mean Scores and Standard Deviations for WCST Consolidation Index Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 WCST Consolidation Index Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 4.59 (5.77) 4.58 (8.42) 11.87 (32.49) 
     Low APP 1.23 (.70) 1.14 (1.31) 1.85 (1.35) 
     Medium APP 5.31 (8.28) 4.17 (4.52) 8.87 (14.81) 
     High APP 2.36 (3.82) 2.67 (2.99) 8.69 (24.40) 
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Table 50 
Mean Scores and Standard Deviations for RAVLT  Scores at Admission, 6 Months, and 
12 Months as a Function of APP Severity Level 
 RAVLT Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  6.80 (3.19) 5.80 (3.11) 8.20 (3.27) 
     Low APP - - - 
     Medium APP 8.50 (2.12) 8.50 (3.54) 9.00 (1.41) 
     High APP 9.25 (2.50) 11.25 (2.99) 8.25 (3.10) 
 
 
 
 
Table 51 
Mean Scores and Standard Deviations for NAB Total Scores at Admission, 6 Months, and 
12 Months as a Function of APP Severity Level 
 NAB Total Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 70.00 (10.23) 75.00 (3.74) 77.75 (9.32) 
     Low APP - - - 
     Medium APP 78.00 (4.24) 75.00 (4.24) 67.00 (7.07) 
     High APP 75.44 (17.76) 81.22 (16.42) 80.78 (14.34) 
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Table 52 
Mean Scores and Standard Deviations for Trails A Scores at Admission, 6 Months, and 
12 Months as a Function of APP Severity Level 
 Trails A Total Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 42.88 (14.57) 50.30 (19.59) 43.03 (14.97) 
     Low APP 64.75 (30.39) 65.00 (27.83) 61.26 (23.81) 
     Medium APP 37.78 (18.91) 31.76 (12.55) 33.03 (14.78) 
     High APP 48.40 (31.61) 44.08 (36.65) 48.88 (49.41) 
 
 
 
 
 
 
 
 
Table 53 
Mean Scores and Standard Deviations for Trails B Scores at Admission, 6 Months, and 
12 Months as a Function of APP Severity Level 
 Trails B Total Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 107.84 (48.26) 112.83 (58.77) 112.03 (93.06) 
     Low APP 174.00 (89.80) 160.50 (30.45) 127.34 (47.63) 
     Medium APP 100.03 (44.58) 96.32 (50.47) 92.53 (54.13) 
     High APP 132.27 (99.94) 110.81 (122.80) 
130.60 
(108.47) 
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Table 54 
Mean Scores and Standard Deviations for COWAT/FAS Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 COWAT/FAS Total Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 30.71 (9.45) 26.75 (12.70) 28.82 (8.87) 
     Low APP 22.50 (8.89) 30.75 (12.76) 28.25 (11.03) 
     Medium APP 27.90 (10.56) 26.20 (10.68) 28.80 (11.58) 
     High APP 27.06 (8.84) 27.82 (9.17) 31.71 (8.41) 
 
 
 
 
Table 55 
Mean Scores and Standard Deviations for RBANS Total Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 RBANS Total Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 73.77 (15.39) 73.19 (13.49) 80.84 (16.03) 
     Low APP 70.60 (13.81) 73.80 (15.01) 81.40 (8.39) 
     Medium APP 68.56 (15.31) 70.22 (14.81) 67.44 (13.96) 
     High APP 67.09 (13.19) 74.00 (12.68) 73.82 (16.28) 
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Table 56 
Mean Scores and Standard Deviations for RCFT Copy Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 RCFT Copy Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 29.85 (6.85) 28.46 (5.52) 29.85 (5.97) 
     Low APP 27.88 (2.32) 27.25 (3.40) 31.25 (5.56) 
     Medium APP 26.75 (9.49) 23.67 (11.42) 26.83 (7.80) 
     High APP 29.78 (4.14) 28.94 (4.90) 30.61 (5.81) 
 
 
 
 
 
Table 57 
Mean Scores and Standard Deviations for RCFT Immediate Memory Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 RCFT Immediate Memory Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 11.58 (5.20) 12.31 (5.53) 16.12 (6.85) 
     Low APP 14.75 (6.36) 14.25 (6.20) 30.00 (17.22) 
     Medium APP 19.33 (18.85) 18.25 (15.55) 18.42 (10.52) 
     High APP 13.94 (7.47) 14.78 (7.16) 37.56 (40.10) 
 
 
216 
 
 
Table 58 
Mean Scores and Standard Deviations for RCFT Delayed Memory Scores at Admission, 
6 Months, and 12 Months as a Function of APP Severity Level 
 RCFT Delayed Memory Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 12.12 (4.98) 11.88 (5.14) 15.23 (6.69) 
     Low APP 10.75 (5.87) 14.00 (6.72) 22.63 (10.48) 
     Medium APP 18.92 (18.69) 16.83 (14.17) 15.42 (11.56) 
     High APP 14.63 (7.38) 15.06 (7.40) 21.28 (11.56) 
 
 
 
Table 59 
Mean Scores and Standard Deviations for RCFT Recognition Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 RCFT Recognition Scores 
 At Admission Six Months 
Twelve 
Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 19.08 (2.53) 18.92 (1.71) 19.08 (2.84) 
     Low APP 16.75 (2.87) 19.25 (1.26) 20.25 (1.50) 
     Medium APP 21.17 (9.58) 23.50 (11.11) 19.83 (2.32) 
     High APP 16.89 (3.30) 17.33 (4.27) 19.89 (3.48) 
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Table 60 
Service Use by FKK Repeated Measures ANOVAs 
 Measures 
 
FKK 
Internal 
FKK Self 
Concept 
FKK Self 
Efficacy 
FKK 
Powerful 
Others 
FKK 
Chance 
FKK 
Externality 
Variable 
F (2,50) F (2,50) F (2, 50) F (2, 50) F (2, 50) F (2, 50) 
Main Effect 
     Assessment Time .27 1.14 .11 1.04 4.66** 3.77* 
Main Effect 
     Service Use .06 .33 .25 .33 1.13 .74 
Interaction        
    Assessment Time *  
    Service Use 
.80 .71 .48 .90 5.29** 3.87* 
*p<.05, **p<.01, ***p<.001 
 
 
 
Table 61 
Service Use by Socialcognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
 
 
Hinting 
CST 
Social 
Support 
CST Self 
Controlling 
CST Escape 
Avoidance 
CST Planful 
Problem 
Solving 
Variable 
F 
(2,102) F (2,40) F (2, 40) F (2, 40) F (2, 40) 
Main Effect 
     Assessment Time 8.32*** 4.83** .14 1.74 .47 
Main Effect 
     Service Use .01 .21 7.05* .13 1.16 
Interaction        
     Assessment Time *  
     Service Use 
.21 .74 .24 1.92 .57 
*p<.05, **p<.01, ***p<.001 
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Table 62 
Service Use by Socialcognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
IPSAQ 
Internal 
Positive 
IPSAQ 
Personal 
Positive 
IPSAQ 
Situational 
Positive 
IPSAQ 
Internal 
Negative 
IPSAQ 
Personal 
Negative 
IPSAQ 
Situational 
Negative 
Variable 
F (2,30) F (2,30) F (2, 30) F (2, 30) F (2, 30) F (2, 30) 
Main Effect 
     Assessment Time .39 4.00* 2.32 .39 .33 .45 
Main Effect 
     Service Use 2.15 .51 4.02 1.41 .63 .69 
Interaction        
 Assessment Time *  
Service Use 
2.85 .93 2.18 3.41* .47 2.14 
*p<.05, **p<.01, ***p<.001 
 
 
 
 
Table 63 
Mean Scores and Standard Deviations for Hinting Scores at Admission, 6 Months, and 
12 Months as a Function of Service Use Before Age 18 
 Hinting Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 14.86 (3.31) 16.48 (3.12) 16.14 (2.90) 
     Service Use 14.50 (3.08) 16.75 (3.35) 16.04 (3.67) 
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Table 64 
Mean Scores and Standard Deviations for FKK Internal Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 FKK Internal Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 33.88 (7.98) 33.94 (5.64) 34.88 (5.37) 
     Service Use 33.36 (6.53) 35.09 (5.63) 32.82 (6.35) 
 
Table 65 
Mean Scores and Standard Deviations for FKK Self Concept Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 FKK Self Concept Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 33.06 (5.08) 32.75 (3.84) 32.88 (3.74) 
     Service Use 33.55 (5.09) 31.09 (4.16) 31.55 (6.36) 
 
 
Table 66 
Mean Scores and Standard Deviations for FKK Self Efficacy Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 FKK Self Efficacy Index Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 66.94 (11.11) 66.69 (7.11) 67.75 (6.90) 
     Service Use 66.91 (8.85) 66.18 (7.01) 64.36 (9.68) 
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Table 67 
Mean Scores and Standard Deviations for FKK Powerful Others Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 FKK Powerful Others Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 26.69 (9.19) 26.88 (7.00) 25.94 (7.23) 
     Service Use 26.73 (7.14) 23.73 (7.88) 24.36 (7.87) 
 
Table 68 
Mean Scores and Standard Deviations for FKK Chance Scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 FKK Chance Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 24.69 (7.79) 25.63 (7.60) 24.19 (5.94) 
     Service Use 26.73 (9.09) 20.09 (6.07) 20.09 (5.19) 
 
 
 
Table 69 
Mean Scores and Standard Deviations for FKK Externality Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 FKK Externality Total Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 51.38 (16.47) 52.50 (13.29) 50.13 (12.12) 
     Service Use 53.45 (13.84) 43.82 (13.11) 44.45 (10.31) 
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Table 70 
Mean Scores and Standard Deviations for IPSAQ Internal Positive Scores at Admission, 
6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Internal Positive Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 8.50 (2.83) 7.37 (3.29) 7.00 (3.89) 
     Service Use 7.67 (2.45) 10.11 (1.69) 9.33 (2.18) 
 
 
Table 71 
Mean Scores and Standard Deviations for IPSAQ Personal Positive Scores at Admission, 
6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Personal Positive Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 4.87 (2.36) 3.75 (1.49) 2.75 (2.82) 
     Service Use 3.56 (1.81) 3.44 (1.42) 2.78 (1.64) 
 
 
Table 72 
Mean Scores and Standard Deviations for IPSAQ Situational Positive Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Situational Positive Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 2.63 (1.51) 4.88 (2.42) 5.38 (2.62) 
     Service Use 3.33 (1.94) 2.44 (1.88) 3.89 (2.32) 
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Table 73 
Mean Scores and Standard Deviations for IPSAQ Internal Negative Scores at Admission, 
6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Internal Negative Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 5.63 (4.21) 6.50 (4.72) 4.00 (3.38) 
     Service Use 6.22 (2.22) 6.78 (3.42) 8.22 (3.11) 
 
Table 74 
Mean Scores and Standard Deviations for IPSAQ Personal Negative Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Personal Negative Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 6.13 (4.19) 5.13 (3.68) 4.87 (3.60) 
     Service Use 4.22 (3.03) 4.56 (1.94) 4.22 (2.91) 
 
 
Table 75 
Mean Scores and Standard Deviations for IPSAQ Situational Negative Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IPSAQ Situational Negative Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 4.25 (2.12) 4.25 (2.05) 6.25 (1.83) 
     Service Use 4.11 (2.62) 4.56 (4.04) 3.56 (3.21) 
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Table 76 
Mean Scores and Standard Deviations for CST Social Support Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 CST Social Support Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 32.75 (10.11) 37.17 (9.16) 40.67 (8.33) 
     Service Use 37.10 (11.06) 36.80 (9.88) 41.50 (10.36) 
 
Table 77 
Mean Scores and Standard Deviations for CST Self Controlling Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 CST Self Controlling Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 54.50 (5.14) 54.08 (7.10) 54.75 (4.83) 
     Service Use 48.90 (5.41) 48.00 (9.15) 46.90 (11.18) 
 
Table 78 
Mean Scores and Standard Deviations for CST Escape Avoidance Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 CST Escape Avoidance Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 33.67 (5.28) 36.25 (6.08) 38.17 (3.74) 
     Service Use 35.60 (5.48) 39.70 (4.57) 34.90 (12.21) 
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Table 79 
Mean Scores and Standard Deviations for CST Planful Problem Solving Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 CST Planful Problem Solving Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 42.08 (8.85) 43.33 (5.03) 45.17 (6.24) 
     Service Use 41.40 (11.05) 39.10 (7.88) 40.90 (10.78) 
 
 
 
 
Table 80 
APP Severity Level by FKK Repeated Measures ANOVAs 
 Measures 
 
FKK 
Internal 
FKK Self 
Concept 
FKK Self 
Efficacy 
FKK 
Powerful 
Others 
FKK 
Chance 
FKK 
Externality 
Variable 
F (6,46) F (6,46) F (6,46) F (6,46) F (6,46) F (6,46) 
Main Effect 
     Assessment Time .54 1.23 .09 1.11 7.81*** 5.47** 
Main Effect 
     APP Severity Level .06 .26 .12 .25 .35 .29 
Interaction        
    Assessment Time *  
    APP 
1.15 1.17 1.19 1.09 2.88* 2.30* 
*p<.05, **p<.01, ***p<.001 
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Table 81 
APP Severity Level by Socialcognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
Hinting CST 
Social 
Support 
CST Self 
Controlling 
CST Escape 
Avoidance 
CST Planful 
Problem 
Solving 
Variable 
F (6,98) F (6,36) F (6, 36) F (6, 36) F (6, 36) 
Main Effect 
     Assessment Time 5.87** 2.71 .48 2.15 .21 
Main Effect 
     APP Severity Level .80 .12 3.39* 1.12 .67 
Interaction        
     Assessment Time * APP .90 .32 1.81 2.26 .52 
*p<.05, **p<.01, ***p<.001 
 
 
Table 82 
APP Severity Level by Socialcognition Measures 
 Repeated Measures ANOVAs 
 Measures 
 
IPSAQ 
Internal 
Positive 
IPSAQ 
Personal 
Positive 
IPSAQ 
Situational 
Positive 
IPSAQ 
Internal 
Negative 
IPSAQ 
Personal 
Negative 
IPSAQ 
Situational 
Negative 
Variable 
F (6,26) F (6,26) F (6, 26) F (6, 26) F (6, 26) F (6, 26) 
Main Effect 
  Assessment Time 1.57 1.74 1.05 1.20 .13 .02 
Main Effect 
  APP Severity 
Level 
1.55 .36 4.23* .66 .24 .64 
Interaction        
 Assessment Time 
* APP 
1.30 1.18 1.77 3.21* .46 1.85 
*p<.05, **p<.01, ***p<.001 
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Table 83 
Mean Scores and Standard Deviations for Hinting Task Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 Hinting Task Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  14.86 (3.31) 16.48 (3.12) 16.14 (2.90) 
     Low APP 12.33 (.58) 14.67 (3.06) 17.33 (.58) 
     Medium APP  14.29 (3.64) 15.86 (3.13) 14.43 (4.93) 
     High APP 15.07 (3.03) 17.64 (3.41) 16.57 (3.23) 
 
Table 84 
Mean Scores and Standard Deviations for FKK Internal Locus of Control Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 FKK Internal Locus of Control Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  33.88 (7.98) 33.94 (5.64) 34.88 (5.37) 
     Low APP 35.33 (9.50) 36.00 (6.56) 32.67 (2.52) 
     Medium APP 34.60 (6.43) 35.00 (6.60) 31.00 (8.25) 
     High APP 29.33 (2.52) 34.33 (5.13) 36.00 (6.00) 
 
 
 
 
 
 
227 
 
Table 85 
Mean Scores and Standard Deviations for FKK Self Concept Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 FKK Self Concept Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 33.06 (5.08) 32.75 (3.84) 32.88 (3.74) 
     Low APP 32.00 (2.65) 33.00 (1.00) 30.33 (4.73) 
     Medium APP 33.80 (6.42) 30.60 (2.88) 30.00 (5.00) 
     High APP 34.67 (5.86) 30.00 (7.81) 35.33 (10.02) 
 
 
Table 86 
Mean Scores and Standard Deviations for FKK Self Efficacy Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 FKK Self Efficacy Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 66.94 (11.11) 66.69 (7.11) 67.75 (6.90) 
     Low APP 67.33 (10.26) 69.00 (7.55) 63.00 (5.57) 
     Medium APP 68.40 (10.69) 65.60 (3.78) 61.00 (6.21) 
     High APP 64.00 (6.25) 64.33 (11.93) 71.33 (16.01) 
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Table 87 
Mean Scores and Standard Deviations for FKK Powerful Others Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 FKK Powerful Others Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP  26.69 (9.19) 26.88 (7.00) 25.94 (7.23) 
     Low APP 28.33 (3.79) 21.67 (3.79) 25.67 (9.87) 
     Medium APP 26.20 (8.84) 21.80 (8.32) 22.60 (9.21) 
     High APP 26.00 (8.89) 29.00 (10.00) 26.00 (5.29) 
 
Table 88 
Mean Scores and Standard Deviations for FKK Chance Scores at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 FKK Chance Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 24.69 (7.79) 25.63 (7.60) 24.19 (5.94) 
     Low APP 29.00 (10.00) 20.33 (1.53) 17.67 (2.08) 
     Medium APP 26.20 (10.71) 18.00 (7.25) 22.20 (6.38) 
     High APP 25.33 (8.51) 23.33 (7.10) 19.00 (5.20) 
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Table 89 
Mean Scores and Standard Deviations for FKK External Locus of Control Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 FKK External Locus of Control Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 51.38 (16.47) 52.50 (13.29) 50.13 (12.12) 
     Low APP 57.33 (3.58) 42.00 (5.29) 43.33 (9.71) 
     Medium APP 52.40 (18.15) 39.80 (15.43) 44.80 (14.72) 
     High APP 51.33 (9.07) 52.33 (14.15) 45.00 (1.00) 
 
 
 
Table 90 
Mean Scores and Standard Deviations for IPSAQ Internal Positive Scores at Admission, 
6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Internal Positive Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 8.50 (2.83) 7.37 (3.29) 7.00 (3.89) 
     Low APP 8.00 (4.36) 11.33 (1.53) 12.00 (1.00) 
     Medium APP 8.00 (1.41) 9.50 (1.92) 8.00 (.82) 
     High APP 6.50 (.71) 9.50 (.71) 8.00 (1.41) 
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Table 91 
Mean Scores and Standard Deviations for IPSAQ Personal Positive Scores at Admission, 
6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Personal Positive Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 4.87 (2.36) 3.75 (1.49) 2.75 (2.82) 
     Low APP 2.00 (1.73) 4.00 (2.00) 2.00 (.00) 
     Medium APP 4.50 (1.73) 3.00 (1.41) 3.00 (2.45) 
     High APP 4.00 (.00) 3.50 (.71) 3.50 (.71) 
 
 
Table 92 
Mean Scores and Standard Deviations for IPSAQ Situational Positive Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Situational Positive Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 2.63 (1.51) 4.88 (2.42) 5.38 (2.62) 
     Low APP 3.67 (1.53) .67 (.58) 2.00 (1.00) 
     Medium APP 2.00 (1.63) 3.50 (2.08) 5.00 (2.58) 
     High APP 5.50 (.71) 3.00 (.00) 4.50 (2.12) 
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Table 93 
Mean Scores and Standard Deviations for IPSAQ Internal Negative Scores at Admission, 
6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Internal Negative Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 5.63 (4.21) 6.50 (4.72) 4.00 (3.38) 
     Low APP 5.00 (1.00) 3.33 (4.16) 9.33 (4.73) 
     Medium APP 7.25 (2.63) 8.00 (.82) 7.25 (.50) 
     High APP 6.00 (2.83) 9.50 (.71) 8.50 (4.95) 
 
 
Table 94 
Mean Scores and Standard Deviations for IPSAQ Personal Negative Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Personal Negative Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 6.13 (4.19) 5.13 (3.68) 4.87 (3.60) 
     Low APP 4.00 (2.65) 5.00 (1.73) 2.67 (2.08) 
     Medium APP 4.00 (4.08) 4.00 (2.58) 5.00 (3.16) 
     High APP 5.00 (2.83) 5.00 (1.41) 5.00 (4.24) 
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Table 95 
Mean Scores and Standard Deviations for IPSAQ Situational Negative Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 IPSAQ Situational Negative Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 4.25 (2.12) 4.25 (2.05) 6.25 (1.83) 
     Low APP 4.00 (4.58) 7.33 (5.51) 4.00 (5.29) 
     Medium APP 3.75 (1.89) 4.00 (2.94) 3.75 (2.75) 
     High APP 5.00 (.00) 1.50 (.71) 2.50 (.71) 
 
 
Table 96 
Mean Scores and Standard Deviations for CST Social Support Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 CST Social Support Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 32.75 (10.11) 37.17 (9.16) 40.67 (8.33) 
     Low APP 39.67 (11.24) 36.67 (3.51) 43.00 (7.21) 
     Medium APP 36.25 (15.90) 35.75 (16.22) 39.75 (13.15) 
     High APP 35.67 (5.51) 38.33 (5.13) 42.33 (12.70) 
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Table 97 
Mean Scores and Standard Deviations for CST Self Controlling Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 CST Self Controlling Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 54.50 (5.14) 54.08 (7.10) 54.75 (4.83) 
     Low APP 49.33 (4.04) 46.33 (5.13) 51.67 (.58) 
     Medium APP 48.75 (5.68) 51.25 (14.10) 51.25 (9.61) 
     High APP 48.67 (8.15) 45.33 (4.04) 36.33 (13.58) 
 
 
 
Table 98 
Mean Scores and Standard Deviations for CST Escape Avoidance Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 CST Escape Avoidance Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 33.67 (5.28) 36.25 (6.08) 38.17 (3.74) 
     Low APP 34.67 (2.52) 37.33 (.58) 37.00 (3.00) 
     Medium APP 36.25 (7.14) 41.50 (5.97) 40.75 (5.32) 
     High APP 35.67 (7.10) 39.67 (5.03) 25.00 (19.93) 
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Table 99 
Mean Scores and Standard Deviations for CST Planful Problem Solving Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 CST Planful Problem Solving Scores 
 At Admission Six Months Twelve Months 
APP Severity Level M (SD) M (SD) M (SD) 
     No APP 42.08 (8.85) 43.33 (5.03) 45.17 (6.24) 
     Low APP 43.00 (3.61) 43.67 (2.08) 41.33 (2.08) 
     Medium APP 40.25 (15.13) 33.75 (8.26) 40.00 (9.27) 
     High APP 41.33 (13.65) 41.67 (8.62) 41.67 (19.66) 
 
 
Table 100 
Service Use by IS Repeated Measures ANOVAs 
 Measures 
 
IS Relabel 
IS 
Awareness 
IS Need 
for 
Treatment 
IS Total 
Insight 
Variable F (2,114) F (2,114) F (2, 114) F (2, 114) 
Main Effect 
     Assessment Time 2.40 1.37 3.22* 2.37 
Main Effect 
     Service Use .52 8.42** 2.77 5.47* 
Interaction        
Assessment Time * 
Service Use 
3.98* 2.52 1.96 3.26* 
*p<.05, **p<.01, ***p<.001 
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Table 101 
Mean Scores and Standard Deviations for IS Relabel Scale Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 IS Relabel Scale Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 2.62 (1.08) 2.76 (.95) 1.97 (1.21) 
     Service Use 2.13 (1.07) 2.43 (.94) 2.43 (.77) 
 
Table 102 
Mean Scores and Standard Deviations for IS Awareness of Illness Scale Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IS Awareness of Illness Scale Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 2.66 (1.17) 2.83 (1.20) 2.21 (1.11) 
     Service Use 2.00 (1.30) 1.70 (1.29) 1.97 (1.22) 
 
Table 103 
Mean Scores and Standard Deviations for IS Need for Treatment Scale Scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 IS Need for Treatment Scale Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 2.52 (1.08) 2.47 (1.21) 1.83 (1.22) 
     Service Use 2.15 (1.18) 1.72 (1.32) 1.85 (1.22) 
 
236 
 
 
Table 104 
Mean Scores and Standard Deviations for IS Total Insight Scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 IS Total Insight Scores 
 At Admission Six Months Twelve Months 
Services Before Age 18 M (SD) M (SD) M (SD) 
     No Service Use 7.79 (2.96) 8.05 (2.87) 6.00 (2.75) 
     Service Use 6.35 (2.87) 5.92 (2.88) 6.25 (2.48) 
 
Table 105 
APP Severity by IS Repeated Measures ANOVAs 
 Measures 
 
IS Relabel 
IS 
Awareness 
IS Need 
for 
Treatment 
IS Total 
Insight 
Variable F (6,110) F (6,110) F (6, 110) F (6, 110) 
Main Effect 
     Assessment Time .91 2.16 3.14* 1.98 
Main Effect 
     Service Use .43 2.89* .91 1.88 
Interaction        
Assessment Time * 
Service Use 
2.90** 2.48* 1.79 3.38** 
*p<.05, **p<.01, ***p<.001   
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Table 106 
Mean Scores and Standard Deviations for IS Relabel Scale Scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 IS Relabel Scale Scores 
 At Admission Six Months Twelve Months 
APP Severity M (SD) M (SD) M (SD) 
No Service Use 2.62 (1.08) 2.76 (.95) 1.97 (1.21) 
Low APP 3.25 (.96) 2.50 (1.00) 2.00 (.00) 
Medium APP 1.63 (.92) 2.75 (.89) 2.63 (.52) 
High APP 2.11 (1.02) 2.28 (.96) 2.44 (.92) 
 
 
Table 107 
Mean Scores and Standard Deviations for IS Awareness of Illness Scale Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 IS Awareness of Illness Scale Scores 
 At Admission Six Months 
Twelve 
Months 
APP Severity M (SD) M (SD) M (SD) 
No Service Use 2.66 (1.17) 2.83 (1.20) 2.21 (1.11) 
Low APP 3.25 (.96) 1.50 (1.00) 1.50 (1.00) 
Medium APP 1.50 (1.41) 2.13 (1.13) 1.75 (1.17) 
High APP 2.28 (1.18) 1.56 (1.42) 2.17 (1.30) 
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Table 108 
Mean Scores and Standard Deviations for IS Need for Treatment Scale Scores at 
Admission, 6 Months, and 12 Months as a Function of APP Severity Level 
 IS Need for Treatment Scale Scores 
 At Admission Six Months Twelve Months 
APP Severity M (SD) M (SD) M (SD) 
No Service Use 2.52 (1.08) 2.47 (1.21) 1.83 (1.22) 
Low APP 3.13 (1.03) 1.50 (1.00) 1.38 (1.11) 
Medium APP 1.69 (.88) 2.00 (1.51) 1.94 (1.08) 
High APP 2.14 (1.23) 1.64 (1.34) 1.92 (1.33) 
 
Table 109 
Mean Scores and Standard Deviations for IS Total Insight score at Admission, 6 Months, 
and 12 Months as a Function of APP Severity Level 
 IS Total Insight Scores 
 At Admission Six Months Twelve Months 
APP Severity M (SD) M (SD) M (SD) 
No Service Use 7.79 (2.96) 8.05 (2.87) 6.00 (2.75) 
Low APP 9.63 (2.75) 5.50 (1.00) 4.88 (1.65) 
Medium APP 4.81 (1.81) 7.13 (3.40) 6.31 (2.19) 
High APP 6.31 (2.77) 5.47 (2.88) 6.53 (2.74) 
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Table 110 
Service Use by NOSIE Subscales and Total Assets Repeated Measures ANOVAs 
 NOSIE Subscales 
 
Daily 
Schedule 
Competence 
Social 
Interest Neatness Irritability Psychoticism 
Motor 
Retardation 
NOSIE 
Total 
Assets 
Variable 
F (2, 188) F (2, 188) F (2, 188) F (2, 188) F (2, 188) F (2, 188) F (2, 188) 
 
Time 26.86*** 39.51*** 20.89*** 3.78* 7.47*** 15.93*** 21.68*** 
Service 
Use 2.54 .06 1.20 1.38 .87 1.50 1.97 
Time *  
Service 
Use 
.57 1.30 .33 .15 .96 .34 .21 
*p<.05, **p<.01, ***p<.001   
 
Table 111 
Means and Standard Deviations on NOSIE Subscales and Total Assets at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 
Admission 6 Months 12 Months 
NOSIE Subscales M  SD M SD M SD 
Daily Schedule Competence 
     No Service 
     Service Use 
32.84 
31.44 
6.96 
6.76 
34.27 
31.89 
5.98 
7.01 
36.68 
35.34 
3.57 
5.52 
Social Interest 
     No Service 
     Service Use 
15.01 
15.14 
5.58 
6.65 
18.95 
18.41 
 
5.96 
6.44 
19.17 
20.40 
5.38 
6.56 
Neatness 
     No Service 
     Service Use 
23.05 
22.34 
5.41 
5.85 
24.00 
22.62 
 
5.41 
5.62 
25.79 
24.72 
4.25 
4.91 
Irritability 
     No Service 
     Service Use 
4.37 
5.85 
5.44 
6.59 
5.89 
7.00 
 
6.14 
6.38 
4.59 
5.43 
4.60 
5.28 
Psychoticism 
     No Service 
     Service Use 
1.55 
1.73 
2.90 
2.68 
2.21 
3.13 
 
3.56 
4.26 
2.03 
2.70 
2.96 
3.96 
Motor Retardation 
     No Service 
     Service Use 
6.43 
7.28 
4.10 
4.60 
6.00 
6.54 
 
3.63 
4.76 
4.18 
5.35 
2.92 
3.88 
NOSIE Total Assets 
     No Service 
     Service Use 
154.54 
148.47 
23.46 
25.70 
159.12 
152.21 
22.60 
26.50 
167.02 
162.71 
16.75 
23.39 
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Table 112 
APP Severity Level by NOSIE Subscales and Total Assets Repeated Measures ANOVAs 
 NOSIE Subscales 
 
Daily 
Schedule 
Competence 
Social 
Interest Neatness Irritability Psychoticism 
Motor 
Retardation 
NOSIE 
Total 
Assets 
Variable 
F (6, 184) F (6, 184) F (6, 184) F (6, 184) F (6, 184) F (6, 184) F (6, 184) 
 
Time 23.23*** 36.58*** 19.85*** 3.40* 8.07*** 13.55*** 22.23*** 
APP 
Severity 
Level 
1.10 .73 .73 1.30 .36 1.63 1.48 
Time *  
APP .85 1.83 3.14** .40 1.58 2.03 2.20* 
*p<.05, **p<.01, ***p<.001   
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Table 113 
Means and Standard Deviations on NOSIE Subscales and Total Assets at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 Admission 6 Months 12 Months 
NOSIE Subscales M  SD M SD M SD 
Daily Schedule Competence 
     No APP 
     Low APP 
     Med APP 
     High APP 
32.84 
30.24 
30.83 
32.75 
6.96 
8.73 
6.36 
5.50 
34.27 
31.04 
33.07 
31.60 
5.98 
7.32 
6.36 
7.48 
36.68 
34.23 
36.27 
35.42 
3.57 
6.99 
3.50 
5.74 
Social Interest 
     No APP 
     Low APP 
     Med APP 
     High APP 
15.01 
13.16 
15.03 
16.60 
5.58 
6.20 
7.02 
6.62 
18.95 
16.11 
21.09 
18.00 
 
5.96 
5.45 
4.35 
7.79 
19.17 
19.64 
20.90 
20.56 
5.38 
7.09 
4.50 
7.65 
Neatness 
     No APP 
     Low APP 
     Med APP 
     High APP 
23.05 
20.42 
21.01 
24.69 
5.41 
6.71 
5.48 
4.87 
24.00 
22.06 
23.24 
22.54 
 
5.41 
5.68 
4.91 
6.27 
25.79 
24.36 
25.26 
24.57 
4.25 
5.47 
3.54 
5.57 
Irritability 
     No APP 
     Low APP 
     Med APP 
     High APP 
4.37 
6.75 
4.31 
6.38 
5.44 
7.46 
5.36 
6.90 
5.89 
7.90 
5.75 
7.31 
 
6.14 
8.64 
6.07 
4.76 
4.59 
5.30 
3.38 
7.05 
4.60 
4.70 
4.30 
5.97 
Psychoticism 
     No APP 
     Low APP 
     Med APP 
     High APP 
1.55 
1.74 
2.06 
1.48 
2.90 
2.58 
3.65 
1.90 
2.21 
3.83 
2.47 
3.13 
 
3.56 
5.50 
4.02 
3.53 
2.03 
2.39 
2.08 
3.37 
2.96 
4.32 
3.20 
4.30 
Motor Retardation 
     No APP 
     Low APP 
     Med APP 
     High APP 
6.43 
8.91 
8.39 
5.31 
4.10 
5.61 
4.70 
2.92 
6.00 
7.96 
5.56 
6.28 
 
3.63 
4.81 
3.83 
5.31 
4.18 
6.23 
4.93 
5.05 
2.92 
4.65 
2.65 
4.16 
NOSIE Total Assets 
     No APP 
     Low APP 
     Med APP 
     High APP 
154.54 
136.62 
148.09 
157.05 
23.46 
30.08 
23.25 
21.68 
159.12 
145.59 
159.65 
151.26 
22.60 
29.43 
18.94 
28.98 
167.02 
160.29 
168.03 
160.42 
16.75 
26.73 
12.23 
27.39 
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Table 114 
Service Use by BPRS Factors and BPRS Total Repeated Measures ANOVAs 
 BPRS Factors 
 BPRS Psychotic 
Disorganization 
BPRS 
Hallucination/ 
Delusions 
BPRS 
Paranoia 
BPRS 
Emotional 
Blunting 
BPRS 
Anxiety/ 
Depression 
BPRS 
Agitation
/ Elation 
BPRS 
Total 
Variable 
F (2, 128) F (2, 134) F (2, 134) F (2, 134) F (2, 134) F (2, 134) F (2, 128) 
 
Time 1.16 .82 .04 1.03 .50 .06 1.23 
Service 
Use 1.20 .47 1.75 1.20 .64 .02 .23 
Time *  
Service 
Use 
3.17* .85 .05 .19 .27 1.08 .86 
*p<.05, **p<.01, ***p<.001   
 
Table 115 
APP Severity Level by BPRS Factors and BPRS Total Repeated Measures ANOVAs 
 BPRS Factors 
 BPRS Psychotic 
Disorganization 
BPRS 
Hallucination/ 
Delusions 
BPRS 
Paranoia 
BPRS 
Emotional 
Blunting 
BPRS 
Anxiety/ 
Depression 
BPRS 
Agitation
/ Elation 
BPRS 
Total 
Variable 
F (6, 124) F (6, 184) F (6, 184) F (6, 184) F (6, 184) F (6, 184) F (6, 124) 
 
Time .88 .52 .06 .75 .25 .07 .71 
APP 
Severity 
Level 
.81 .64 .79 1.53 2.22 .24 .50 
Time *  
APP 
Severity 
1.71 .79 .46 .45 .32 .67 .57 
*p<.05, **p<.01, ***p<.001   
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Table 116 
Mean Scores and Standard Deviations for BPRS Total scores at Admission, 6 Months, 
and 12 Months as a Function of Service Use Before Age 18 
 BPRS Total Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 45.75 (10.47) 46.34 (13.75) 45.32 (14.75) 
     Service Use 49.53 (16.32) 47.13 (12.52) 44.64 (13.22) 
 
 
 
Table 117 
Mean Scores and Standard Deviations for BPRS Psychotic Disorganization Factor 
scores at Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 
18 
 BPRS Psychotic Disorganization Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 5.81 (2.13) 6.31 (2.69) 6.13 (2.91) 
     Service Use 7.45 (3.82) 6.67 (2.80) 6.12 (2.76) 
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Table 118 
Mean Scores and Standard Deviations for BPRS Hallucinations/Delusions Factor scores 
at Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 BPRS Hallucination/Delusions Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 6.83 (4.20) 6.99 (4.31) 6.80 (5.23) 
     Service Use 6.96 (4.01) 6.15 (3.87) 5.76 (3.64) 
 
 
Table 119 
Mean Scores and Standard Deviations for BPRS Paranoia Factor scores at Admission, 6 
Months, and 12 Months as a Function of Service Use Before Age 18 
 BPRS Paranoia Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 8.92 (2.86) 8.88 (3.56) 8.68 (3.40) 
     Service Use 8.01 (3.58) 8.04 (2.95) 8.04 (3.27) 
 
Table 120 
Mean Scores and Standard Deviations for BPRS Emotional Blunting Factor scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 BPRS Emotional Blunting Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 5.99 (3.64) 5.59 (2.27) 5.63 (2.53) 
     Service Use 6.77 (3.62) 6.52 (3.69) 6.12 (3.39) 
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Table 121 
Mean Scores and Standard Deviations for BPRS Anxiety/Depression Factor scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 BPRS Anxiety/Depression Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 8.55 (2.81) 8.36 (3.24) 8.42 (3.32) 
     Service Use 9.41 (4.21) 9.04 (4.55) 8.65 (3.65) 
 
 
 
 
 
Table 122 
Mean Scores and Standard Deviations for BPRS Agitation/Elation Factor scores at 
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18 
 BPRS Agitation/Elation Factor Scores 
 At Admission Six Months Twelve Months 
Service Use M (SD) M (SD) M (SD) 
     No Service Use 3.31 (1.18) 3.63 (2.38) 3.41 (1.78) 
     Service Use 3.58 (1.66) 3.28 (1.19) 3.36 (1.45) 
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Table 123 
Mean Scores and Standard Deviations for BPRS Total and Factor scores at Admission, 6 
Months, and 12 Months as a Function of APP Severity Level 
 
Admission Six Months Twelve Months 
BPRS  
APP 
Severity 
Level M (SD) M (SD) M (SD) 
BPRS Total  No APP 
Low APP 
Med APP 
High APP 
45.75 (10.47) 
49.19 (14.37) 
42.67 (9.05) 
51.52 (18.39) 
46.34 (13.75) 
47.81 (9.52) 
43.42(10.22) 
47.90 (14.19) 
45.32 (14.75) 
48.13 (14.62) 
41.33 (9.37) 
44.27 (13.83) 
BPRS Psychotic 
Disorganization Factor  
No APP 
Low APP 
Med APP 
High APP 
5.81 (2.13) 
8.00 (3.89) 
5.52 (1.52) 
7.77 (4.17) 
6.31 (2.69) 
6.80 (2.35) 
5.98 (2.48) 
6.80 (3.10) 
6.13 (2.91) 
6.94 (3.42) 
5.92 (2.25) 
5.87 (2.69) 
BPRS 
Hallucination/Delusion 
Factor  
No APP 
Low APP 
Med APP 
High APP 
6.83 (4.20) 
7.25 (3.88) 
6.17 (3.13) 
7.07 (4.37) 
6.99 (4.31) 
8.31 (5.30) 
4.58 (2.54) 
5.80 (3.40) 
6.80 (5.23) 
7.13 (5.61) 
5.67 (2.80) 
5.30 (2.99) 
BPRS Paranoia Factor  No APP 
Low APP 
Med APP 
High APP 
8.92 (2.86) 
8.68 (4.63) 
7.50 (2.21) 
7.92 (3.59) 
8.88 (3.56) 
7.90 (2.64) 
8.57 (2.36) 
7.95 (3.27) 
8.68 (3.40) 
9.22 (3.43) 
6.62 (1.95) 
7.99 (3.44) 
BPRS Emotional 
Blunting Factor  
No APP 
Low APP 
Med APP 
High APP 
5.99 (3.64) 
7.75 (2.98) 
4.75 (1.41) 
6.96 (4.09) 
5.59 (2.27) 
6.75 (2.65) 
4.08 (2.33) 
7.08 (4.10) 
5.63 (2.53) 
6.72 (2.83) 
5.00 (2.86) 
6.21 (3.73) 
BPRS 
Anxiety/Depression 
Factor  
No APP 
Low APP 
Med APP 
High APP 
8.55 (2.81) 
6.63 (1.73) 
9.25 (4.29) 
10.41 (4.47) 
8.36 (3.24) 
6.78 (2.37) 
9.67 (3.78) 
9.67 (5.15) 
8.42 (3.32) 
7.00 (1.87) 
8.67 (3.92) 
9.22 (3.98) 
BPRS Agitation/Elation 
Factor  
No APP 
Low APP 
Med APP 
High APP 
3.31 (1.18) 
3.13 (1.06) 
3.33 (.93) 
3.80 (1.95) 
3.63 (2.38) 
3.16 (1.03) 
3.08 (.97) 
3.37 (1.32) 
3.41 (1.78) 
2.94 (.73) 
3.83 (1.63) 
3.39 (1.60) 
*p<.05  
 
 
 
 
 
 
 
247 
 
Table 124 
Mean Scores and Standard Deviations for BPRS item scores at Admission, 6 Months, and 12 Months as a 
Function of Service Use Before Age 18 
Admission Six Months Twelve Months 
BPRS Items M (SD) M (SD) M (SD) 
Somatic Concern No Service 
Service Use 
2.78 (1.66) 
2.39 (1.71) 
2.58 (1.68) 
2.68 (1.54) 
2.59 (1.72) 
2.29 (1.49) 
Anxiety No Service 
Service Use 
2.39 (.97) 
2.54 (1.51) 
2.45 (1.24) 
2.53 (1.35) 
2.16 (1.25) 
2.37 (1.38) 
Depression No Service 
Service Use 
2.09 (1.11) 
2.39 (1.51) 
2.02 (1.16) 
2.20 (1.41) 
1.95 (1.07) 
2.16 (1.16) 
Suicidality No Service 
Service Use 
1.16 (.37) 
1.63 (1.26) 
1.22 (.51) 
1.57 (1.03) 
1.09 (.30) 
1.45 (1.23) 
Guilt No Service 
Service Use 
1.81 (1.38) 
2.07 (1.29) 
1.77 (1.18) 
2.13 (1.51) 
2.02 (1.49) 
2.07 (1.47) 
Hostility No Service 
Service Use 
2.44 (1.36) 
2.71 (1.63) 
2.52 (1.45) 
2.91 (1.76) 
2.64 (1.42) 
2.61 (1.71) 
Elevated Mood No Service 
Service Use 
1.44 (.91) 
1.54 (1.22) 
1.56 (1.30) 
1.25 (.68) 
1.33 (.90) 
1.45 (.98) 
Grandiosity No Service 
Service Use 
2.14 (1.78) 
1.66 (1.40) 
2.14 (1.94) 
1.76 (1.78) 
2.39 (2.14) 
1.63 (1.49) 
Suspiciousness No Service 
Service Use 
3.03 (1.85) 
2.28 (1.73) 
2.97 (2.06) 
2.21 (1.46) 
2.53 (1.81) 
2.17 (1.45) 
Hallucinations No Service 
Service Use 
1.72 (1.46) 
2.72 (2.10) 
2.17 (1.85) 
2.13 (1.68) 
2.23 (1.84) 
2.04 (1.60) 
Unusual Thought Content No Service 
Service Use 
2.97 (2.10) 
2.57 (1.99) 
2.68 (1.66) 
2.26 (1.84) 
2.17 (1.91) 
2.14 (1.69) 
Bizarre Behavior No Service 
Service Use 
1.59 (1.34) 
2.54 (1.76) 
2.08 (1.31) 
2.17 (1.45) 
1.80 (1.32) 
1.95 (1.55) 
Self-Neglect No Service 
Service Use 
1.97 (.83) 
2.46 (1.11) 
2.56 (.93) 
2.46 (.90) 
2.20 (1.05) 
1.95 (.96) 
Disorientation No Service 
Service Use 
1.41 (.76) 
1.54 (1.07) 
1.41 (.76) 
1.57 (1.13) 
1.50 (1.02) 
1.47 (1.12) 
Conceptual Disorganization No Service 
Service Use 
1.89 (1.10) 
2.14 (1.65) 
1.86 (1.26) 
1.89 (1.16) 
1.91 (1.21) 
1.69 (1.15) 
Blunted Affect No Service 
Service Use 
2.50 (1.50) 
2.78 (1.52) 
2.56 (1.12) 
2.97 (1.69) 
2.64 (1.07) 
2.82 (1.47) 
Emotional Withdrawal No Service 
Service Use 
2.19 (1.40) 
2.42 (1.30) 
2.12 (1.30) 
2.22 (1.38) 
2.12 (1.18) 
2.11 (1.18) 
Motor Retardation No Service 
Service Use 
2.05 (1.19) 
2.20 (1.27) 
1.67 (.99) 
1.93 (1.16) 
1.67 (.88) 
1.82 (1.06) 
Tension No Service 
Service Use 
1.67 (.91) 
1.55 (.82) 
1.52 (.91) 
1.51 (.87) 
1.75 (1.04) 
1.30 (.78) 
Uncooperativeness No Service 
Service Use 
1.70 (1.09) 
1.50 (.99) 
1.72 (1.14) 
1.49 (.80) 
1.64 (1.30) 
1.85 (1.16) 
Excitement No Service 
Service Use 
1.48 (.82) 
1.27 (.73) 
1.53 (1.22) 
1.20 (.60) 
1.63 (1.19) 
1.27 (.89) 
Distractibility No Service 
Service Use 
1.72 (.92) 
1.99 (1.42) 
1.59 (1.16) 
1.76 (1.23) 
1.88 (1.28) 
1.70 (1.10) 
Motor hyperactivity No Service 
Service Use 
1.30 (.49) 
1.20 (.64) 
1.45 (1.10) 
1.23 (.63) 
1.53 (1.09) 
1.18 (.65) 
Mannerisms and Posturing No Service 
Service Use 
1.30 (.60) 
1.26 (.65) 
1.07 (.37) 
1.14 (.54) 
1.27 (.73) 
1.31 (.94) 
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Table 125 
Mean Scores and Standard Deviations for BPRS item scores at Admission, 6 Months, and 
12 Months as a Function of APP Severity Level 
Admission Six Months Twelve Months 
BPRS Items APP Severity Level M (SD) M (SD) M (SD) 
Somatic Concern No APP 
Low APP 
Med APP 
High APP 
2.78 (1.66) 
1.63 (.92) 
2.67 (2.09) 
2.58 (1.79) 
2.58 (1.68) 
2.56 (1.64) 
3.33 (1.63) 
2.56 (1.51) 
2.59 (1.72) 
2.62 (1.62) 
1.42 (.80) 
2.40 (1.54) 
Anxiety No APP 
Low APP 
Med APP 
High APP 
2.39 (.97) 
1.63 (.74) 
2.33 (1.97) 
2.90 (1.49) 
2.45 (1.24) 
2.06 (1.27) 
2.67 (.98) 
2.66 (1.47) 
2.16 (1.25) 
2.31 (.88) 
2.50 (1.76) 
2.35 (1.47) 
Depression No APP 
Low APP 
Med APP 
High APP 
2.09 (1.11) 
1.50 (.54) 
2.58 (1.56) 
2.65 (1.64) 
2.02 (1.16) 
1.50 (1.07) 
2.25 (1.41) 
2.42 (1.49) 
1.95 (1.07) 
1.63 (.74) 
2.42 (1.39) 
2.27 (1.21) 
Suicidality No APP 
Low APP 
Med APP 
High APP 
1.16 (.37) 
1.00 (.00) 
1.83 (.98) 
1.79 (1.47) 
1.22 (.51) 
1.19 (.53) 
1.33 (.52) 
1.75 (1.21) 
1.09 (.30) 
1.13 (.35) 
1.00 (.00) 
1.67 (1.50) 
Guilt No APP 
Low APP 
Med APP 
High APP 
1.81 (1.38) 
1.25 (.46) 
1.75 (.99) 
2.42 (1.41) 
1.77 (1.18) 
1.13 (.35) 
2.58 (1.74) 
2.35 (1.59) 
2.02 (1.49) 
1.25 (.54) 
2.08 (1.11) 
2.33 (1.67) 
Hostility No APP 
Low APP 
Med APP 
High APP 
2.44 (1.36) 
2.38 (1.51) 
2.67 (1.37) 
2.83 (1.76) 
2.52 (1.45) 
2.06 (1.43) 
3.17 (1.72) 
3.13 (1.85) 
2.64 (1.42) 
3.00 (2.25) 
1.92 (1.20) 
2.65 (1.63) 
Elevated Mood No APP 
Low APP 
Med APP 
High APP 
1.44 (.91) 
1.25 (.46) 
1.42 (.67) 
1.67 (1.47) 
1.56 (1.30) 
1.13 (.35) 
1.25 (.42) 
1.29 (.81) 
1.33 (.90) 
1.25 (.71) 
2.33 (1.63) 
1.29 (.75) 
Grandiosity No APP 
Low APP 
Med APP 
High APP 
2.14 (1.78) 
1.88 (1.73) 
1.67 (1.63) 
1.58 (1.27) 
2.14 (1.94) 
3.75 (2.66) 
1.00 (.00) 
1.29 (1.08) 
2.39 (2.14) 
2.25 (2.32) 
1.67 (1.63) 
1.42 (1.09) 
Suspiciousness No APP 
Low APP 
Med APP 
High APP 
3.03 (1.85) 
2.63 (2.07) 
1.67 (.82) 
2.31 (1.79) 
2.97 (2.06) 
2.81 (2.45) 
2.42 (.97) 
1.96 (1.08) 
2.53 (1.81) 
2.94 (1.78) 
1.75 (1.41) 
2.02 (1.31) 
Hallucinations No APP 
Low APP 
Med APP 
High APP 
1.72 (1.46) 
2.13 (2.10) 
2.67 (2.25) 
2.94 (2.11) 
2.17 (1.85) 
1.63 (1.41) 
2.00 (1.27) 
2.33 (1.86) 
2.23 (1.84) 
2.13 (1.81) 
2.17 (2.04) 
1.98 (1.49) 
Unusual Thought 
Content 
No APP 
Low APP 
Med APP 
High APP 
2.97 (2.10) 
3.25 (2.19) 
1.83 (1.60) 
2.52 (2.01) 
2.68 (1.66) 
2.94 (2.28) 
1.58 (1.43) 
2.20 (1.76) 
2.17 (1.91) 
2.75 (2.14) 
1.83 (1.33) 
2.00 (1.62) 
Bizarre Behavior No APP 
Low APP 
Med APP 
High APP 
1.59 (1.34) 
2.81 (1.89) 
1.33 (.52) 
2.75 (1.84) 
2.08 (1.31) 
2.13 (1.53) 
1.92 (1.20) 
2.25 (1.53) 
1.80 (1.32) 
2.56 (1.99) 
1.83 (1.60) 
1.77 (1.40) 
Self-Neglect No APP 
Low APP 
Med APP 
High APP 
1.97 (.83) 
2.38 (1.06) 
2.67 (.52) 
2.44 (1.25) 
2.56 (.93) 
2.44 (.62) 
2.42 (.92) 
2.48 (.99) 
2.20 (1.05) 
2.25 (.93) 
2.67 (1.03) 
1.67 (.86) 
Disorientation No APP 
Low APP 
Med APP 
High APP 
1.41 (.76) 
2.63 (1.69) 
1.00 (.00) 
1.30 (.64) 
1.41 (.76) 
2.56 (1.80) 
1.33 (.82) 
1.28 (.65) 
1.50 (1.02) 
2.19 (1.69) 
1.17 (.41) 
1.30 (.93) 
 
249 
Conceptual 
Disorganization 
No APP 
Low APP 
Med APP 
High APP 
1.89 (1.10) 
2.75 (1.75) 
1.50 (1.23) 
2.09 (1.70) 
1.86 (1.26) 
2.38 (1.41) 
1.33 (.82) 
1.87 (1.12) 
1.91 (1.21) 
2.13 (1.46) 
1.50 (1.23) 
1.59 (1.02) 
Blunted Affect No APP 
Low APP 
Med APP 
High APP 
2.50 (1.50) 
3.25 (1.49) 
1.67 (.82) 
2.91 (1.58) 
2.56 (1.12) 
2.94 (1.61) 
2.00 (1.10) 
3.24 (1.80) 
2.64 (1.07) 
3.25 (1.51) 
1.92 (1.11) 
2.91 (1.50) 
Emotional 
Withdrawal 
No APP 
Low APP 
Med APP 
High APP 
2.19 (1.40) 
2.88 (1.13) 
1.83 (1.17) 
2.41 (1.37) 
2.12 (1.30) 
2.44 (.94) 
1.50 (1.23) 
2.33 (1.53) 
2.12 (1.18) 
2.38 (1.06) 
2.08 (1.02) 
2.02 (1.28) 
Motor Retardation No APP 
Low APP 
Med APP 
High APP 
2.05 (1.19) 
2.25 (1.04) 
1.75 (.61) 
2.30 (1.47) 
1.67 (.94) 
1.88 (.84) 
1.17 (.41) 
2.15 (1.31) 
1.67 (.88) 
1.75 (.89) 
1.58 (.92) 
1.91 (1.17) 
Tension No APP 
Low APP 
Med APP 
High APP 
1.67 (.91) 
1.75 (1.04) 
1.67 (.82) 
1.46 (.75) 
1.52 (.91) 
1.50 (1.07) 
1.50 (.55) 
1.52 (.90) 
1.75 (1.04) 
1.25 (.46) 
1.17 (.41) 
1.35 (.94) 
Uncooperativeness No APP 
Low APP 
Med APP 
High APP 
1.70 (1.09) 
2.00 (1.31) 
1.67 (1.03) 
1.28 (.81) 
1.72 (1.14) 
1.63 (.52) 
1.50 (.55) 
1.43 (.95) 
1.64 (1.30) 
1.88 (1.13) 
1.67 (1.03) 
1.89 (1.24) 
Excitement No APP 
Low APP 
Med APP 
High APP 
1.48 (.82) 
1.25 (.46) 
1.00 (.00) 
1.35 (.89) 
1.53 (1.22) 
1.00 (.00) 
1.17 (.41) 
1.28 (.72) 
1.63 (1.19) 
1.31 (.70) 
1.17 (.41) 
1.28 (1.05) 
Distractibility No APP 
Low APP 
Med APP 
High APP 
1.72 (.92) 
1.88 (.84) 
1.50 (.84) 
2.15 (1.68) 
1.59 (1.16) 
1.63 (.74) 
1.83 (1.60) 
1.78 (1.30) 
1.88 (1.28) 
1.81 (1.00) 
1.50 (.84) 
1.72 (1.20) 
Motor 
hyperactivity 
No APP 
Low APP 
Med APP 
High APP 
1.30 (.49) 
1.38 (.74) 
1.00 (.00) 
1.20 (.69) 
1.45 (1.10) 
1.44 (1.05) 
1.17 (.41) 
1.17 (.49) 
1.53 (1.09) 
1.13 (.35) 
1.00 (.00) 
1.24 (.80) 
Mannerisms and 
Posturing 
No APP 
Low APP 
Med APP 
High APP 
1.30 (.60) 
1.50 (.76) 
1.00 (.00) 
1.25 (.69) 
1.07 (.37) 
1.13 (.35) 
1.00 (.00) 
1.18 (.66) 
1.27 (.73) 
1.00 (.00) 
1.00 (.00) 
1.50 (1.18) 
*p<.05  
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Table 126 
Relationship Between Level of Discharge Location Restrictiveness 
and Service Use Before Age 18 (N=242) 
 
                                                                                                      Service Use 
Discharge Location Restrictiveness No Service Use Service Use Total 
 
1 – Same or Higher Restrictiveness (LRC Transfer)  13 13 26 
 
2 - Psychiatric Residential Rehabilitation 42 55 97 
 
3 - Assisted Living 33 48 81 
 
4 – Independent Living/Living with Family 20 18 38 
 
Total 108 134 242 
 
 
 
 
 
 
Table 127 
Relationship Between Level of Discharge Location Restrictiveness  
 and APP Severity Level (N=242) 
 
                                                                                                      APP Severity Level 
Discharge Location Restrictiveness No  Low Med High Total 
 
1 – Same or Higher Restrictiveness (LRC Transfer)  13 1 1 11 26 
 
2 - Psychiatric Residential Rehabilitation 42 8 15 32 97 
 
3 - Assisted Living 33 8 10 30 81 
 
4 – Independent Living/Living with Family 20 2 3 13 38 
 
Total 108 19 29 86 242 
 
 
